10-Q

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

_________________

FORM 10-Q

_________________

x    QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended: September 30, 2013

or

o    TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from: ______ to ______

_________________

OrGANIC ALLIANCE, INC.

(Exact name of registrant as specified in its charter) 

_________________

Nevada	000-51119	26-1997130
(State or Other Jurisdiction	(Commission	(I.R.S. Employer
of Incorporation or Organization)	File Number)	Identification No.)

PO Box 6465, Carmel, CA 93921
(Address of Principal Executive Offices) (Zip Code)

(386)409--0200
(Registrant’s telephone number, including area code)

N/A
(Former name or former address and former fiscal year, if changed since last report)

_________________

(Registrant’s telephone number)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes x No o

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes x No o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” as defined in Rule 12b-2 of the Exchange Act. (Check one):

Large accelerated filer  o Accelerated filer  o Non-accelerated filer  o Smaller reporting company  x

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).     Yes o     No x

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.

Class	Outstanding at December 31, 2013
Common stock, $0.0001 par value	18,473,554

ORGANIC ALLIANCE, INC.

FORM 10-Q

TABLE OF CONTENTS

		Page
PART I - FINANCIAL INFORMATION
ITEM 1.	FINANCIAL STATEMENTS
	Condensed Consolidated Balance Sheets as of September 30, 2013 (unaudited) and December 31, 2012	F-1
	Condensed Consolidated Statements of Operations for the three and nine months ended September 30, 2013 and 2012 and Development Stage from July 1, 2013 to September 30, 2013 (unaudited)	F-2
	Condensed Consolidated Statements of Cash Flows for the nine months ended September 30, 2013 and 2012 and Development Stage from July 1, 2013 to September 30, 2013 (unaudited)	F-3
	Notes to Condensed Consolidated Financial Statements (unaudited)	F-4
ITEM 2.	MANAGEMENTS DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS	3
ITEM 3.	QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK	11
ITEM 4.	CONTROLS AND PROCEDURES	11
PART II - OTHER INFORMATION

ITEM 1.	LEGAL PROCEEDINGS	12
ITEM 2.	UNREGISTERED SALE OF EQUITY SECURITIES AND USE OF PROCEEDS	13
ITEM 3.	DEFAULTS UPON SENIOR SECURITIES	13
ITEM 6.	EXHIBITS	14
SIGNATURES		15

PART I - FINANCIAL INFORMATION

Organic Alliance Inc.
(A Development Stage Company)
Condensed Consolidated Balance Sheet
	As of
	September 30, 2013			December 31, 2012
	(Unaudited)
Assets
Current assets:
Cash	$	1,431		$	159,346
Accounts receivable, net		—			211,288
Inventory		—			139,888
Prepaid expenses and other current assets		9,752			98,074
Total current assets		11,183			608,596
Total Assets	$	11,183		$	608,596
Liabilities and Stockholders' Deficiency
Current liabilities:
Accounts payable	$	1,537,313		$	993,240
Due to factor		118,561			213,778
Accrued expenses and other current liabilities		1,828,834			1,734,863
Derivative liabilities		1,393,054			432,030
Notes payable to related parties and others, net of discounts		4,972,257			3,936,955
Total current liabilities		9,850,019			7,310,866
Commitments and contingencies
Stockholders' Deficiency:
Preferred stock, no stated value;
10,000,000 shares authorized; -0- shares issued
and outstanding as of September 30, 2013 and December 31, 2012		—			—
Common stock, $.0001 par value, 100,000,000 shares
authorized, 18,473,554 and 17,795,376 shares issued and outstanding
as of September 30, 2013 and December 31, 2012, respectively;  In addition,
36,300,000 and 0 shares issued in reserve and outstanding at
September 30, 2013 and December 31, 2012, respectively		1,848			1,780
Additional paid-in capital		14,287,582			13,872,597
Accumulated deficit		(22,478,147	)		—
Deficit accumulated during the development stage		(1,650,119	)		(20,576,647	)
Total stockholders' deficiency		(9,838,836	)		(6,702,270	)
Total Liabilities and Stockholders' Deficiency	$	11,183		$	608,596
The accompanying notes are an integral part of these condensed consolidated financial statements.

F-1

Organic Alliance Inc.
(A Development Stage Company)
Condensed Consolidated Statements of Operations (Unaudited)
													Development Stage Period from
	For the Three Months Ended						For the Nine Months Ended						July 1, 2013 to
	September 30, 2013			September 30, 2012			September 30, 2013			September 30, 2012			September 30, 2013
Revenue	$	—		$	335,456		$	981,205		$	1,301,757			—
Cost of sales		—			304,274			861,180			1,177,694			—
Gross margin		—			31,182			120,025			124,063			—
General and administrative expenses		297,235			564,486			1,809,087			2,118,500			297,235
Operating loss		(297,235	)		(533,304	)		(1,689,062	)		(1,994,437	)		(297,235	)
Other expense:
Interest expense		252,434			806,428			1,055,501			1,612,249			252,434
Change in fair value of derivative liability		1,100,450			2,274,621			807,056			4,272,565			1,100,450
Total other expense		1,352,884			3,081,049			1,862,557			5,884,814			1,352,884
Net loss	$	(1,650,119	)	$	(3,614,353	)	$	(3,551,619	)	$	(7,879,251	)		(1,650,119	)
Basic and diluted loss per share	$	(0.08	)	$	(0.21	)	$	(0.18	)	$	(0.46	)
Weighted average number of common
shares outstanding - basic and diluted		19,629,743			16,971,814			19,519,853			17,228,350
The accompanying notes are an integral part of these condensed consolidated financial statements.

F-2

Organic Alliance Inc.
(A Development Stage Company)
Condensed Consolidated Statements of Cash Flows (Unaudited)
							Development Stage
							Period from
	For the Nine Months Ended						July 1, 2013 to
	September 30, 2013			September 30, 2012			September 30, 2013
Cash flows from operating activities:
Net loss	$	(3,551,619	)	$	(7,879,251	)	$	(1,650,119	)
Adjustments to reconcile net loss to net cash used in operating activities:
Common stock issued for services		55,000			47,250			—
Share-based compensation		330,266			587,456			31,277
Non-cash interest		535,570			77,172			181,941
Provision for doubtful accounts		2,001			(500	)		2,001
Change in fair value of derivative liability		843,338			4,272,565			1,136,732
Amortization on discount of note payable		433,638			1,067,539			30,196
Changes in operating assets and liabilities:
Accounts receivable		209,287			(79,679	)		36,577
Inventory		139,888			(244,630	)		75,228
Prepaid expenses and other current assets		88,322			(37,955	)		60,975
Accounts payable		544,073			(99,560	)		51,856
Accrued expenses and other current liabilities		127,543			242,629			11,555
Net cash used in operating activities		(242,693	)		(2,046,964	)		(31,781	)
Cash flows from financing activities
Proceeds from notes and loans payable		190,995			2,055,000			96,167
Principal payments on note payable		(11,000	)		(8,000	)		—
Cash  overdraft		—			—			(34,536	)
Net advances (repayments) from/to factor		(95,217	)		66,755			(28,419	)
Net cash provided by financing activities		84,778			2,113,755			33,212
Net decrease in cash		(157,915	)		66,791			1,431
Cash - beginning of the period		159,346			5,852			—
Cash - end of the period	$	1,431		$	72,643		$	1,431
Supplemental disclosures:
Interest paid	$	85,145		$	467,538		$	39,151
Supplemental disclosure for non-cash financing activities:
Discount on notes payable	$	113,901		$	1,343,248		$	84,500
Reclassification of derivative liabilities upon conversion of note	$	—		$	1,787,541		$	—
Issuance of common stock to convert notes payable	$	—		$	12,380		$	—
Issuance of common stock to settle liability	$	33,572		$	1,146,702		$	—
The accompanying notes are an integral part of these condensed consolidated financial statements.

F-3

Organic Alliance, Inc. and Subsidiary

(A Development Stage Company)

Notes to Condensed Consolidated Financial Statements (unaudited)

1.  NATURE OF BUSINESS

Organic Alliance, Inc. is a global grower and marketer of organic, Fair Trade and conventional fresh fruits and vegetables. By establishing collaborative relationships with key growers, the Company has built a vertically integrated supply chain that enables it to support its customers with an increasing variety of certified sustainable products, sensible pricing, steady supply and inspiring multi-media stories from our many producing communities.

History - NB Design & Licensing, Inc. (“NB Design”), a Nevada corporation, was organized in September 2001. Its former parent, New Bridge Products, Inc., incorporated in August 1995 as a manufacturer of minivans, filed a petition in bankruptcy under Chapter 11 of the U.S. Bankruptcy Code. Its Plan of Reorganization was approved by the U.S. Bankruptcy Court for the District of Arizona in September 2002, and NB Design was discharged from bankruptcy in October 2002. NB Design was inactive from October 2002 to April 29, 2008.

Organic Alliance, Inc., a Texas corporation (“Organic Texas”) was organized on February 19, 2008 to sell organically grown fruits and vegetables. During the second quarter of 2009, it ceased being a development stage company when it commenced its operations.

On April 29, 2008, NB Design acquired all 10,916,917 issued and outstanding shares of common stock of Organic Texas for 464,999 shares of the NB Design’s common stock. Organic Texas thereupon became a wholly-owned subsidiary of NB Design. The business of Organic Texas is the only business of NB Design. The Company operates in California.

The acquisition of Organic Texas, a private operating company, by NB Design, a non-operating public shell corporation with nominal net assets, was accounted for as a reverse capitalization in accordance with the Securities and Exchange Commission’s (“SEC”) Division of Corporate Financial Reporting manual Topic 12 “Reverse Acquisition and Reverse Capitalization”. As such, the acquisition was treated as a capital transaction rather than a business combination, and no goodwill was recorded. NB Design was the legal acquirer because it issued its equity interests, and Organic Texas was the legal acquiree because its equity interests were acquired. However, NB Design was the acquiree and Organic Texas was the acquirer for accounting purposes. Organic Texas is treated as the continuing reporting entity that acquired the registrant, NB Design. The pre-acquisition financial statements of Organic Texas are treated as the historical financial statements of the consolidated companies.

On June 2, 2008, NB Design changed its name to Organic Alliance, Inc. On August 29, 2008, Organic Texas changed its name to Organic Texas, Inc. All references throughout this report to “Organic Alliance, Inc.” or the “Company” refers to Organic Alliance, Inc. and its wholly-owned subsidiary, Organic Texas, except where the context makes clear that the reference is only to Organic Alliance, Inc.

On July 1, 2013, the Company temporarily suspended operations and elected to enter the development stage. The Company will be pursuing other business opportunities in addition to the organic and Fair Trade certified fruits and vegetables global market.

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Development Stage – The Company is considered to be in the development stage as defined in ASC 915, “Accounting and Reporting by Development Stage Enterprises”.

On July 1, 2013, the Company temporarily suspended operations and elected to enter the development stage. All inventories and deposits from the former operations were written off as of July 1, 2013.

Due to unfavorable financing conditions and inability to obtain suitable financing, the Company has determined that it will develop other markets in addition to the organic and Fair Trade certified fruits and vegetables global market.

Basis of Presentation - The Company's unaudited condensed consolidated financial statements have been prepared on an accrual basis of accounting, in conformity with accounting principles generally accepted in the United States of America (US GAAP) for interim financial information applicable for a going concern, which assumes that the Company will realize its assets and discharge its liabilities in the ordinary course of the business, and in accordance with the instructions for Form 10-Q and Article 10 of Regulation S-X promulgated under the Securities Exchange Act of 1934, as amended. Certain information and disclosures included in the financial statements prepared in accordance with US GAAP have been condensed or omitted pursuant to such rules and regulations.

In the opinion of management, the condensed consolidated financial statements contain all material adjustments, consisting

F-4

only of normal recurring adjustments necessary to present fairly the financial condition, results of operations, and cash flows of the Company for the interim periods presented.

The results for the three and nine months ended September 30, 2013 are not necessarily indicative of the results of operations for the full year. These financial statements and related footnotes should be read in conjunction with the consolidated financial statements and footnotes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2012 filed with the Securities and Exchange Commission on June 13, 2013.

Use of Estimates - The preparation of consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Significant estimates that are particularly sensitive to change in the near term include, but are not limited to, realization of deferred tax assets, allowance for doubtful accounts, and assumptions used in derivative valuations and share based payment transactions. Actual results could differ from those estimates.

Principles of Consolidation - The consolidated financial statements include the accounts of Organic Alliance, Inc. and its wholly-owned subsidiary, Organic Texas, Inc. (collectively, the “Company”). All significant inter-company transactions and balances have been eliminated in consolidation.

Allowance for Doubtful Accounts - An allowance for uncollectible accounts receivable is recorded based on a combination of aging analysis, past practices and any specific troubled accounts. The Company’s produce is sold to the Company’s customers for cash or on credit terms which are established in accordance with local and industry practices and typically require payment within 10 to 30 days of delivery. Accounts are written off when uncollectibility is confirmed. Subsequent recoveries, if any, are credited to the allowance account. The allowance for doubtful accounts amounted to $7,001 and $5,000 at September 30, 2013 and December 31, 2012, respectively.

In addition, the Company factors its receivables with full recourse and, as a result, accounts for the factoring akin to a secured borrowing, maintaining the gross receivable asset and due to factor liability on its books and records. In connection with the factoring of its receivables, the Company estimates an allowance for factoring fees associated with the collections. These fees range from 3% to 5% depending on the actual timing of the collection. The actual recognition and amount of such fees may differ from the estimates depending upon the timing of collections. The Company has not factored any receivables since May 2013.

Inventory - Inventory is stated at the lower of cost (first-in, first-out) or market. All inventories were written off as of July 1, 2013. At December 31. 2012, inventory included principally produce the Company purchased from growers ($34,547) and packaging materials ($105,341). The Company held $139,888 of inventory as of December 31, 2012.

Income Taxes - The Company uses the asset and liability method of accounting for income taxes in accordance with ASC Topic 740, “Income Taxes”. Under this method, income tax expense is recognized for the amount of (i) taxes payable or refundable for the current year and (ii) deferred tax consequences of temporary differences resulting from matters that have been recognized in an entity’s financial statements or tax returns. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the results of operations in the period that includes the enactment date. A valuation allowance is provided to reduce the deferred tax assets reported if based on the weight of the available positive and negative evidence, it is more likely than not some portion or all of the deferred tax assets will not be realized.

Fair Value of Financial Instruments - The carrying amounts of financial instruments, including cash, receivables, accounts payable and accrued expenses approximated fair value as of the balance sheet dates presented, because of the relatively short maturity dates on these instruments. The carrying amounts of the notes payable issued approximate fair value as of the balance sheet dates presented, because interest rates and other terms on these instruments approximate terms currently available on similar instruments.

Derivative Financial Instruments - The Company does not use derivative instruments to hedge exposures to cash flow, market or foreign currency risks. The Company evaluates all of its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement of the instrument could be required within 12 months of the balance sheet date.

F-5

The accounting treatment of derivative financial instruments requires that the Company record the conversion option and related warrants at their fair values as of the inception date of the agreements, and at fair value as of each subsequent balance sheet date. As a result of entering into the convertible notes, the Company is required to classify certain non-employee warrants as derivative liabilities and record them at their fair values at each balance sheet date. Any change in fair value was recorded as a change in the fair value of derivative liabilities for each reporting period at each balance sheet date. The Company reassesses the classification at each balance sheet date. If the classification changes as a result of events during the period, the contract is reclassified as of the date of the event that caused the reclassification.

The fair value of conversion options at a fixed number of shares are recorded using the intrinsic value method. Conversion options at variable rates and any options and warrants with ratchet provisions are deemed to contain a “down-round protection”. Accordingly, they do not meet the scope exception for treatment as a derivative under ASC 815 since “down-round protection” is not an input into the calculation of the fair value of the equity instruments and cannot be considered “indexed to the Company’s own stock”, which is a requirement for the scope exception as outlined under ASC 815.

The Company signed convertible notes and has determined that a conversion option is embedded in the note and it is required to bifurcate the conversion option from the host contract under ASC 815 and account for the derivatives at fair value. The estimated fair value of the conversion option was determined using the binomial model. The fair value of the conversion option will be classified as a liability until the debt is converted by the note holders or paid back by the Company. The fair value will be affected by changes in inputs to that model including our stock price, expected stock price volatility, the contractual term, and the risk-free interest rate. The Company will continue to classify the fair value of the conversion option as a liability until the conversion option is exercised, expires or is amended in a way that would no longer require these conversion options to be classified as a liability, whichever comes first. The Company has adopted a sequencing policy that reclassifies contracts (from equity to assets or liabilities) with the most recent inception date first. Thus any available shares are allocated first to contracts with the most recent inception dates.

For the binomial lattice options pricing model, the Company used the following assumptions and weighted average fair value ranges for the nine months ended September 30:

	2013	2012
Risk-free interest rate	0.02%-0.63%	0.14%-0.31%
Dividend yield	N/A	N/A
Expected volatility	26.4%-48.7%	31.6%-56.0%
Expected life in months and years	3 months – 2.8 years	3 months – 4.3 years

Since the Company’s common is thinly traded, the expected volatility is based on the average historical stock volatility data for three similar public companies over the expected term of the derivative financial instrument.

Revenue Recognition - Revenue is recorded when (1) the customer accepts delivery of the product, title has been transferred, and the Company has no significant obligations remaining to be performed; (2) a final understanding as to specific nature and terms of the agreed upon transaction has occurred; (3) price is fixed and (4) collection is reasonably assured.

Share Based Compensation – The Company accounts for share-based compensation in accordance with the fair value recognition provisions of the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) No. 718. For employees and directors, the fair value of the award is measured on the grant date, and for non-employees the fair value of the award is generally re-measured on interim financial reporting dates until the service period is complete.

Option valuation models require the input of highly subjective assumptions, including the expected life of the option, and such assumptions can materially affect the fair value estimate. The fair value of share-based payment awards was estimated using the Black-Scholes option pricing model. The Company uses historical data to estimate option exercise and employee termination within the valuation model; separate groups of employees that have similar historical exercise behavior are considered separately for valuation purposes. The expected term of options granted is derived from the output of the option valuation model and represents the period of time that options granted are expected to be outstanding. The risk-free interest rate for periods within the contractual life of the option is based on the U.S. Treasury yield curve in effect at the time of grant.

F-6

For the Black-Scholes pricing model, the Company used the following assumptions and weighted average fair value ranges for the nine months ended September 30:

	2013	2012
Risk-free interest rate	0.34%-2.54%	0.32%-2.54%
Dividend yield	N/A	N/A
Expected volatility	34.7%-54.2%	36.4%-50.2%
Expected life in years	3-7	2.5-7

Concentrations - The Company maintains cash balances at various high quality federally insured financial institutions, with balances at times, in excess of federally insured limits. Management believes that the financial institutions that hold the Company’s deposits are financially sound and therefore pose a minimum credit risk. The Company has not experienced any losses in such accounts.

The Company had no sales, receivables or purchases during the three months ended September 30, 2013.

Net Loss Per Share - Basic loss per share was computed using the weighted average number of outstanding common shares. Diluted loss per share includes the effect of dilutive common stock equivalents from the assumed exercise of options, warrants and convertible notes. Common stock equivalents were excluded in the computation of diluted loss per share since their inclusion would be anti-dilutive.

In accordance with ASC 260 “Earnings per Share”, the Company has given effect to the issuance of warrants to purchase approximately 1,100,000 shares of the Company’s common stock as of September 30, 2013 and 2012, exercisable at $0.01. These warrants have been included in computing the basic net loss per share for the three and nine months ended September 30, 2013 and 2012. Additionally, included in the Company’s weighted average shares outstanding are 56,189 shares earned, but not issued, as at September 30, 2013 and 2012.

Total common stock equivalents which were excluded (since their inclusion would be anti-dilutive) are those shares issuable upon the exercise of warrants, options and the conversion of convertible notes, as of September 30, 2013 and 2012 were as follows:

	September 30,
	2013		2012
Options		7,717,896		4,455,177
Warrants		14,004,927		9,104,403
Convertible notes (1)		89,155,749		4,938,403
Total Common stock equivalents		110,878,572		18,497,983

Due to the insufficient authorized but unissued shares of common stock to meet the required amount of shares for options, warrants and convertible instruments, the Company has accounted for the excess in common stock equivalents as a derivative liability in accordance with FASB ASC 815 Derivatives and Hedging.  Accordingly, the derivative is marketed to market through earnings at the end of each reporting period.  For the three and nine months ended September 30, 2013 the Company has recorded an expense of $25,047, as a part of the derivative liability on the accompanying condensed balance sheet.

(1) At September 30, 2013, the Company reserved 36,300,000 shares of Common Stock from its authorized shares, which covers 8,442,099 shares of common stock issuable upon conversion of certain convertible notes. The remaining 80,713,650 shares of common stock issuable upon conversion of convertible notes are not covered by reserve shares. There were no reserves shares at September 30, 2012.

Recently Issued Accounting Standards

Management does not believe that any recently issued, but not effective, accounting standards, if currently adopted, would have a material effect on the Company’s financial statements.

F-7

3 . GOING CONCERN

The condensed consolidated financial statements have been prepared using accounting principles generally accepted in the United States of America applicable for a going concern, which assume that the Company will realize its assets and discharge its liabilities in the ordinary course of business. As of September 30, 2013, the Company had limited cash, a working capital deficit of approximately $9,839,000, accumulated losses of approximately $24,128,000 since its inception of which $1,650,119 are deficits accumulated during the development stage, and has $320,622 of payroll tax liabilities inclusive of penalties and interest withheld from wages paid which have yet to be remitted to the taxing authorities and are delinquent. The Company currently is delinquent with its payroll tax filings since December 31, 2008; however, since April 1, 2012 the Company has been remitting payroll tax on a current basis. The Company ceased paying payroll beginning May 1, 2013. Most employees were furloughed or resigned by May 31, 2013. At September 30, 2013, the Company was not compliant with the repayments terms of various notes payable for an aggregate of approximately $4,838,000 including accrued interest. Its ability to continue as a going concern is dependent upon the ability of the Company to obtain the necessary financing to meet its obligations and pay its liabilities arising from normal business operations when they come due, and increasing its revenue in order to achieve profitable operations. The outcome of these matters cannot be predicted with any certainty at this time and raise substantial doubt that the Company will be able to continue as a going concern. These consolidated financial statements do not include any adjustments to the amounts and classification of assets and liabilities that may be necessary should the Company be unable to continue as a going concern.

The Company intends to overcome the circumstances that impact its ability to remain a going concern through pursing new business opportunities, with interim cash flow deficiencies being addressed through additional equity and debt financing. The Company anticipates raising additional funds through public or private financing, strategic relationships or other arrangements in the near future to support its business operations; however the Company does not have commitments from third parties for a sufficient amount of additional capital, the Company cannot be certain that any such financing will be available on acceptable terms, or at all, and its failure to raise capital when needed could limit its ability to continue or resume its operations. The Company’s ability to obtain additional funding will determine its ability to continue as a going concern. Furthermore, additional equity financing may be dilutive to the holders of the Company’s common stock, and debt financing, if available, may involve restrictive covenants or may require that the Company relinquish valuable rights.

4 . DUE TO FACTOR

On November 1, 2010, the Company signed a one year agreement with a financial services company for the purchase and sale of accounts receivables which expired on October 31, 2011. The agreement is continuing on a month to month basis. The financial services company commenced funding during February 2011. The financial services company advances up to 80% of qualified customer invoices, less applicable discount fees, and holds the remaining 20% as a reserve until the customer pays the financial services company. The released reserves are used to fund other vendor purchases or returned to the Company. The Company is charged 3% for the first 30 days outstanding plus 1/10 of 1% daily for funds outstanding over 30 days. Uncollectable customer invoices are charged back to the Company. At September 30, 2013 and December 31, 2012 the advances from the factor, inclusive of fees, amounted to $118,561 and $213,778, respectively. Advances from the factor are collateralized by substantially all assets of the Company. The Company is in default of this agreement.

5 . PREFERRED STOCK

The Company’s articles of incorporation authorize its Board of Directors to issue up to 10,000,000 shares of preferred stock in one or more series without stockholder approval. Each such series of preferred stock may have such number of shares, designations, preferences, voting powers, qualifications, and special or relative rights or privileges as are determined by The Company’s Board of Directors. At September 30, 2013 and December 31 2012, no shares of preferred stock were issued or outstanding.

6. EQUITY TRANSACTIONS

During March 2013, the Company issued 500,000 shares of the Company’s common stock to a consultant for investor and public relations services. The fair value of the award was fully vested on the date of issuance and accordingly the Company recorded a charge for stock based compensation of $55,000 or $0.11 per share in the accompanying condensed consolidated statements of operations.

F-8

7.  NOTES PAYABLE, LOANS AND DERIVATIVE LIABILITIES

Notes payable to related parties and others, net of discounts consist of the following:

	September 30,		December 31,
	2013		2012
	(unaudited)
Notes Payable (net of debt discount $0 and $133,827 at September 30, 2013 and December 31, 2012, respectively) (A)	$	2,995,390	$	2,512,753
Notes Payable – Related Parties (net of debt discount of $0 and $47,673 at September 30, 2013 and December 31, 2012, respectively) (B)		671,257		509,696
Convertible Notes Payable (net of debt discount of $79,298and  $217,535 at September 30, 2013 and at December 31, 2012, respectively) (C)		1,305,610		914,506
Totals	$	4,972,257	$	3,936,955

(A) Notes Payable

i. In May 2010, an individual advanced to the Company $20,000 bearing interest at 6% per annum. As a financing incentive, the individual received a warrant to purchase 20,000 shares of the Company’s common stock at $1.00 per share. The warrants expired in November 2011. The gross proceeds of the note were recorded net of a debt discount of $9,200. The debt discount consisted of the relative fair value of the warrant of $9,200 and is accreted to interest expense ratably over the term of the note. The promissory note matured on November 17, 2011. The unpaid balance, including accrued interest, was $23,944 and $23,046 at September 30, 2013 and December 31, 2012, respectively. The Company is not compliant with the repayment terms of the note.

ii. On February 3, 2011, the Company signed a $500,000 promissory note with a maturity date of August 2, 2012, and has a stated interest rate of 15% per annum. As a financing incentive, the lender received a three-year warrant vesting on January 31, 2011, to purchase 452,354 shares of common stock at an exercise price of $0.01 per share, and also received a five-year warrant, vesting on June 30, 2011, to purchase 452,354 shares at an exercise price of $0.01 per share. The gross proceeds from the sale of the note of $500,000 were recorded net of a discount of $137,703. The debt discount consisted of $137,703 related to the fair value of the warrants and is accreted to interest expense ratably over the term of the note which amounted to $63,114 for the nine months ended September 30, 2012. The Company has not made any note payments and received a waiver from the lender on September 1, 2011 that deferred payment until September 1, 2012 and increased the interest rate to 21% beginning April 4, 2011, the date of the first event of default. The unpaid balance, including accrued interest, was $777,069 and $698,534 at September 30, 2013 and December 31, 2012, respectively. The Company is not compliant with the repayment terms of the note.

iii. On August 1, 2012, the Company issued a $60,000 promissory note with an original issue discount of 20%. The promissory note is due on the earlier of (i) the closing by the Company of a financing or series of financings for aggregate cash proceeds of at least $1,850,000, or, (ii) July 31, 2013. As a financing incentive, the lender received a three-year warrant, vesting immediately, to purchase 50,000 shares of common stock at an exercise price of $0.50 per share. The gross proceeds from the sale of the note of $60,000 were recorded net of a discount of $11,088. The debt discount consisted of $11,088 related to the fair value of the warrant and is accreted to interest expense ratably over the term of the note which amounted to $11,088 for the year ended December 31, 2012. Since the Company satisfied the requirement of item (i) and raised $1,875,000 after August 1, 2012, the discount was recognized over the shorter maturity term. The carrying value of the unpaid balance was $60,000 at September 30, 2013 and December 31, 2012. The Company is not compliant with the repayment terms of the note.

F-9

iv. On August 7, 2012, the Company issued a $30,000 promissory note with an original issue discount of 20%. The promissory note is due on the earlier of (i) the closing by the Company of a financing or series of financings for aggregate cash proceeds of at least $1,850,000, or, (ii) August 6, 2013. As a financing incentive, the lender received a three-year warrant, vesting immediately, to purchase 25,000 shares of common stock at an exercise price of $0.50 per share. The gross proceeds from the sale of the note of $30,000 were recorded net of a discount of $3,406. The debt discount consisted of $3,406 related to the fair value of the warrant and is accreted to interest expense ratably over the term of the note which amounted to $3,406 for the year ended December 31, 2012. Since the Company satisfied the requirement of item (i) and raised $1,875,000 after August 7, 2012, the discount was recognized over the shorter maturity term. The carrying value of the unpaid balance was $30,000 at September 30, 2013 and December 31, 2012. The Company is not compliant with the repayment terms of the note.

v. On August 22, 2012, the Company issued a $60,000 promissory note with an original issue discount of 20%. The promissory note is due on the earlier of (i) the closing by the Company of a financing or series of financings for aggregate cash proceeds of at least $1,850,000, or, (ii) August 21, 2013. As a financing incentive, the lender received a three-year warrant, vesting immediately, to purchase 50,000 shares of common stock at an exercise price of $0.50 per share. The gross proceeds from the sale of the note of $60,000 were recorded net of a discount of $9,495. The debt discount consisted of $9,495 related to the fair value of the warrant and is accreted to interest expense ratably over the term of the note which amounted to $9,495 for the year ended December 31, 2012. Since the Company satisfied the requirement of item (i) and raised $1,875,000 after August 22, 2012, the discount was recognized over the shorter maturity term. The carrying value of the unpaid balance was $60,000 September 30, 2013 and December 31, 2012. The Company is not compliant with the repayment terms of the note.

vi. In December 2012, the Company commenced an offering of secured promissory notes for an aggregate principal amount of $2,500,000 with three-year warrants to purchase an aggregate of 5,000,000 shares our common stock (two shares for each $1 of the principal amount of the notes purchased) exercisable at $0.50 per share. The notes bear interest at 18% and have a maturity date of September 30, 2013. Notes in the aggregate principal amount of $1,000,000 and warrants to purchase an aggregate of 2,000,000 common shares were sold in the offering. In addition, the investment banker who facilitated the sale of the notes and warrants received a three-year warrant to purchase 200,000 shares of our common stock (10% of the number of shares of common stock issuable upon exercise of the warrants sold in the offering) exercisable at $0.50 per share. The fair value of the three-year warrants issued in connection with the notes on the date of issuance aggregated $32,202, and was recorded as debt discount. The debt discount was amortized through the term of the notes and amounted to $28,257 for the nine months ended September 30, 2013. The unpaid balance, including accrued interest, was $1,134,630 and $1,000,000 at September 30, 2013 and December 31, 2012, respectively. The Company is not compliant with the repayment terms of the note.

vii. On May 8, 2013, the Company issued a $30,000 promissory note with an original issue discount of 20%. The promissory note is due on the earlier of (i) the closing by the Company of a financing or series of financings for aggregate cash proceeds of at least $1,850,000, or, (ii) July 5, 2013. As a financing incentive, the lender received a three-year warrant, vesting immediately, to purchase 25,000 shares of common stock at an exercise price of $0.10 per share. The gross proceeds from the sale of the note of $30,000 were recorded net of a discount of $928. The debt discount consisted of $928 related to the fair value of the warrant and is accreted to interest expense ratably over the term of the note which amounted to $80 and $928 for the three months and nine months ended September 30, 2013, respectively. The Company repaid $10,000 during May and June 2013. The carrying value of the unpaid balance was $20,000 at September 30, 2013. The Company is not compliant with the repayment terms of the note.

viii. On July 9, 2013, an individual advanced to the Company $10,000. The advance is evidenced by a promissory note payable with interest at 18% and is due on demand. The unpaid balance, including accrued interest, was $10,409 at September 30, 2013.

F-10

(B) Notes Payable – Related Parties

i. In September 2008, Earnest Mathis, a former shareholder, advanced to the Company $15,000. The advance is evidenced by a promissory note bearing interest at 10% per annum. The promissory note matured on September 13, 2009. The unpaid balance, including accrued interest, was $22,568 and $21,446 at September 30, 2013 and December 31, 2012, respectively. The Company is not compliant with the repayment terms of the note.

ii. In November 2009 and February 2010, Morrison Partners, LLC (an affiliate of Thomas Morrison, former CEO and Chairman of the Board of Directors of the Company), advanced to the Company $10,000 and $15,000, respectively. The advances are evidenced by promissory notes bearing interest at 5% per annum. The November advance provides for the issuance of 2,770 shares of the Company’s common stock as a financing incentive. The Company recorded a debt discount of $2,935 for the relative fair value of the common stock. The discount was accreted over the life of the note.   The November 2009 and February 2010 notes were due on June 30, 2010 and September 30, 2010, respectively. The unpaid balance, including accrued interest, was $29,661 and $28,726 at September 30, 2013 and December 31, 2012, respectively. The shares have not been issued to Morrison Partners, LLC, and the Company is not in compliance with the repayment terms of the notes.

iii. During March, 2010 through October 2011, a former employee of the Company loaned to the Company $65,958, of which $16,000 and $49,958 was advanced during 2011 and 2010, respectively. The loans are evidenced by promissory notes payable with interest at 5% and are due on demand. The Company repaid $9,000 during 2010 and $8,000 during April 2012. In addition, the former employee will be issued 47,690 shares of the Company’s common stock upon repayment of the promissory notes as additional consideration. The Company will record a fair value for these shares on the measurement date as a charge to interest expense. The unpaid balance, including accrued interest, was $56,381 and $54,551 at September 30, 2013 and December 31, 2012, respectively.

iv. On October 17, 2011, the Company entered into a $400,000 convertible multi-draw term loan facility with an entity owned by a related party. The loan bears interest at 21% and has a maturity date of the earlier of an event of default or April 17, 2012. The Company has not made a note payment and is currently negotiating an extension of such loan. At the time of any new debt or equity financing of the Company, the loan balance, including principal and interest, may be converted into the number of fully paid and non-assessable debt instruments, shares/or units to be issued in the financing. In addition, with each drawdown the related party received a three-year warrant to purchase 2.5 shares of the Company’s common stock for each $1.00 of principal loaned at such time, up to 1,000,000 shares in the aggregate for all drawdowns. Each warrant has an exercise price of $0.10 per share, is vested upon issuance, and expires on October 17, 2014. The Company received $125,000 and $275,000 in gross proceeds during the years ended December 31, 2012 and December 31, 2011, respectively. The Company issued warrants to purchase an aggregate of 312,500 and 687,500 shares of the Company’s common stock during the years ended December 31, 2012 and December 31, 2011, respectively. The unpaid balance of the loan, including accrued interest, was $462,828 and $400,000 at September 30, 2013 and December 31, 2012, respectively. The Company is not compliant with the repayment terms of the note.   The conversion price of the outstanding loan amounts was not fixed and determinable on the date of issuance and, as such in accordance with ASC Topic 815 “Derivatives and Hedging” (“ASC 815”), the embedded conversion option on the date of issuance was valued using the binomial lattice options pricing model and recorded as derivative liabilities. The fair value of the three-year warrants on the date of issuance aggregated $105,363, and was recorded as debt discount. The debt discount was fully amortized through the term of the loan and amounted to $85,342 for the nine months ended September 30, 2012.

F-11

During December 2012 the Company amended the notes to remove the conversion right and extend the due date to June 30, 2013, and to amend the warrants to remove certain anti-dilution provisions. For executing the agreement, the holder was granted a three-year warrant to purchase 1,000,000 shares of the Company’s common stock, equal to two and one-half times the principal amount of the note amended, exercisable at $0.20 per share. The Company evaluated the change in cash flows in connection with the December amendment and determined that there was a greater than 10% change between the present value of the existing debt and the amended debt. As a result, the fair value of the three-year warrants aggregated $49,439 and were recorded as a discount to the modified debt and will be accreted over the remaining term of the modified debt and recognized as interest expense. The debt discount on the modified debt amounted to $42,376 for the nine months ended September 30, 2013.

v. On February 28, 2012, Michael Rosenthal, Chairman of the Company’s Board of Directors, advanced the Company $50,000. The advance is evidenced by a promissory note bearing interest at 21% and has a maturity date of the earlier of an event of default or August 28, 2012. In addition, Mr. Rosenthal received a three-year warrant to purchase 125,000 shares of the Company’s common stock at an exercise price of $0.10 per share. The Company recorded a debt discount of $7,997 to the face value of the note based upon the fair values of the warrants. The discount was being accreted over the life of the note which amounted to $2,592 and $7,997 for the three and nine months ended September 30, 2012, respectively. The unpaid balance, including accrued interest, was $60,500 and $52,647 at September 30, 2013 and December 31, 2012, respectively. The Company is not compliant with the repayment terms of the note.   During December 2012 the Company amended the note to extend the due date to June 30, 2013. For executing the agreement, the holder was granted a three-year warrant to purchase 125,000 shares of the Company’s common stock, equal to two and one-half times the principal amount of the note amended, exercisable at $0.20 per share. The Company evaluated the change in cash flows in connection with the December amendment and determined that there was a greater than 10% change between the present value of the existing debt and the amended debt. As a result, the fair value of the three-year warrants aggregated $6,180 and were recorded as a discount to the modified debt and will be accreted over the remaining term of the modified debt and recognized as interest expense. The debt discount on the modified debt amounted to $5,298 nine months ended September 30, 2013.

vi. During April 2013 and June 2013, Barry Brookstein, CFO, loaned to the Company $37,050. The loan is evidenced by a promissory note payable with interest at 18% and is due on demand. The unpaid balance, including accrued interest, was $39,319 at September 30, 2013.

 (C) Convertible Notes Payable

i. On July 30, 2010, an individual advanced the Company $8,000. The advance is evidenced by a promissory note bearing interest at 6% per annum and maturing on March 2, 2011. The holder, at any time, may convert the promissory note into shares of the Company’s common stock at $0.05 per share. The Company calculated the fair value of the beneficial conversion feature using the Black-Scholes pricing model on the date of issuance. The fair value of the conversion option in connection with the note on the date of issuance aggregated $8,000, and was recorded as debt discount. The debt discount was amortized through the term of the note. The unpaid balance, including accrued interest, was $9,523 and $9,164 at September 30, 2013 and December 31, 2012, respectively. The Company is not compliant with the repayment terms of the note.

ii. On April 28, 2011, the Company issued a $70,588 convertible promissory note with an original issue discount of 15%. The convertible promissory note has a maturity date of the earlier of (i) the Company raising debt or equity financing of $600,000 or more, or (ii) May 31, 2011. The note may be converted into the Company’s common stock by the holder at $0.05 per share. As a financing incentive, the lender received a five-year warrant, vesting April 28, 2011, to purchase 705,882 shares of the Company’s common stock at an exercise price of $0.25 per share. The Company has not made a note payment, and the Company received a waiver from the lender on September 1, 2011 that defers payment until May 31, 2012 and waives the provision for payment upon the Company’s closing a debt or equity financing of $600,000 or more. The unpaid balance on the note was $70,588 at September 30, 2013 and December 31, 2012. The Company is not compliant with the repayment terms of the note.

F-12

The conversion price of the note and five-year warrants was not fixed and determinable on the date of issuance and as such in accordance with ASC Topic 815 “Derivatives and Hedging” (“ASC 815”), the embedded conversion options of the note and warrants on the date of issuance were valued using the binomial lattice options pricing model and recorded as derivative liabilities. The fair value of the conversion option and five-year warrants issued in connection with the note on the date of issuance aggregated $60,000, and were recorded as debt discount. The debt discount was amortized through the term of the note.

During December 2012 the Company amended the note to remove the conversion right and extend the due date to June 30, 2013, and to amend the warrants to remove certain anti-dilution provisions. For executing the agreement, the holder was granted a three-year warrant to purchase 61,856 shares of the Company’s common stock, exercisable at $0.18 per share. The Company evaluated the change in cash flows in connection with the December amendment and determined that there was a less than 10% change between the present value of the existing debt and the amended debt. As a result, the fair value of the new three-year warrants of $4,923 was expensed on the date of the amendment.

On July 15, 2011, the Company issued a $109,822 convertible promissory note with an original issue discount of 15% that consolidated various demand notes from September 2010 through July 2011. The convertible promissory note has a maturity date of the earlier of (i) the Company raising debt or equity financing of $600,000 or more, or (ii) August 31, 2011. The loan holder advanced an additional $1,750 in September 2011. The note may be converted into the Company’s common stock by the holder at $0.05 per share. As a financing incentive, the lender received a five-year warrant, vesting July 15, 2011, to purchase 1,098,220 shares of the Company’s common stock at an exercise price of $0.25 per share. The Company repaid $1,784 during 2012. The unpaid balance was $109,789 at September 30, 2013 and December 31, 2012. The Company is not compliant with the repayment terms of the note.

The conversion price of the note and five-year warrants were not fixed and determinable on the date of issuance and as such in accordance with ASC Topic 815 “Derivatives and Hedging” (“ASC 815”), the embedded conversion options of the note and warrants on the date of issuance were valued using the binomial lattice options pricing model and recorded as derivative liabilities. The fair value of the conversion option and five-year warrants issued in connection with the note on the date of issuance aggregated $95,497, and were recorded as debt discount. The debt discount was amortized through the term of the note.

iii. In March 2012, the Company commenced an offering of secured promissory notes for an aggregate principal amount of $1,000,000 with three-year warrants to purchase an aggregate of 2,500,000 shares the Company’s common stock (2.5 shares for each $1 of the principal amount of the notes purchased) exercisable at $0.10 per share. The notes bear interest at 18% and have various maturity dates beginning September 2, 2012. At the time of any new debt or equity financing by the Company, the principal and interest then due under the notes may be converted into the number of fully paid and non-assessable debt instruments, shares/or units issued in the financing. Notes in the aggregate principal amount of $850,000 and warrants to purchase an aggregate of 2,125,000 common shares were sold in the offering. In addition, the investment banker who facilitated the sale of the notes and warrants received a three-year warrant to purchase 212,500 shares of the Company’s common stock (10% of the number of shares of common stock issuable upon exercise of the warrants sold in the offering) exercisable at $0.10 per share. The unpaid balance, included accrued interest was $963,356 and $850,000 at September 30, 2013 and December 31, 2012, respectively. Since only a portion of the March 2012 secured promissory notes are convertible into shares of the Company’s common stock, the note value is split to reflect $879,338 in section A and $84,018 in section C at September 30, 2013, and $775,000 in Section A and $75,000 in section C at December 31, 2012 in the Note 7 table above. The Company is not compliant with the repayment terms of the notes.   The conversion price of the note and three-year warrants were not fixed and determinable on the date of issuance and as such in accordance with ASC Topic 815 “Derivatives and Hedging” (“ASC 815”), the embedded conversion options of the note and warrants on the date of issuance were valued using the binomial lattice options pricing model and recorded as derivative liabilities. The fair value of the conversion option and three-year warrants issued in connection with the note on the date of issuance aggregated $789,073, and was recorded as debt discount. The debt discount was fully amortized through the term of the notes and amounted to $443,655 and $789,073 for the three and nine months ended September 30, 2012, respectively.   During October 2012 the Company amended the notes to remove the conversion right and extend the due date to June 30, 2013, and to amend the warrants to remove certain anti-dilution provisions. Holders of an aggregate of

F-13

$775,000 of principal agreed to such amendments and were granted a warrant to purchase 1,550,000 shares of our common stock equal to two times the principal amount of the note amended, exercisable at $0.50 per share.

The Company evaluated the change in cash flows in connection with the October amendment and determined that there was a greater than 10% change between the present value of the existing debt and the amended debt. As a result, the fair value of the three-year warrants aggregated $140,759 and were recorded as a discount to the modified debt and will be accreted over the remaining term of the modified debt and recognized as interest expense. The accretion of the debt discount on the modified debt amounted to $105,570 for the nine months ended September 30, 2013.

iv. In August 2012, the Company commenced an offering of secured promissory notes for an aggregate principal amount of $3,000,000 with three-year warrants to purchase an aggregate of 6,000,000 shares of the Company’s common stock (two shares for each $1 of the principal amount of the notes purchased) exercisable at $0.50 per share. The notes bear interest at 18% and have various maturity dates beginning March 13, 2013. At the time of any new debt or equity financing by the Company, the principal and interest then due under the notes may be converted into the number of fully paid and non-assessable debt instruments, shares/or units issued in the financing. During year ended December 31, 2012, notes in the aggregate principal amount of $875,000 and warrants to purchase an aggregate of 1,750,000 shares of the Company’s common stock were sold in the offering. In addition, the investment banker who facilitated the sale of the notes and warrants received a three-year warrant to purchase 175,000 shares of the Company’s common stock (10% of the number of shares of common stock issuable upon exercise of the warrants sold in the offering) exercisable at $0.50 per share. The unpaid balance, included accrued interest was $992,801 and $875,000 at September 30, 2013 and December 31, 2012, respectively. The Company is not compliant with the repayment terms of the note.   The conversion price of the note and three-year warrants were not fixed and determinable on the date of issuance and as such in accordance with ASC Topic 815 “Derivatives and Hedging” (“ASC 815”), the embedded conversion options of the note and warrants on the date of issuance were valued using the binomial lattice options pricing model and recorded as derivative liabilities. The fair value of the conversion option and three-year warrants issued in connection with the note on the date of issuance aggregated $499,186, and were recorded as debt discount. The debt discount was amortized through the term of the notes and amounted to $64, 116 for the three months ended September 30, 2012 and $217,535 and $64,116 for the nine months ended September 30, 2013 and September 30, 2012, respectively.

v. During May 2013, the Company issued a $500,000 convertible promissory note with an original issue discount of $50,000. The convertible promissory note is due one year from each advance. After 90 days from each advance, a one-time 12% interest charge shall also be added to note. At any time, the outstanding principle and interest may be converted into fully paid and non-assessable shares of the Company’s common stock. The conversion price shall be 60% of the lowest closing price of the stock for the twenty-five (25) business days preceding the conversion notice. As of December 31, 2013, the Company has been advanced $40,000 on this note. In addition, the agreement requires the Company reserve 28,000,000 shares of the Company’s common stock for issuance upon conversion of the convertible promissory note. The unpaid balance, included accrued interest was $47,445 at September 30, 2013.   The conversion price of the note was not fixed and determinable on the date of issuance and as such in accordance with ASC Topic 815 “Derivatives and Hedging” (“ASC 815”), the embedded conversion options of the note and warrants on the date of issuance were valued using the binomial lattice options pricing model and recorded as derivative liabilities. The fair value of the conversion option issued in connection with the note on the dates of issuance was $61,033, and $40,000 was recorded as a debt discount and the excess balance was booked directly to interest expense. The debt discount was amortized through the term of the notes and amounted to $7,118 and $10,677 for the three and nine months ended September 30, 2013, respectively.

vi. During July 2013, the Company issued a $53,000 convertible promissory note bearing interest at 8% per annum. The convertible promissory note is due on March 10, 2014 and may be converted at any time into fully paid and non-assessable shares of the Company’s common stock. The conversion price shall be 51% of the closing price for the average three lowest trading days during the previous thirty (30) trading days preceding the conversion notice. In addition, the agreement requires the Company reserve 6,500,000 shares of the Company’s common stock for issuance upon full conversion of the convertible promissory note. The unpaid balance, included accrued interest was $54,045 at September 30, 2013.

F-14

The conversion price of the note was not fixed and determinable on the date of issuance and as such in accordance with ASC Topic 815 “Derivatives and Hedging” (“ASC 815”), the embedded conversion options of the note on the date of issuance was valued using the binomial lattice options pricing model and recorded as a derivative liability. The fair value of the conversion option issued in connection with the note on the dates of issuance was $68,488, and $53,000 was recorded as a debt discount and the excess balance was booked directly to interest expense. The debt discount was amortized through the term of the notes and amounted to $18,706 for the three and nine months ended September 30, 2013.

During August 2013, the Company issued a $16,500 convertible promissory note bearing interest at 8% per annum. The convertible promissory note is due on May 8, 2014 and may be converted at any time into fully paid and non-assessable shares of the Company’s common stock. The conversion price shall be 51% of the closing price for the average three lowest trading days during the previous ten (10) trading days preceding the conversion notice. In addition, the agreement requires the Company reserve 1,800,000 shares of the Company’s common stock for issuance upon full conversion of the convertible promissory note. The unpaid balance, included accrued interest was $16,699 at September 30, 2013.

The conversion price of the note was not fixed and determinable on the date of issuance and as such in accordance with ASC Topic 815 “Derivatives and Hedging” (“ASC 815”), the embedded conversion options of the note on the date of issuance was valued using the binomial lattice options pricing model and recorded as a derivative liability. The fair value of the conversion option issued in connection with the note on the dates of issuance was $19,734, and $16,500 was recorded as a debt discount and the excess balance was booked directly to interest expense. The debt discount was amortized through the term of the notes and amounted to $3,667 for the three and nine months ended September 30, 2013.

8. FAIR VALUE MEASURES 

ASC 820 “Fair Value Measurements and Disclosures” defines fair value, establishes a framework for measuring fair value and requires enhanced disclosures about fair value measurements. As defined in ASC 820, fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The Standard clarifies that the exchange price is the price in an orderly transaction between market participants to sell an asset or transfer a liability at the measurement date, and emphasizes that fair value is a market-based measurement and not an entity-specific measurement.

ASC 820 establishes the following hierarchy used in fair value measurements and expands the required disclosures of assets and liabilities measured at fair value:

· Level 1 – Inputs use quoted prices in active markets for identical assets or liabilities that the Company has the ability to access.

· Level 2 – Inputs use other inputs that are observable, either directly or indirectly. These inputs include quoted prices for similar assets and liabilities in active markets as well as other inputs such as interest rates and yield curves that are observable at commonly quoted intervals.

· Level 3 – Inputs are unobservable inputs, including inputs that are available in situations where there is little, if any, market activity for the related asset or liability.

In instances where inputs used to measure fair value fall into different levels in the above fair value hierarchy, fair value measurements in their entirety are categorized based on the lowest level input that is significant to the valuation. The Company’s assessment.

The following table provides the assets and liabilities carried at fair value measured on a recurring basis as of September 30, 2013 and December 31, 2012, respectively:

	Fair Value Measurements
		Level 1		Level 2		Level 3		Total
Derivative liabilities:
September 30, 2013	$	—	$	—	$	1,393,054	$	1,393,054
December 31, 2012	$	—	$	—	$	432,030	$	432,030

F-15

The 2013 and 2012 derivative liabilities are measured at fair value using the binomial lattice options pricing model, and are classified within Level 3 of the valuation hierarchy. The following table sets forth a summary of the changes in the fair value of the Company’s Level 3 financial liabilities that are measured at fair value on a recurring basis:

		Nine months Ended September 30, 2013		Year Ended December 31, 2012
Fair value, beginning of period	$	432,030	$	155,813
Derivative liabilities recorded during the period		153,968		1,323,548
Reclassification to equity upon conversion of note		—		(1,787,542	)
Reclassification to equity upon amendment of notes and warrants		—		(1,152,144	)
Net unrealized (gain) loss on derivative financial instruments		807,056		1,892,355
Fair value, end of period	$	1,393,054	$	432,030

9. STOCK OPTIONS AND WARRANTS

Stock Options – Employment Letter Agreement:

On July 3, 2011, in conjunction with Chris White’s employment as the Company’s Vice President of Global Supply Chain, the Company granted Mr. White a seven-year option to purchase 2,950,000 shares of the Company’s common stock at $0.20 per share. The option vested as to 1,180,000 shares on the date of grant, and vests as to 295,000 on each of the first six semi-annual anniversaries of the grant date. The fair value of the option was approximately $317,400. During May 2013, Mr. White resigned from the Company and in accordance with the terms of his non-qualified stock option agreement, all the option shares vest immediately with a revised expiration date of November 17, 2013.

On January 6, 2012, in conjunction with Mark Zeller’s employment as the Company’s North American Director of Sales, the Company granted Mr. Zeller a five-year option to purchase 1,500,000 shares of the Company’s common stock at $0.20 per share. The option vested as to 250,000 on the date of grant, and vests as to 416,667 on each of the first three anniversaries of the grant date. The fair value of the option was approximately $44,000. On May 1, 2012, Mr. Zeller resigned from the Company and the option terminated in accordance with its terms.

On April 24, 2012, in conjunction with Roger Zardo’s employment as the Company’s Director of National Procurement, the Company granted Mr. Zardo a three-year option to purchase 325,000 shares of the Company’s common stock at $0.25 per share. The option vested as to 100,000 on the date of grant, vests as to 75,000 shares on each of the first two anniversaries of the grant date, and vests as to 75,000 shares on November 28, 2014. The fair value of the option was approximately $18,400. During March 2013, Mr. Zardo resigned from the Company and the option terminated in accordance with its terms.

On May 18, 2012, in conjunction with Jack Connelly’s employment as the Company’s Director of National Sales, the Company granted Mr. Connelly a three-year option to purchase 500,000 shares of the Company’s common stock at $0.25 per share. The option vested as to 100,000 on the date of grant, vests as to 134,000 shares on each of the first two anniversaries of the grant date, and vests as to the final 132,000 shares on November 29, 2014. The fair value of the option was approximately $33,900. On July 1, 2013, Mr. Connelly resigned from the Company and in accordance with the terms of his non-qualified stock option agreement, all the option shares vest immediately with a revised expiration date of December 31, 2013.

On August 31, 2012, in conjunction with George Borzilleri’s employment as the Company’s Manager, National Retail Sales, the Company granted Mr. Borzilleri a three-year option to purchase 396,427 shares of the Company’s common stock at $0.35 per share. The option vested as to 135,714 shares on the date of grant, vests as to 86,904 shares on each of the first two anniversaries of the grant date, and vests as to the final 86,905 shares on March 6, 2015. The fair value of the option was approximately $102,524. On July 1, 2013, Mr. Borzilleri resigned from the Company and in accordance with the terms of his non-qualified stock option agreement, all the option shares vest immediately with a revised expiration date of December 31, 2013.

F-16

On October 5, 2012, Chris White, the Company’s Vice President of Global Supply was granted a seven year non-qualified stock option to purchase 3,837,719 shares of the Company’s common stock at $0.62 per share. The fair value of the option was $1,221,493. The option vests as follows:

750,000 shares vest immediately.

750,000 shares vest upon receipt of certificates issued by IMO Control (Institute for Marker Ecology) certifying compliance with IMO Controls ‘For Life’ Fair Trade standards for three key Company suppliers.

750,000 shares vest upon the launch by Mr. White of an internal “alpha” demonstration website that contains certain functionality.

198,250 shares vest on each of the next 8 quarter dates starting January 6, 2013 through October 6,^, 2014. The final quarterly vesting will be 199,969 shares.

The Company recognized stock based compensation expense associated with stock options included in general and administrative expenses on the condensed consolidated statement of operations of $0 and $35,099 for the three months ended September 30, 2013 and 2012, respectively, and $294,276 and $97,922 for the nine months ended September 30, 2013 and 2012, respectively for these awards.

Options Summary:

A summary of option activity during the nine months ended September 30, 2013 and the year ended December 31, 2012 is presented below:

						Weighted
				Weighted		Average
				Average		Remaining
				Exercise		Contractual		Intrinsic
	Shares			Price		Term		Value
Balance at December 31, 2011		2,983,750		$	0.31		4.00	$	—
Granted		6,559,146			0.46		3.55		—
Exercised		—			—		—		—
Forfeited		(1,500,000	)		0.20		—		—
Balance at December 31, 2012		8,042,896			0.45		3.47		88,500
Granted		—			—		—		—
Exercised		—			—		—		—
Forfeited		(325,000	)		0.25		—		—
Balance at September 30, 2013		7,717,896		$	0.46		.18	$	—
Exercisable at September 30, 2013		7,191,183		$	0.46		.18	$	—

The Company has fully amortized all stock options.

F-17

Common Stock Warrants:

During June 2013, a consultant was granted a three-year warrant to purchase 250,000 shares of our Company’s common stock at $0.15 per share for accounting services to our Company. The warrant vests immediately.

Warrant transactions during the nine months ended September 30, 2013 and the year ended December 31, 2012 were as follows:

				Weighted		Average
				Average		Remaining
	Number of			Exercise		Life		Intrinsic
	Warrants			Price		In Years		Value
Balance, December 31, 2011		5,862,140		$	0.12
Granted		10,775,000			0.34
Exercised		(2,039,735	)		0.10
Forfeited		(103,064	)		0.10
Balance, December 31, 2012		14,494,341		$	0.28
Granted		610,586			0.18
Exercised		—			—
Forfeited		—			—
Balance, September 30, 2013		15,104,927		$	0.28		2.14	$	23,758
Exercisable, September 30, 2013		15,104,927		$	0.28		2.14	$	23,758

The intrinsic value is calculated on the difference between the fair market value of the Company’s restricted stock, which was $0.03 per share as of September 30, 2013, and the exercise price of the warrants.

F-18

The following table presents information related to warrants at September 30, 2013:

Warrants Outstanding				Warrants Exercisable
				Weighted
				Average		Exercisable
Exercise		Number of		Remaining Life		Number of
Price		Warrants		In Years		Warrants
$	0.01		452,354		2.33		452,354
	0.10		692,802		2.38		692,802
	0.25		705,882		2.58		705,882
	0.25		575,000		2.71		575,000
	0.01		452,355		2.75		452,355
	0.25		1,098,220		2.79		1,098,220
	0.001		195,291		1.00		195,291
	0.10		1,000,000		1.13		1,000,000
	0.10		125,000		1.42		125,000
	0.25		300,000		1.42		300,000
	0.10		1,197,437		1.46		1,197,437
	0.50		50,000		1.83		50,000
	0.50		25,000		1.83		25,000
	0.50		50,000		1.92		50,000
	0.50		25,000		1.92		25,000
	0.25		250,000		1.75		250,000
	0.50		1,870,000		1.92		1,870,000
	0.50		55,000		2.00		55,000
	0.50		1,550,000		2.08		1,550,000
	0.50		1,125,000		2.17		1,125,000
	0.50		1,000,000		2.17		1,000,000
	0.25		1,200,000		2.25		1,200,000
	0.50		500,000		2.25		500,000
	0.10		25,000		2.63		25,000
	0.20		335,586		4.21		335,587
	0.15		250,000		2.67		250,000
			15,104,927		2.14		15,104,927

10. RELATED PARTY TRANSACTIONS

Consulting Agreement

On July 1, 2008, the Company signed a 16-month consulting agreement with a related party. The consulting services include financial advisory, investment relations and certain administrative and other services for $6,250 monthly fees. At September 30, 2013 and December 31, 2012, the Company owed $100,000 related to above consulting services, which is included in accrued expenses and other current liabilities in the condensed consolidated balance sheets.

F-19

Employee Warrants

On February 29, 2012, an employee was granted a three year warrant to purchase 300,000 shares of the Company’s common stock for services rendered. The warrant vested upon grant, and was exercisable at $0.25 per share. The Company recorded a charge for $6,149 to stock based compensation for the nine months ended September 30, 2012.

11 . COMMITMENTS AND CONTINGENCIES

Agreements

During October 2012 we leased approximately 1,641 square feet of office space located at 2030 Addison Street, Berkeley, CA for approximately $4,200 per month under a 29 month agreement with rental payments commencing on January 1, 2013. The rental fee escalated to approximately $4,350 on April 1, 2013 and approximately $4,500 on April 1, 2014. The lease was terminated on August 31, 2013.

Legal matters

In the normal course of business, the Company is, and in the future may be, subject to various disputes, claims, lawsuits, and administrative proceedings arising in the ordinary course of business with respect to commercial, product liability, employment, and other matters, which could involve substantial amounts of damages. In the opinion of management, any liability related to any such known proceedings would not have a material adverse effect on the business or financial condition of the Company. Additionally, from time to time, the Company may pursue litigation against third parties to enforce or protect the Company’s rights under the Company’s trademarks, trade secrets and intellectual property rights generally.

During 2010, the Company was served with a lawsuit for the Company’s past due liabilities. The lawsuit was Peri & Sons, plaintiff, vs. Organic Alliance, Inc. and Parker Booth, defendants, for past due produce liabilities. An agreement was reached and the Company has been making payments to the plaintiff. The Company was dismissed from the action and signed a confession of judgment. Over half of the past due amount has been paid with a balance of approximately $21,000 remaining. The Company has accrued for this balance.

On June 20, 2013, the Company was served a lawsuit for a disputed loan issued by the Company. The lawsuit was Austin Noll Jr. plaintiff, vs. Organic Alliance, Inc. and DOES 1 through 50, defendants, for a $50,000 loan issued in July 2009. The case will be reviewed by the Company’s legal counsel. In July 2010, the Company issued stock to a third party with the obligation to pay Mr. Noll. The Company’s position is the loan was repaid by the Company in July 2010.

On July 30, 2013, the Company was served with a lawsuit for past due liabilities of the Company.  The lawsuit was Tom Ver. LLC d/b/a MexFresh Produce, plaintiff, vs. Organic Alliance, Inc., et al, for past due produce liabilities of $53,863.53. The lawsuit was filed in the United States District Court of the Northern District of California. . The case will be reviewed by the Company’s legal counsel.

On August 1, 2013, the Company received a “Notice of Labor Laws Violation” under California Labor Code 2699, 2699.3 and 2699.5. The notice was file by an employee, Kenneth Horwitz and all current and former employees against Organic Alliance, Inc. Parker Booth, CEO and Barry Brookstein, CFO. The notice alleges various California labor laws violations and seeks wages and penalties from the Company, Mr. Booth and Mr. Brookstein. The notice will be reviewed by the Company’s legal counsel.

F-20

12. ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES

Accrued expenses and other current liabilities consist of the following:

	September 30, 2013		December 31, 2012
Due to consultant (Note 10)	$	100,000	$	100,000
Payroll and payroll taxes payable (A)		1,692,089		1,399,049
Other accrued liabilities		36,745		235,814
	$	1,828,834	$	1,734,863

(A) As of September 30, 2013 and December 31, 2012, the Company has unpaid payroll taxes including penalties and interest of $320,622 and $286,027, respectively, which have yet to be remitted to the taxing authorities and returns have yet to be filed.

13. SUBSEQUENT EVENTS

During December 2013, the Company issued a $13,000 convertible promissory note bearing interest at 8% per annum. The convertible promissory note is due on September 15, 2014 and may be converted at any time into fully paid and non-assessable shares of the Company’s common stock. The conversion price shall be 51% of the closing price for the average three lowest trading days during the previous ten (10) trading days preceding the conversion notice. In addition, the agreement requires the Company reserve 20,000,000 shares of the Company’s common stock for issuance upon full conversion of the convertible promissory note. The conversion price of the note was not fixed and determinable on the date of issuance and as such in accordance with ASC Topic 815 “Derivatives and Hedging” (“ASC 815”), the embedded conversion options of the note on the date of issuance was valued using the binomial lattice options pricing model and recorded as a derivative liability.

F-21

 ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The following discussion should be read in conjunction with the condensed consolidated financial statements and related notes thereto included elsewhere in this report. This discussion contains forward-looking statements that relate to future events or our future financial performance. These statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. These forward-looking statements are based largely on our current expectations and are subject to a number of uncertainties and risks including the Risk Factors identified in our Annual Report on Form 10-K for the year ended December 31, 2012. Actual results could differ materially from these forward-looking statements.

OVERVIEW

History

Our company, a Nevada corporation, was organized in September 2001 under the name NB Design & Licensing, Inc. We were inactive until April 2008, when we completed a reverse merger transaction with Organic Alliance, Inc., a Texas corporation organized in 2008 to sell organically grown fruits and vegetables. In June 2008, we changed our name to Organic Alliance, Inc.

Going Concern

The condensed consolidated financial statements have been prepared using accounting principles generally accepted in the United States of America applicable for a going concern, which assume that the Company will realize its assets and discharge its liabilities in the ordinary course of business. As of September 30, 2013, the Company had limited cash, a working capital deficit of approximately $9,788,000, accumulated losses of approximately $24,078,000 since its inception of which $1,599,560 are deficits accumulated during the development stage, and has $320,622 of payroll tax liabilities inclusive of penalties and interest withheld from wages paid which have yet to be remitted to the taxing authorities and are delinquent. The Company currently is delinquent with its payroll tax filings since December 31, 2008; however, since April 1, 2012 the Company has been remitting payroll tax on a current basis. The Company ceased paying payroll beginning May 1, 2013. Most employees were furloughed or resigned by May 31, 2013. At September 30, 2013, the Company was not compliant with the repayments terms of various notes payable for an aggregate of approximately $4,838,000 including accrued interest. Its ability to continue as a going concern is dependent upon the ability of the Company to obtain the necessary financing to meet its obligations and pay its liabilities arising from normal business operations when they come due, and increasing its revenue in order to achieve profitable operations. The outcome of these matters cannot be predicted with any certainty at this time and raise substantial doubt that the Company will be able to continue as a going concern. These consolidated financial statements do not include any adjustments to the amounts and classification of assets and liabilities that may be necessary should the Company be unable to continue as a going concern.

The Company intends to overcome the circumstances that impact its ability to remain a going concern through pursing new business opportunities, with interim cash flow deficiencies being addressed through additional equity and debt financing. The Company anticipates raising additional funds through public or private financing, strategic relationships or other arrangements in the near future to support its business operations; however the Company does not have commitments from third parties for a sufficient amount of additional capital, the Company cannot be certain that any such financing will be available on acceptable terms, or at all, and its failure to raise capital when needed could limit its ability to continue or resume its operations. The Company’s ability to obtain additional funding will determine its ability to continue as a going concern. Furthermore, additional equity financing may be dilutive to the holders of the Company’s common stock, and debt financing, if available, may involve restrictive covenants or may require that the Company relinquish valuable rights.

Development Stage

The Company is considered to be in the development stage as defined in ASC 915, “Accounting and Reporting by Development Stage Enterprises”.

On July 1, 2013, the Company temporarily suspended operations and elected to enter the development stage. All inventories and deposits from the former operations were written off as of July 1, 2013.

-3-

Due to unfavorable financing conditions and inability to obtain suitable financing, the Company has determined that it will develop other markets in addition to the organic and Fair Trade certified fruits and vegetables global market.

Our Company

We are a global grower and marketer of organic and Fair Trade certified fruits and vegetables in the rapidly growing $29.2 billion U.S. natural, organic and Fair Trade foods marketplace. Through our collaborative relationships with growers and our direct involvement in growing operations, we have built a vertically-integrated supply chain that enables us to support our customers with an increasing variety of certified sustainable products, sensible pricing, and steady supply -- the primary obstacles facing buyers in the fast-growing organic and Fair Trade market segments. Our Organic Alliance branded mangoes, tomatoes, cucumbers, bell peppers and more are already on the shelves of leading national grocery chains including Whole Foods, Heinen’s, Kroger, Safeway, Trader Joes and others. Our Company also sources and distributes some conventional produce (non-organic and Fair Trade) to generate revenues that we believe will help us develop our organic and Fair Trade production.

Currently, we are focusing our sourcing and development strategy in Mexico, the U.S.’s largest food supplier with sales to the United States growing 25% in 2010 to $6 billion. We intend to continue our development of company-owned or managed organic production in the United States as well as other key Latin American food exporting countries where we currently have strong grower and professional networks, including in Argentina, Chile, Peru, Dominican Republic and Costa Rica.

The primary segments for marketing our products are the mainstream supermarket channel, natural grocery chains, mass merchandisers, food service distributors, fresh produce processors, consumer package goods companies, and overseas markets focusing on grocery chains and their importer partners. Our Company has strong food industry relationships and currently supplies product to many of these market segments.

Our products also address the value proposition sought by many consumers of organic and Fair Trade goods, namely the social responsibility associated with Fair Trade’s contribution to sustainable development and worker prosperity, and environmental responsibility associated with organic farming.

Fair Trade 

Fair Trade certification offers producers the ability to trade directly with improved payment terms while paying workers dignified wages and providing a premium for community development. This allows marginalized agricultural communities the opportunity to improve their lives with technical training, better business infrastructure, improved schooling, health care and nutritious food. Fair Trade investment provides a platform from which communities can rise out of poverty, be economically sustainable and take control of their future while providing the market with better, more sustainable products. Fair Trade certified products offer consumers a powerful way to reduce poverty through their everyday shopping.

The key objectives of the Fair Trade standards are to:

· ensure that producers receive prices that cover their average costs of sustainable production;

· provide a Fair Trade premium which can be invested in projects that enhance social, economic and environmental development;

· ensure safe working conditions and dignified wages for agriculture workers;

· facilitate long-term trading partnerships and enable greater producer control over the trading process; and

· set clear minimum and progressive criteria to ensure that the conditions of production and trade of all Fair Trade certified products are socially, economically fair and environmentally responsible.

Industry Overview

The organic and Fair Trade marketplace is characterized by strong producer and retailer pricing power as consumer demand continually outstrips supply. As a result, organic and Fair Trade produce prices remain high compared with prices for conventional products. We believe enormous earnings leverage is available to producers and retailers at far higher sales volumes if certified supplies can be increased and prices made more affordable for more consumers.

U.S. organic food sales rose from $6.1 billion in 2000 to $29.2 billion in 2011, a compounded growth rate of over 15 percent. Registering a third straight year of double-digit gains, sales of organic fruits and vegetables rose 11.7 percent in 2011 to $11.8 billion. U.S. Fair Trade sales were $1.5 billion in 2011, growing 20% over 2010 sales and closely following the rise of organic foods into the mainstream¹.

¹- Source: http://www.helpguide.org/life/organic_foods_pesticides_gmo.htm.

-4-

Wall Street clearly favors the organic industry’s strong prospects. Industry leading specialty grocer Whole Foods last month posted second fiscal quarter sales that increased 14 percent to $2.7 billion. “Sales trends remain strong as it appears that the growth of the natural and organic industry has accelerated,” wrote Meredith Adler, an analyst for Barclays Plc. Another market leader, United Natural Foods, Inc. (UNFI), reported sales for the quarter ended April 28 of $1.39 billion, a 15.3 percent increase year over year¹.

Global Fair Trade sales have followed the rise of organic at an 18% annual growth rate, reaching a total of $4.8 billion in 2009. Mainstream retailers such as Wal-Mart and Whole Foods have demonstrated strong interest in the segment, with each offering a growing number of Fair Trade products including retail-brand private label options. In 2007, Whole Foods launched its “Whole Trade” initiative, requiring 50% of its imported food to be certified as Fair Trade within 10 years. Fair Trade sales in U.S. mainstream grocery outlets grew 24% in 2010. Like organic, the principal barrier to growth is lack of supply and inconsistent quality and/or pricing, which we believe our Company directly addresses².

²- Source: http://www.fairtrade.net/what_is_fairtrade.html.

Growth Strategy 

Due to the continued increase in demand for certified organic and Fair Trade products, our customers’ procurement departments are actively seeking additional sources for such products. Their challenge is to attain a reliable, year round supply at sensible pricing, in part due to short supply and the fractionalized nature of the organic and Fair Trade farm bases. Our strategy to address this challenge includes:

Rapidly Increase Organic and Fair Trade Produce Supply. We intend to utilize our industry leading expertise in rapidly developing Fair Trade certified and organic production to increase our ability to supply the marketplace. We believe our Fair Trade tomatoes sold through Whole Foods in 2012 were the first of their kind to be introduced to the market, and we intend to develop a number of other Fair Trade certified products that also will be the first of their kind to market. In doing so, we believe this will give us preferred access to high-value markets.

Control & Integrate Supply Chains. We expect to build company controlled production capacity in the United States, Mexico and other countries, adding to our existing short-term leased Mexican mango orchards and greenhouses established in early 2013. By continuing to build company-owned production capacity, we believe we attract buyer favor by creating supply and price conditions that more closely resemble the conventional food alternative.

Build Market Share. We intend to leverage our increasing portfolio of Fair Trade and organic certified products, along with our price-competitiveness and ability to customize client programs through vertical integration, to further expand our penetration into the North American and European food retail markets.

Build Brand Value. Through partnerships with retailers and scanable QR technology, our “Make Life Sweet^TM” campaign allows us to tell the inspiring stories and impact of our products to consumers at the point-of-purchase. We intend to build the Organic Alliance brand with the intrinsic value our products carry: “Food that is good for the planet, good for farmers and good for you.”

Diversify into Growing Market Segments. We intend to continue using our operational infrastructure to sell a small core list of conventional produce to generate resources for the execution of large-scale development in the organic and Fair Trade agriculture sectors. Specifically, we expect to develop capacity to process our fruit and vegetable production into organic and Fair Trade certified value-added foods such as dried, juices and frozen, a new and rapidly growing sector in the organic foods market with healthy margins and long-term growth potential.

Critical Accounting Estimates and Policies

Use of Estimates - The preparation of consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Significant estimates that are particularly sensitive to change in the near term include, but are not limited to, realization of deferred tax assets, allowance for doubtful accounts, and assumptions used in derivative valuations and share based payment transactions. Actual results could differ from those estimates.

Principles of Consolidation - The consolidated financial statements include the accounts of Organic Alliance, Inc. and its wholly-owned subsidiary, Organic Texas, Inc. All significant inter-company transactions and balances have been eliminated in consolidation.

-5-

In addition, our Company also factors our receivables with full recourse and, as a result, accounts for the factoring akin to a secured borrowing, maintaining the gross receivable asset and due to factor liability on our books and records. In connection with the factoring of our receivables, our Company estimates an allowance for factoring fees associated with the collections. These fees range from 3% to 5% depending on the actual timing of the collection. The actual recognition and amount of such fees may differ from the estimates depending upon the timing of collections. The Company has not factored any receivables since May 2013 and is in default of the agreement.

Inventory - Inventory is stated at the lower of cost (first-in, first-out) or market. All inventories were written off as of July 1, 2013. Our Company held $0 and $139,888 of inventory as of September 30, 2013 and December 31, 2012, respectively.

Income Taxes - The Company uses the asset and liability method of accounting for income taxes in accordance with ASC Topic 740, “Income Taxes”. Under this method, income tax expense is recognized for the amount of (i) taxes payable or refundable for the current year and (ii) deferred tax consequences of temporary differences resulting from matters that have been recognized in an entity’s financial statements or tax returns. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the results of operations in the period that includes the enactment date. A valuation allowance is provided to reduce the deferred tax assets reported if based on the weight of the available positive and negative evidence, it is more likely than not some portion or all of the deferred tax assets will not be realized.

Fair Value of Financial Instruments - The carrying amounts of financial instruments, including cash, receivables, accounts payable and accrued expenses approximated fair value as of the balance sheet date presented, because of the relatively short maturity dates on these instruments. The carrying amounts of the notes payable issued approximate fair value as of the balance sheet date presented, because interest rates and other terms on these instruments approximate terms currently available on similar instruments.

Derivative Financial Instruments - Our Company does not use derivative instruments to hedge exposures to cash flow, market or foreign currency risks. Our Company evaluates all of our financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement of the instrument could be required within 12 months of the balance sheet date.

Due to the insufficient authorized but unissued shares of common stock to meet the required amount of shares for options, warrants and convertible instruments, the Company has accounted for the excess in common stock equivalents as a derivative liability in accordance with FASB ASC 815 Derivatives and Hedging.  Accordingly, the derivative is marketed to market through earnings at the end of each reporting period.

Revenue Recognition - Revenue is recorded when (1) the customer accepts delivery of the product and title has been transferred and our Company has no significant obligations remaining to be performed; (2) a final understanding as to specific nature and terms of the agreed upon transaction has occurred; (3) price is fixed and (4) collection is reasonably assured. Sales are presented net of discounts and allowances.

Share Based Compensation - Our Company accounts for share-based compensation in accordance with the fair value recognition provisions of the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) No. 718. Share-based compensation expense for all share-based payment awards is based on the estimated grant-date fair value. Our Company recognizes these compensation costs over the requisite service period of the award, which is generally the option vesting term. Option valuation models require the input of highly subjective assumptions, including the expected life of the option, and such assumptions can materially affect the fair value estimate. The fair value of share-based payment awards was estimated using the Black-Scholes option pricing model. Our Company accounts for the expected life of options in accordance with the “simplified” method provisions of SEC Staff Accounting Bulletin (“SAB”) No. 110, which enables the use of the simplified method for “plain vanilla” share options as defined in SAB No. 107.

Reserve Shares – As of September 30, 2013, the Company reserved 36,300,000 shares of Common Stock from its authorized shares, which covers 8,442,099 shares of common stock issuable upon conversion of certain convertible notes. The remaining

-6-

80,713,650 shares of common stock issuable upon conversion of convertible notes are not covered by reserve shares. There were no reserves shares at September 30, 2012.

Results of Operations

Results of operations for the three months ended September 30, 2013 compared to the three months ended September 30, 2012

For the three months ended September 30, 2013, we had no sales compared to $335,456 for the three months ended September 30, 2012. The Company temporarily suspended selling activities during early May 2013 due to cash flow difficulties. The Company is pursuing other business opportunities in addition to the organic and Fair Trade certified fruits and vegetables global market.

For the three months ended September 30, 2013, our cost of goods sold was $0 compared to $304,274 for the three months ended September 30, 2012.

For the three months ended September 30, 2013, our gross margin was $0 compared to a gross margin of $31,182 or 9.3% of sales for the three months ended September 30, 2012.

For the three months ended September 30, 2013, we had general and administrative (G&A) expenses of $297,235 compared to $564,486 for the three months ended September 30, 2012. The decrease in G&A expenses of $267,069, or 47%, is primarily attributable to decreased payroll expenses of approximately $307,000 as no payroll expense was recording for the three months ended September 30, 2013, decreased travel of approximately $55,000 and decreased other expenses of approximately $21,000, offset by the write off inventory and deposits for approximately $116,000.

For the three months ended September 30, 2013, our operating loss was $297,235 compared to $533,304 for the three months ended September 30, 2012. The $236,069, or 44%, decrease in net operating loss was primarily attributable to the lower G&A expenses described above.

For the three months ended September 30, 2013, other expense was $1,352,884 compared to $3,081,049 for the three months ended September 30, 2012. Included in other expense were the following items:

·         interest expense of $219,450 and $119,051 on notes and loans payable for the three months ended September 30, 2013 and 2012, respectively. The increase is due to increased loan amounts and a reclassification from a prior quarter in the three month ended September 30, 2012;

·         amortization of discount on notes payable of $30,196 and $553,288 for the three months ended September 30, 2013 and 2012, respectively. The decrease is due to overall decrease in notes issued during the period with equity instruments fair valued and recorded as debt discounts;

·         factor advance fees of $2,788 and $20,089 for the three months ended September 30, 2013 and 2012, respectively. The decrease is due to suspending selling activities;

·         a loss of $1,100,450 and $2,274,621 on the change in fair value of derivative liability for the three months ended September 30, 2013 and September 30, 2012, respectively. The change is due to removing the derivative requirement from certain convertible promissory notes in December 2012 and a decrease in the market price of our common stock; and

·         finance fees of $114,000 for the three months ended September 30, 2012 relating to our offering of $850,000 of secured promissory notes that began funding during August 2012.

For the three months ended September 30, 2013, the net loss was $1,650,119, or $0.08, basic and diluted loss per share compared to $3,614,353, or $0.21, basic and diluted loss per share for the three months ended September 30, 2012. The $1,964,234 or 54% decrease in net loss was primarily attributable to factors described above.

-7-

Results of operations for the nine months ended September 30, 2013 compared to the nine months ended September 30, 2012

For the nine months ended September 30, 2013, we had net sales of $981,205 compared to $1,301,757, for the nine months ended September 30, 2012. The $320,552 or 25% decrease was attributable to temporality suspending selling activities during May 2013 due to cash flow difficulties. The Company is pursuing other business opportunities in addition to the organic and Fair Trade certified fruits and vegetables global market.

For the nine months ended September 30, 2013, our cost of goods sold was $861,180 compared to $1,177,694 for the nine months ended September 30, 2012, a decrease of $316,514 or 27%.

For the nine months ended September 30, 2013, our gross margin was $120,025 or 12.2% of sales compared to a gross margin of $124,063 or 9.5% of sales for the nine months ended September 30, 2012.

For the nine months ended September 30, 2013, we had general and administrative (G&A) expenses of $1,809,087 compared to $2,118,500 for the nine months ended September 30, 2012. The decrease in G&A expenses of $309,413, or 15%, is primarily attributable to decreased stock based compensation of approximately $249,000 for key employee compensation, financing compensation and investor relations compensation, decreased payroll expenses of approximately $231,000 as most employees were furloughed or resigned by May 31, 2013 due to cash flow difficulties and decreased other expenses of approximately $40,000, offset by the write-off of approximated $211,000 of grower inventory and deposits that were deemed worthless.

For the nine months ended September 30, 2013, our operating loss was $1,689,062 compared to $1,994,437 for the nine months ended September 30, 2012. The $305,375, or 15%, decrease in net operating loss was primarily attributable to the lower G&A expenses described above.

For the nine months ended September 30, 2013, other expense was $1,862,557 compared to $5,884,814 for the nine months ended September 30, 2012. Included in other expense were the following items:

·         interest expense of $577,999 and $255,478 on notes and loans payable for the nine months ended September 30, 2013 and 2012, respectively. The increase is due to increased loan amounts;

·         amortization of discount on notes payable of $433,638 and $1,067,540 for the nine months ended September 30, 2013 and 2012, respectively. The decrease is due to overall decrease in notes issued during the period with equity instruments fair valued and recorded as debt discounts;

·         factor advance fees of $43,864 and $60,981 for the nine months ended September 30, 2013 and 2012, respectively. The decrease is the due to suspending sales in May 2013;

·         a loss of $807,056 and $4,272,565 on the change in fair value of derivative liability for the nine months ended September 30, 2013 and September 30, 2012, respectively. The change is due to removing the derivative requirement from certain convertible promissory notes in December 2012 and a decrease in the market price of our common stock; and

·         finance fees of $228,250 for the nine months ended September 30, 2012 relating to our offering of $1,700,000 of secured promissory notes in March 2012 and August 2012.

For the nine months ended September 30, 2013, the net loss was $3,551,619, or $0.18, basic and diluted loss per share compared to $7,879,251, or $0.46, basic and diluted loss per share for the nine months ended September 30, 2012. The $4,327,632 or 55% decrease in net loss was primarily attributable to factors described above.

-8-

Liquidity and Capital Resources

Our operations to date have generated substantial losses that have been funded through our sale of common stock to, and loans from, related parties and others. We will require additional sources of outside capital to continue our operations. We expect that our primary sources of cash in the future will be from the issuance of common stock, loans, accounts receivable factoring and a line of credit. On November 1, 2010, we signed a one year agreement with a financial services company for the purchase and sale of accounts receivables which expired on October 31, 2011. The agreement is continuing on a month to month basis. The financial services company commenced funding during February 2011. Under the agreement, the financial services company advances up to 80% of qualified customer invoices less an applicable discount fee, and holds the remaining 20% as a reserve until the customer pays the financial services company. The released reserves are used to fund other vendor purchases or returned to our company. We are charged 3% for the first 30 days outstanding plus 1/10 of 1% daily for funds outstanding over 30 days. Uncollectable customer invoices are charged back to our Company. We ceased factoring receivable during May 2013. We are in default of this agreement.

As of September 30, 2013, we have $320,622 of payroll tax liabilities inclusive of penalties and interest, from wages paid which have yet to be remitted to the taxing authorities.

The condensed consolidated financial statements have been prepared using accounting principles generally accepted in the United States of America applicable for a going concern which assume that we will realize our assets and discharge our liabilities in the ordinary course of business. As of September 30, 2013, we had limited cash, a working capital deficit of approximately $9,788,000 and accumulated losses of approximately $24,078,000 since its inception of which $1,599,560 are deficits accumulated during the development stage. During early May 2013, we suspended selling activities due to cash flow difficulties. Most employees were furloughed or resigned by May 31, 2013. We are pursuing other business opportunities in addition to the organic and Fair Trade certified fruits and vegetables global market.

Our ability to continue as a going concern is dependent upon the ability of our Company to obtain the necessary financing to meet our obligations and pay our liabilities arising from normal business operations when they come due, and increasing our revenues in order to achieve profitable operations. The outcome of these matters cannot be predicted with any certainty at this time and raise substantial doubt that our Company will be able to continue as a going concern. Our condensed consolidated financial statements do not include any adjustments to the amounts and classification of assets and liabilities that may be necessary should our Company be unable to continue as a going concern.

At September 30, 2013, we are not compliant with the repayments terms of various notes payable for an aggregate of approximately $4,838,000 including accrued interest.

We have limited funding available for marketing and will rely solely on the Company’s ability to raise debt or equity funds in the immediate future.

Our contractual obligations consist of notes and loans payable in the amount of $5,051,555 including accrued interest of $749,225, at September 30, 2013.

On February 28, 2012, we issued a $50,000 promissory note to a related party. The loan bears interest at 21% and had a maturity date of the earlier of an event of default or August 28, 2012. During December 2012, we amended the note to extend the due date to June 30, 2013. For consideration, the holder was granted a warrant to purchase 125,000 shares of our common stock equal to two and a half times the principal amount of the note amended, exercisable at $0.20 per share. We are not compliant with of the repayment terms of the note.

In March 2012, we commenced an offering of secured promissory notes for an aggregate principal amount of $1,000,000 with three-year warrants to purchase an aggregate of 2,500,000 shares our common stock (2.5 shares for each $1 of the principal amount of the notes purchased) exercisable at $0.10 per share. The notes bear interest at 18% and have various maturity dates beginning September 2, 2012. At the time of any new debt or equity financing by our Company, the principal and interest then due under the notes may be converted into the number of fully paid and non-assessable debt instruments, shares/or units issued in the financing. The full amount of the offering was not reached and notes in the aggregate principal amount of $850,000 and warrants to purchase an aggregate of 2,125,000 common shares were sold in the offering. In addition, the investment banker who facilitated the sale of the notes and warrants received a three-year warrant to purchase 212,500 shares of our common stock (10% of the number of shares of common stock issuable upon exercise of the warrants sold in the offering) exercisable at $0.10 per share. During October 2012 we amended the notes to remove the conversion right and extend the due date to June 30, 2013, and to amend the warrants to remove certain anti-dilution provisions. Holders of an aggregate of $775,000 in principal agreed to such amendments were granted a warrant to purchase 1,550,000 shares of our common stock equal to two times the principal amount of the note amended, exercisable at $0.50 per share. We are not compliant with of the repayment terms of the note.

-9-

In August 2012, we commenced an offering of secured promissory notes for an aggregate principal amount of $3,000,000 with three-year warrants to purchase an aggregate of 6,000,000 shares our common stock (two shares for each $1 of the principal amount of the notes purchased) exercisable at $0.50 per share. The notes bear interest at 18% and have a various maturity dates beginning March 13, 2013. At the time of any new debt or equity financing by our Company, the principal and interest then due under the notes may be converted into the number of fully paid and non-assessable debt instruments, shares/or units issued in the financing. The full amount of the offering was not reached and notes in the aggregate principal amount of $875,000 and warrants to purchase an aggregate of 1,750,000 common shares were sold in the offering. In addition, the investment banker who facilitated the sale of the notes and warrants received a three-year warrant to purchase 175,000 shares of our common stock (10% of the number of shares of common stock issuable upon exercise of the warrants sold in the offering) exercisable at $0.50 per share. We are not compliant with of the repayment terms of the note.

On August 1, 2012, we issued a $60,000 promissory note with an original issue discount of 20%. The promissory note had a maturity date of October 29, 2012. As a financing incentive, the lender received three-year warrants to purchase 50,000 shares of common stock at an exercise price of $0.50 per share. We are not compliant with of the repayment terms of the note.

On August 7, 2012, we issued a $30,000 promissory note with an original issue discount of 20%. The promissory note had a maturity date of November 5, 2012. As a financing incentive, the lender received three-year warrants to purchase 25,000 shares of common stock at an exercise price of $0.50 per share. We are not compliant with of the repayment terms of the note.

On August 22, 2012, we issued a $60,000 promissory note with an original issue discount of 20%. The promissory note had a maturity date of November 20, 2012. As a financing incentive, the lender received three-year warrants vesting to purchase 50,000 shares of common stock at an exercise price of $0.50 per share. We are not compliant with of the repayment terms of the note.

On August 23, 2012, we issued a $30,000 promissory note with an original issue discount of 20%. The promissory note had a maturity date of November 21, 2012. As a financing incentive, the lender received three-year warrants to purchase 25,000 shares of common stock at an exercise price of $0.50 per share. In December 2012, we re-paid the note.

In December 2012, we commenced an offering of secured promissory notes for an aggregate principal amount of $2,500,000 with three-year warrants to purchase an aggregate of 5,000,000 shares our common stock (two shares for each $1 of the principal amount of the notes purchased) exercisable at $0.50 per share. The notes bear interest at 18% and have a maturity date of June 30, 2013. The full amount of the offering was not reached and notes in the aggregate principal amount of $1,000,000 and warrants to purchase an aggregate of 2,000,000 common shares were sold in the offering. In addition, the investment banker who facilitated the sale of the notes and warrants received a three-year warrant to purchase 200,000 shares of our common stock (10% of the number of shares of common stock issuable upon exercise of the warrants sold in the offering) exercisable at $0.50 per share. We are not compliant with of the repayment terms of the note.

On May 8, 2013, the Company issued a $30,000 promissory note with an original issue discount of 20%.  The promissory note is due on the earlier of (i) the closing by the Company of a financing or series of financings for aggregate cash proceeds of at least $1,850,000, or, (ii) July 5, 2013. As a financing incentive, the lender received a three-year warrant, vesting immediately, to purchase 25,000 shares of common stock at an exercise price of $0.10 per share. We are not compliant with of the repayment terms of the note.

On May 15, 2013, the Company issued a $500,000 convertible promissory note with an original issue discount of $50,000. The convertible promissory note is due one year from each advance. After 90 days from each advance, a one-time 12% interest charge shall also be added to note. At any time, the outstanding principle and interest may be converted into fully paid and non-assessable shares of the Company’s common stock. The conversion price shall be 60% of the average closing price of the stock for the twenty-five (25) business days preceding the conversion notice. As of December 31, 2013, we have been advanced $40,000 on this note.

During April 2013 and June 2013, Barry Brookstein, CFO, loaned to the Company $37,050. The loan is evidenced by a promissory note payable with interest at 18% and is due on demand.

During June 2013, the Company issued a $53,000 convertible promissory note bearing interest at 8% per annum. The note funded on July 2, 2013. The convertible promissory note is due on March 10, 2014 and may be converted at any time into fully paid and non-assessable shares of the Company’s common stock. The conversion price shall be 51% of the closing price for the average three lowest trading days during the previous thirty (30) trading days preceding the conversion notice. In addition, the agreement requires the Company reserve 6,500,000 shares of the Company’s common stock for issuance upon full conversion of the of the convertible promissory note.

One July 9, 2013, an individual loaned to the Company $10,000. The loan is evidenced by a promissory note payable with interest at 18% and is due on demand.

-10-

During August 2013, the Company issued a $16,500 convertible promissory note bearing interest at 8% per annum. The convertible promissory note is due on May 8, 2014 and may be converted at any time into fully paid and non-assessable shares of the Company’s common stock. The conversion price shall be 51% of the closing price for the average three lowest trading days during the previous ten (10) trading days preceding the conversion notice. In addition, the agreement requires the Company reserve 1,800,000 shares of the Company’s common stock for issuance upon full conversion of the convertible promissory note.

During December 2013, the Company issued a $13,000 convertible promissory note bearing interest at 8% per annum. The convertible promissory note is due on September 15, 2014 and may be converted at any time into fully paid and non-assessable shares of the Company’s common stock. The conversion price shall be 51% of the closing price for the average three lowest trading days during the previous ten (10) trading days preceding the conversion notice. In addition, the agreement requires the Company reserve 20,000,000 shares of the Company’s common stock for issuance upon full conversion of the convertible promissory note.

Net Cash Flows

Net cash used in operating activities was $242,693 and $2,046,964 for the nine months ended September 30, 2013 and September 30, 2012, respectively. The decrease of $1,084,271 or 88% primarily was attributable to increased accounts payable and decreased accounts receivables and inventory as the Company suspending selling activities during the nine months ended September 30, 2013.

For the nine months ended September 30, 2013, net cash provided by financing activities was $84,778 compared to $2,113,755 for nine months ended September 30, 2012. The decrease of $2,028,977, or 96%, was related to proceeds from the sales of secured promissory notes in the nine months ended September 30, 2012.

At September 30, 2013 and 2012, respectively, we had outstanding options to purchase 7,717,896 and 4,455,177 shares of our common stock, and warrants to purchase 15,104,927 and 10,204,404 shares of our common stock. The outstanding stock options have a weighted average exercise price of $0.46 per share. The outstanding warrants have an exercise price from $0.001 to $0.50 per share. Accordingly, at September 30, 2013, the outstanding options and warrants represented a total of 22,822,823 shares issuable for a maximum of $7,762,912 if all of the options and warrants were exercised. The exercise of these options and warrants is at the discretion of the holder. There is no assurance that any of these options or any additional warrants will be exercised.

Off Balance Sheet Arrangements

Our Company does not have any off-balance sheet arrangements.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Not applicable.

ITEM 4. CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

The Company’s management team, under the supervision and with the participation of the Company’s principal executive officer and principal financial officer, evaluated the effectiveness of the design and operation of the Company’s disclosure controls and procedures as such term is defined under Rule 13a-15(e) promulgated under the Securities Exchange Act of 1934, as amended (Exchange Act), as of the last day of the fiscal period covered by this report, September 30, 2013. The term disclosure controls and procedures means the Company’s controls and other procedures that are designed to ensure that information required to be disclosed by us in the reports that the Company filed or submitted under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by us in the reports that the Company filed or submitted under the Exchange Act is accumulated and communicated to management, including the Company’s principal executive officer and principal financial officer, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.

-11-

The Company’s principal executive officer and principal financial officer are responsible for establishing and maintaining adequate internal control over financial reporting, as such term is defined in Exchange Act Rules 13a-15(f). Management is required to base its assessment of the effectiveness of the Company’s internal control over financial reporting on a suitable, recognized control framework, such as the framework developed by the Committee of Sponsoring Organizations (COSO). The COSO framework, published in Internal Control-Integrated Framework, is known as the COSO Report. The Company’s principal executive officer and principal financial officer, has chosen the COSO framework on which to base its assessment and conducted an evaluation of the effectiveness of the design and operation our disclosure controls and procedures as such term is defined under Rule 13a-15(e) promulgated under the Securities Exchange Act of 1934, as amended. Based on this evaluation, the Company’s principal executive officer and principal financial officer concluded that the Company’s disclosure controls and procedures were not effective as of September 30, 2013.

The controls designed were adequate for financial disclosures required for the preparation of the 10-Q filing; however due to lack of resources in the Company’s accounting department the controls were not operating effectively. The remediation plan for improving the effectiveness over financial disclosure controls, include the creation of a financial disclosures roll-forward model in accordance with the disclosures contained in the 10-Q report. This model will be maintained and updated by Company staff and management as new business transactions require additional financial disclosures. As the Company obtains additional resources these financial disclosures will be reviewed by an outside financial disclosure expert for completeness and accuracy earlier in the financial statement closing process cycle in order to help ensure completeness and accuracy for reporting financial disclosures.

It should be noted that any system of controls, however well designed and operated, can provide only reasonable and not absolute assurance that the objectives of the system are met. In addition, the design of any control system is based in part upon certain assumptions about the likelihood of certain events. Because of these and other inherent limitations of control systems, there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions, regardless of how remote.

Changes in internal control over financial reporting

There were no changes in our internal control over financial reporting, as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act, during our most recently completed fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

PART II-OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

In the normal course of business, we are, and in the future may be, subject to various disputes, claims, lawsuits, and administrative proceedings arising in the ordinary course of business with respect to commercial, product liability, employment, and other matters, which could involve substantial amounts of damages. In the opinion of management, any liability related to any such known proceeding would not have a material adverse effect on our business or financial condition. Additionally, from time to time, we may pursue litigation against third parties to enforce or protect our rights under our trademarks, trade secrets and our intellectual property rights generally.

During 2010, we were served with a lawsuit for our past due liabilities. The lawsuit was Peri & Sons, plaintiff, vs. Organic Alliance, Inc. and Parker Booth, defendants, for past due produce liabilities. An agreement was reached and OAI has been making payments to the plaintiff. OAI was dismissed from the action and signed a confession of judgment. Over half of the past due amount has been paid with a balance of approximately $21,000 remaining. The Company has accrued for this balance.

On June 20, 2013, the Company was served a lawsuit for a disputed loan issued by the Company. The lawsuit was Austin Noll Jr. plaintiff, vs. Organic Alliance, Inc. and DOES 1 through 50, defendants, for a $50,000 loan issued in July 2009. The case will be reviewed by the Company’s legal counsel. In July 2010, the Company issued stock to a third party with the obligation to pay Mr. Noll. The Company’s position is the loan was repaid by the Company in July 2010.

On July 30, 2013, the Company was served with a lawsuit for past due liabilities of the Company.  The lawsuit was Tom Ver. LLC d/b/a MexFresh Produce, plaintiff, vs. Organic Alliance, Inc., et al, for past due produce liabilities of $53,863.53. The lawsuit was filed in the United States District Court of the Northern District of California. . The case will be reviewed by the Company’s legal counsel.

-12-

On August 1, 2013, the Company received a “Notice of Labor Laws Violation” under California Labor Code 2699, 2699.3 and 2699.5. The notice was file by an employee, Kenneth Horwitz and all current and former employees against Organic Alliance, Inc. Parker Booth, CEO and Barry Brookstein, CFO. The notice alleges various California labor laws violations and seeks wages and penalties from the Company, Mr. Booth and Mr. Brookstein. The notice will be reviewed by the Company’s legal counsel.

ITEM 2. UNREGISTERED SALE OF EQUITY SECURITIES AND USE OF PROCEEDS

During March 2013, the Company issued 500,000 shares of the Company’s common stock to a consultant for investor and public relations services. The shares were valued at $0.11 per share or $55,000. The shares were issued pursuant to Section 4(2) of the Securities Act.

During May 2013, the Company issued a $30,000 promissory note with an original issue discount of 20%.  The promissory note is due on the earlier of (i) the closing by the Company of a financing or series of financings for aggregate cash proceeds of at least $1,850,000, or, (ii) July 5, 2013. As a financing incentive, the lender received a three-year warrant, vesting immediately, to purchase 25,000 shares of common stock at an exercise price of $0.10 per share. 

During June 2013, a consultant was granted a three-year warrant to purchase 250,000 shares of our Company’s common stock at $0.15 per share for accounting services to our Company. The warrant vests immediately.

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

In March 2012, we commenced an offering of secured promissory notes for an aggregate principal amount of $1,000,000 with three-year warrants to purchase an aggregate of 2,500,000 shares our common stock (2.5 shares for each $1 of the principal amount of the notes purchased) exercisable at $0.10 per share. The notes bear interest at 18% and have various maturity dates beginning September 2, 2012. At the time of any new debt or equity financing by our Company, the principal and interest then due under the notes may be converted into the number of fully paid and non-assessable debt instruments, shares/or units issued in the financing. The full amount of the offering was not reached and notes in the aggregate principal amount of $850,000 and warrants to purchase an aggregate of 2,125,000 common shares were sold in the offering. In addition, the investment banker who facilitated the sale of the notes and warrants received a three-year warrant to purchase 212,500 shares of our common stock (10% of the number of shares of common stock issuable upon exercise of the warrants sold in the offering) exercisable at $0.10 per share. During October 2012 we amended the notes to remove the conversion right and extend the due date to September 30, 2013, and to amend the warrants to remove certain anti-dilution provisions. Holders of an aggregate of $775,000 agreed to such amendments were granted a warrant to purchase 1,550,000 shares of our common stock equal to two times the principal amount of the note amended, exercisable at $0.50 per share. We defaulted on the notes, and the unpaid balance, including accrued interest, was $963,356 at September 30, 2013. We currently are seeking to amend the notes.

In August 2012, we commenced an offering of secured promissory notes for an aggregate principal amount of $3,000,000 with three-year warrants to purchase an aggregate of 6,000,000 shares our common stock (two shares for each $1 of the principal amount of the notes purchased) exercisable at $0.50 per share. The notes bear interest at 18% and have a various maturity dates beginning March 13, 2013. At the time of any new debt or equity financing by our Company, the principal and interest then due under the notes may be converted into the number of fully paid and non-assessable debt instruments, shares/or units issued in the financing. The full amount of the offering was not reached and notes in the aggregate principal amount of $875,000 and warrants to purchase an aggregate of 1,750,000 common shares were sold in the offering. In addition, the investment banker who facilitated the sale of the notes and warrants received a three-year warrant to purchase 175,000 shares of our common stock (10% of the number of shares of common stock issuable upon exercise of the warrants sold in the offering) exercisable at $0.50 per share. We defaulted on the notes, and the unpaid balance, including accrued interest, was $992,801 at September 30, 2013. We currently are seeking to amend the notes.

In December 2012, we commenced an offering of secured promissory notes for an aggregate principal amount of $2,500,000 with three-year warrants to purchase an aggregate of 5,000,000 shares our common stock (two shares for each $1 of the principal amount of the notes purchased) exercisable at $0.50 per share. The notes bear interest at 18% and have a maturity date of September 30, 2013. The full amount of the offering was not reached and notes in the aggregate principal amount of $1,000,000 and warrants to purchase an aggregate of 2,000,000 common shares were sold in the offering. In addition, the investment banker who facilitated the sale of the notes and warrants received a three-year warrant to purchase 200,000 shares of our common stock (10% of the number of shares of common stock issuable upon exercise of the warrants sold in the offering) exercisable at $0.50 per share. We defaulted on the notes, and the unpaid balance, including accrued interest, was $1,134,630 at September 30, 2013. We currently are seeking to amend the notes.

-13-

ITEM 6. EXHIBITS

31.1	Certification of Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act
31.2	Certification of Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act
32.1	Certification of Chief Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act
32.2	Certification of Chief Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act

-14-

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

ORGANIC ALLIANCE, INC.

Date: December 31, 2013	Organic Alliance, Inc.
	By: /s/ Parker Booth
	Parker Booth Chief Executive Officer and Director

Date: December 31, 2013	Organic Alliance, Inc.
	By: /s/ Barry Brookstein
	Barry Brookstein Chief Financial Officer

-15-

INDEX TO EXHIBIT

Exhibit No. Description

31.1 31.2 32.1 32.2 Certification of Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act Certification of Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act Certification of Chief Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act Certification of Chief Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act

EX-31.1

Exhibit 31.1

Certification of Principal Executive Officer

Required By Rule 13a-14(A) of the Securities Exchange Act of 1934, As Amended,

As Adopted Pursuant To Section 302 of the Sarbanes-Oxley Act of 2002

I, Parker Booth, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Organic Alliance, Inc. for the quarter ended September 30, 2013;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: December 31, 2013

/s/ Parker Booth

Name: Parker Booth

Title: Chief Executive Officer

EX-31.2

Exhibit 31.2

Certification of Principal Financial Officer

Required By Rule 13a-14(A) of the Securities Exchange Act of 1934, As Amended,

As Adopted Pursuant To Section 302 of the Sarbanes-Oxley Act of 2002

I, Barry Brookstein, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Organic Alliance, Inc. for the quarter ended September 30, 2013;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: December 31, 2013

/s/ Barry Brookstein

Name: Barry Brookstein

Title: Chief Financial Officer

EX-32.1

Exhibit 32.1

Certification of Principal Executive Officer, pursuant to 18 U.S.C. Section 1350,

as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

In connection with the quarterly report of Organic Alliance, Inc. (the “Company”) on Form 10-Q for the quarter ended September 30, 2013 (the “Report”), I, Parker Booth, Chief Executive Officer of the Company hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:

1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2.

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

This certification accompanies the Form 10-Q to which it relates, is not deemed filed with the Securities and Exchange Commission and is not to be incorporated by reference into any filing of Organic Alliance, Inc. under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended (whether made before or after the date of the Form 10-Q), irrespective of any general incorporation language contained in such filing. /s/ Parker Booth Name: Parker Booth Title: Chief Executive Officer Date: December 31, 2013

EX-32.2

Exhibit 32.2

Certification of Principal Financial Officer, pursuant to 18 U.S.C. Section 1350,

as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

In connection with the quarterly report of Organic Alliance, Inc. (the “Company”) on Form 10-Q for the quarter ended September 30, 2013 (the “Report”), I, Barry Brookstein, Chief Executive Officer of the Company hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:

1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

This certification accompanies the Form 10-Q to which it relates, is not deemed filed with the Securities and Exchange Commission and is not to be incorporated by reference into any filing of Organic Alliance, Inc. under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended (whether made before or after the date of the Form 10-Q), irrespective of any general incorporation language contained in such filing.

/s/ Barry Brookstein

Name: Barry Brookstein

Title: Chief Financial Officer

Date: December 31, 2013

XML

Accrued Expenses and other Liabilities

9 Months Ended

Sep. 30, 2013

Payables and Accruals [Abstract]

Accrued Expenses and other Liabilities

12. ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES

Accrued expenses and other current liabilities consist of the following:

	September 30, 2013		December 31, 2012
Due to consultant (Note 10)	$	100,000	$	100,000
Payroll and payroll taxes payable (A)		1,692,089		1,399,049
Other accrued liabilities		36,745		235,814
	$	1,828,834	$	1,734,863

(A) As of September 30, 2013 and December 31, 2012, the Company has unpaid payroll taxes including penalties and interest of $320,622 and $286,027, respectively, which have yet to be remitted to the taxing authorities and returns have yet to be filed.

XML

Condensed Consolidated Statements of Operations (USD $)	3 Months Ended		9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Revenue		$ 335,456	$ 981,205	$ 1,301,757
Cost of sales		304,274	861,180	1,177,694
Gross margin		31,182	120,025	124,063
General and administrative expenses	297,235	564,486	1,809,087	2,118,500
Operating loss	(297,235)	(533,304)	(1,689,062)	(1,994,437)
Other expense (income) :
Interest expense	252,434	806,428	1,055,501	1,612,249
Change in fair value of derivative liability	1,100,450	2,274,621	807,056	4,272,565
Total other expense (income)	1,352,884	3,081,049	1,862,557	5,884,814
Net loss	(1,650,119)	(3,614,353)	(3,551,619)	(7,879,251)
Basic and diluted loss per share	$ (0.08)	$ (0.21)	$ (0.18)	$ (0.46)
Weighted average number of common shares outstanding - basic and diluted	19,629,743	16,971,814	19,519,853	17,228,350
Development Stage [Member]
Revenue
Cost of sales
Gross margin
General and administrative expenses	297,235
Operating loss	(297,235)
Other expense (income) :
Interest expense	252,434
Change in fair value of derivative liability	1,100,450
Total other expense (income)	1,352,884
Net loss	$ (1,650,119)

XML

Preferred Stock

9 Months Ended

Sep. 30, 2013

Equity [Abstract]

Preferred Stock

5 . PREFERRED STOCK

The Company’s articles of incorporation authorize its Board of Directors to issue up to 10,000,000 shares of preferred stock in one or more series without stockholder approval. Each such series of preferred stock may have such number of shares, designations, preferences, voting powers, qualifications, and special or relative rights or privileges as are determined by The Company’s Board of Directors. At September 30, 2013 and December 31 2012, no shares of preferred stock were issued or outstanding.

XML

Accrued Expenses and other Liabilities (Tables)

9 Months Ended

Sep. 30, 2013

Payables and Accruals [Abstract]

Accrued Liabilities

	September 30, 2013		December 31, 2012
Due to consultant (Note 10)	$	100,000	$	100,000
Payroll and payroll taxes payable (A)		1,692,089		1,399,049
Other accrued liabilities		36,745		235,814
	$	1,828,834	$	1,734,863

XML

Subsequent Events

9 Months Ended

Sep. 30, 2013

Subsequent Events [Abstract]

Subsequent Events

13. SUBSEQUENT EVENTS

During December 2013, the Company issued a $13,000 convertible promissory note bearing interest at 8% per annum. The convertible promissory note is due on September 15, 2014 and may be converted at any time into fully paid and non-assessable shares of the Company’s common stock. The conversion price shall be 51% of the closing price for the average three lowest trading days during the previous ten (10) trading days preceding the conversion notice. In addition, the agreement requires the Company reserve 20,000,000 shares of the Company’s common stock for issuance upon full conversion of the convertible promissory note. The conversion price of the note was not fixed and determinable on the date of issuance and as such in accordance with ASC Topic 815 “Derivatives and Hedging” (“ASC 815”), the embedded conversion options of the note on the date of issuance was valued using the binomial lattice options pricing model and recorded as a derivative liability.

XML

Commitments - Leases (Details) (USD $)	9 Months Ended	12 Months Ended
	Sep. 30, 2013	Jun. 30, 2015	Mar. 30, 2014
Commitments - Leases Details
Monthly rent	$ 4,200	$ 4,500	$ 4,350

XML

Notes payable, Loans and Derivative Liabilities:Notes Payable-Related Party Additional(Details Narrative) (Notes Payable Related Party, USD $)	3 Months Ended	9 Months Ended
	Sep. 30, 2013	Sep. 30, 2013
Note 4
Debt Discount Interest Expense		$ 85,342
Debt Discount Interest Expense - on Modified Note		42,376
Note 5
Debt Discount Interest Expense	2,592	7,997
Debt Discount Interest Expense - on Modified Note		$ 5,298

XML

Summary of Significant Accounting Policies Fair Value Assumptions (Details Narrative) (Binomial lattice)	9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012
Minimum
Risk-free rate interest rate	0.02%	0.14%
Dividend yield	0.00%	0.00%
Expected volatility	26.40%	31.60%
Expected life in months and years	0 years 3 months 0 days	0 years 3 months 0 days
Maximum
Risk-free rate interest rate	0.63%	0.31%
Dividend yield	0.00%	0.00%
Expected volatility	48.70%	56.00%
Expected life in months and years	2 years 8 months 0 days	4 years 3 months 0 days

XML

Summary of Significant Accounting Policies (Details Narrative) (USD $) (USD $)	Sep. 30, 2013	Dec. 31, 2012
Allowance for Doubtful Accounts	$ 7,001	$ 5,000
Inventory from growers		(34,547)
Packing materials		(105,341)
Inventory		$ 139,888
Minimum
Days of payment	10
Factoring Accounts Receivable, fees	3.00%
Maximum
Days of payment	30
Factoring Accounts Receivable, fees	5.00%

XML

Stock options and Warrants - Warrants (Details)	9 Months Ended
	Sep. 30, 2013
Total Warrants
Number of Warrants Outstanding and Exercisable	15,104,927
Weighted Average Remaining Life in years	2 years 1 month 4 days
452,354
Exercise Price	0.01
Number of Warrants Outstanding and Exercisable	452,354
Weighted Average Remaining Life in years	2 years 3 months 3 days
692,802
Exercise Price	0.10
Number of Warrants Outstanding and Exercisable	692,802
Weighted Average Remaining Life in years	2 years 3 months 8 days
705,882
Exercise Price	0.25
Number of Warrants Outstanding and Exercisable	705,882
Weighted Average Remaining Life in years	2 years 5 months 8 days
575,000
Exercise Price	0.25
Number of Warrants Outstanding and Exercisable	575,000
Weighted Average Remaining Life in years	2 years 7 months 1 day
452,355
Exercise Price	0.01
Number of Warrants Outstanding and Exercisable	452,355
Weighted Average Remaining Life in years	2 years 7 months 5 days
1.098,220
Exercise Price	0.25
Number of Warrants Outstanding and Exercisable	1,098,220
Weighted Average Remaining Life in years	2 years 7 months 9 days
195,291
Exercise Price	0.001
Number of Warrants Outstanding and Exercisable	195,291
Weighted Average Remaining Life in years	1 year 0 months 0 days
1,000,000
Exercise Price	0.10
Number of Warrants Outstanding and Exercisable	1,000,000
Weighted Average Remaining Life in years	1 year 1 month 3 days
125,000
Exercise Price	0.10
Number of Warrants Outstanding and Exercisable	125,000
Weighted Average Remaining Life in years	1 year 4 months 2 days
300,000
Exercise Price	0.25
Number of Warrants Outstanding and Exercisable	300,000
Weighted Average Remaining Life in years	1 year 4 months 72 days
1,197,437
Exercise Price	0.10
Number of Warrants Outstanding and Exercisable	1,197,437
Weighted Average Remaining Life in years	1 year 4 months 6 days
50,000
Exercise Price	0.50
Number of Warrants Outstanding and Exercisable	50,000
Weighted Average Remaining Life in years	1 year 8 months 3 days
25,000
Exercise Price	0.50
Number of Warrants Outstanding and Exercisable	25,000
Weighted Average Remaining Life in years	1 year 8 months 3 days
50,000
Exercise Price	0.50
Number of Warrants Outstanding and Exercisable	50,000
Weighted Average Remaining Life in years	1 year 9 months 2 days
25,000
Exercise Price	0.50
Number of Warrants Outstanding and Exercisable	25,000
Weighted Average Remaining Life in years	1 year 9 months 2 days
250,000
Exercise Price	0.25
Number of Warrants Outstanding and Exercisable	250,000
Weighted Average Remaining Life in years	1 year 7 months 5 days
1,870,000
Exercise Price	0.50
Number of Warrants Outstanding and Exercisable	1,870,000
Weighted Average Remaining Life in years	1 year 9 months 2 days
55,000
Exercise Price	0.50
Number of Warrants Outstanding and Exercisable	55,000
Weighted Average Remaining Life in years	2 years 0 months 0 days
1,550,000
Exercise Price	0.50
Number of Warrants Outstanding and Exercisable	1.550000
Weighted Average Remaining Life in years	2 years 0 months 8 days
1,125,000
Exercise Price	0.50
Number of Warrants Outstanding and Exercisable	1,125,000
Weighted Average Remaining Life in years	2 years 1 month 7 days
1,000,000
Exercise Price	0.50
Number of Warrants Outstanding and Exercisable	1,000,000
Weighted Average Remaining Life in years	2 years 1 month 7 days
1,200,000
Exercise Price	0.25
Number of Warrants Outstanding and Exercisable	1,200,000
Weighted Average Remaining Life in years	2 years 2 months 5 days
500,000
Exercise Price	0.50
Number of Warrants Outstanding and Exercisable	500,000
Weighted Average Remaining Life in years	2 years 2 months 5 days
25,000
Exercise Price	0.10
Number of Warrants Outstanding and Exercisable	25,000
Weighted Average Remaining Life in years	2 years 6 months 3 days
335,586
Exercise Price	0.20
Number of Warrants Outstanding and Exercisable	335,586
Weighted Average Remaining Life in years	4 years 2 months 1 day
250,000
Exercise Price	0.15
Number of Warrants Outstanding and Exercisable	250,000
Weighted Average Remaining Life in years	2 years 6 months 7 days

XML

Notes payable, Loans and Derivative Liabilities - Notes payable (Details) (USD $)	Sep. 30, 2013	Dec. 31, 2012
Notes to Financial Statements
Notes Payable (net of debt discount $0 and $133,827 at September 30, 2013 and December 31, 2012, respectively) (A)	$ 2,995,390	$ 2,512,753
Notes Payable- Related Parties (net of debt discount of $0 and $47,673 at September 30, 2013 and December 31, 2012, respectively) (B)	671,257	509,696
Convertible Notes Payable (net of debt discount of $79,298and $217,535 at September 30, 2013 and at December 31, 2012, respectively) (C)	1,305,610	914,506
Total	$ 4,972,257	$ 3,936,955

XML

Notes payable, Loans and Derivative Liabilities:Notes Payable-Convertible Notes Payable Additional (Details Narrative) (Convertible Notes Payable, USD $)	3 Months Ended		9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Note 4
Debt Discount Interest Expense	$ 443,655		$ 789,073
Note 4 Modifed Note
Debt Discount Interest Expense			105,570
Note 5
Debt Discount Interest Expense		64,116	217,535	64,116
Note 6
Debt Discount Interest Expense	$ 7,118	$ 10,677	$ 7,118	$ 10,677

XML

Commitments and Contingencies Litigation (Details Narrative) (USD $) (USD $)	9 Months Ended
	Sep. 30, 2013
Lawsuit 1
Litigation
Damages Sought	$ 21,000
Lawsuit 2
Litigation
Damages Sought	50,000
Lawsuit 3
Litigation
Damages Sought	$ 53,863

XML

Due to Factor (Details Narrative) (USD $)	Sep. 30, 2013	Dec. 31, 2012
Notes to Financial Statements
Factor, Accounts Receivable percentage	80.00%
Collateral, Accounts Receivable percentage	20.00%
Advances from Accounts Receivable	$ 118,561	$ 213,778

XML

Stock options and Warrants (Details Narrative) (USD $)	3 Months Ended		9 Months Ended		0 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012	Oct. 05, 2012 Vice President	Jul. 03, 2011 Vice President	Jan. 06, 2012 Director of Sales	Apr. 24, 2012 Director	May 18, 2012 Director of National Sales	Aug. 31, 2012 Manager, National Retail Sales
Options					3,837,719	2,950,000	1,500,000	325,000	500,000	396,427
Per Share					$ 0.62	$ 0.20	$ 0.20	$ 0.25	$ 0.25	$ 0.35
Life					7 years	7 years	5 years	3 years	3 years	3 years
Options Vested					2,250,000	1,180,000	250,000	100,000	100,000	135,714
Options vest each three months					198,250
Options vest each six months						295,000
Options vest each year							416,667	75,000	134,000	86,904
Fair Value options					$ 1,221,493	$ 317,400	$ 44,000	$ 18,400	$ 33,900	$ 102,524
Stock Based Compensation Expense	$ 0	$ 35,099	$ 294,276	$ 97,922

XML

Nature of Business (Details Narrative)	0 Months Ended
	Apr. 29, 2008
Notes to Financial Statements
Common Stock, Shares for Mergers	10,916,917
Common Stock, shares acquired	464,999

XML

Nature of Business

9 Months Ended

Sep. 30, 2013

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Nature of Business

1.  NATURE OF BUSINESS

Organic Alliance, Inc. is a global grower and marketer of organic, Fair Trade and conventional fresh fruits and vegetables. By establishing collaborative relationships with key growers, the Company has built a vertically integrated supply chain that enables it to support its customers with an increasing variety of certified sustainable products, sensible pricing, steady supply and inspiring multi-media stories from our many producing communities.

History - NB Design & Licensing, Inc. (“NB Design”), a Nevada corporation, was organized in September 2001. Its former parent, New Bridge Products, Inc., incorporated in August 1995 as a manufacturer of minivans, filed a petition in bankruptcy under Chapter 11 of the U.S. Bankruptcy Code. Its Plan of Reorganization was approved by the U.S. Bankruptcy Court for the District of Arizona in September 2002, and NB Design was discharged from bankruptcy in October 2002. NB Design was inactive from October 2002 to April 29, 2008.

Organic Alliance, Inc., a Texas corporation (“Organic Texas”) was organized on February 19, 2008 to sell organically grown fruits and vegetables. During the second quarter of 2009, it ceased being a development stage company when it commenced its operations.

On April 29, 2008, NB Design acquired all 10,916,917 issued and outstanding shares of common stock of Organic Texas for 464,999 shares of the NB Design’s common stock. Organic Texas thereupon became a wholly-owned subsidiary of NB Design. The business of Organic Texas is the only business of NB Design. The Company operates in California.

The acquisition of Organic Texas, a private operating company, by NB Design, a non-operating public shell corporation with nominal net assets, was accounted for as a reverse capitalization in accordance with the Securities and Exchange Commission’s (“SEC”) Division of Corporate Financial Reporting manual Topic 12 “Reverse Acquisition and Reverse Capitalization”. As such, the acquisition was treated as a capital transaction rather than a business combination, and no goodwill was recorded. NB Design was the legal acquirer because it issued its equity interests, and Organic Texas was the legal acquiree because its equity interests were acquired. However, NB Design was the acquiree and Organic Texas was the acquirer for accounting purposes. Organic Texas is treated as the continuing reporting entity that acquired the registrant, NB Design. The pre-acquisition financial statements of Organic Texas are treated as the historical financial statements of the consolidated companies.

On June 2, 2008, NB Design changed its name to Organic Alliance, Inc. On August 29, 2008, Organic Texas changed its name to Organic Texas, Inc. All references throughout this report to “Organic Alliance, Inc.” or the “Company” refers to Organic Alliance, Inc. and its wholly-owned subsidiary, Organic Texas, except where the context makes clear that the reference is only to Organic Alliance, Inc.

On July 1, 2013, the Company temporarily suspended operations and elected to enter the development stage. The Company will be pursuing other business opportunities in addition to the organic and Fair Trade certified fruits and vegetables global market.

XML

Going Concern

9 Months Ended

Sep. 30, 2013

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Going Concern

3 . GOING CONCERN

The condensed consolidated financial statements have been prepared using accounting principles generally accepted in the United States of America applicable for a going concern, which assume that the Company will realize its assets and discharge its liabilities in the ordinary course of business. As of September 30, 2013, the Company had limited cash, a working capital deficit of approximately $9,839,000, accumulated losses of approximately $24,128,000 since its inception of which $1,650,119 are deficits accumulated during the development stage, and has $320,622 of payroll tax liabilities inclusive of penalties and interest withheld from wages paid which have yet to be remitted to the taxing authorities and are delinquent. The Company currently is delinquent with its payroll tax filings since December 31, 2008; however, since April 1, 2012 the Company has been remitting payroll tax on a current basis. The Company ceased paying payroll beginning May 1, 2013. Most employees were furloughed or resigned by May 31, 2013. At September 30, 2013, the Company was not compliant with the repayments terms of various notes payable for an aggregate of approximately $4,838,000 including accrued interest. Its ability to continue as a going concern is dependent upon the ability of the Company to obtain the necessary financing to meet its obligations and pay its liabilities arising from normal business operations when they come due, and increasing its revenue in order to achieve profitable operations. The outcome of these matters cannot be predicted with any certainty at this time and raise substantial doubt that the Company will be able to continue as a going concern. These consolidated financial statements do not include any adjustments to the amounts and classification of assets and liabilities that may be necessary should the Company be unable to continue as a going concern.

The Company intends to overcome the circumstances that impact its ability to remain a going concern through pursing new business opportunities, with interim cash flow deficiencies being addressed through additional equity and debt financing. The Company anticipates raising additional funds through public or private financing, strategic relationships or other arrangements in the near future to support its business operations; however the Company does not have commitments from third parties for a sufficient amount of additional capital, the Company cannot be certain that any such financing will be available on acceptable terms, or at all, and its failure to raise capital when needed could limit its ability to continue or resume its operations. The Company’s ability to obtain additional funding will determine its ability to continue as a going concern. Furthermore, additional equity financing may be dilutive to the holders of the Company’s common stock, and debt financing, if available, may involve restrictive covenants or may require that the Company relinquish valuable rights.

XML

Equity Transactions

9 Months Ended

Sep. 30, 2013

Equity [Abstract]

Equity Transactions

6. EQUITY TRANSACTIONS

During March 2013, the Company issued 500,000 shares of the Company’s common stock to a consultant for investor and public relations services. The fair value of the award was fully vested on the date of issuance and accordingly the Company recorded a charge for stock based compensation of $55,000 or $0.11 per share in the accompanying condensed consolidated statements of operations.

XML

Due to Factor

9 Months Ended

Sep. 30, 2013

Receivables [Abstract]

Due to Factor

4 . DUE TO FACTOR

On November 1, 2010, the Company signed a one year agreement with a financial services company for the purchase and sale of accounts receivables which expired on October 31, 2011. The agreement is continuing on a month to month basis. The financial services company commenced funding during February 2011. The financial services company advances up to 80% of qualified customer invoices, less applicable discount fees, and holds the remaining 20% as a reserve until the customer pays the financial services company. The released reserves are used to fund other vendor purchases or returned to the Company. The Company is charged 3% for the first 30 days outstanding plus 1/10 of 1% daily for funds outstanding over 30 days. Uncollectable customer invoices are charged back to the Company. At September 30, 2013 and December 31, 2012 the advances from the factor, inclusive of fees, amounted to $118,561 and $213,778, respectively. Advances from the factor are collateralized by substantially all assets of the Company. The Company is in default of this agreement.

XML

FAIR VALUE MEASUREMENTS - Liability measured at fair value on a recurring basis (Details) (USD $)	Sep. 30, 2013	Dec. 31, 2012	Dec. 31, 2011
Warrant derivative liability	$ 1,393,054	$ 432,030	$ 155,813
Level 1
Warrant derivative liability	0	0
Level 2
Warrant derivative liability	0	0
Level 3
Warrant derivative liability	$ 1,393,054	$ 432,030

XML

Summary of Significant Accounting Policies Share Based Compensation (Details Narrative)	9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012
Minimum
Risk -free interest rates	0.34%	0.32%
Dividend yield	0	0
Expected Volatility	34.70%	36.40%
Expected life in years	3 years 0 months 0 days	2 years 5 months 0 days
Maximum
Risk -free interest rates	2.54%	2.54%
Dividend yield	0	0
Expected Volatility	54.20%	50.20%
Expected life in years	7 years 0 months 0 days	7 years 0 months 0 days

XML

Preferred Stock (Details Narrative) (USD $)	Sep. 30, 2013	Dec. 31, 2012
Notes to Financial Statements
Preferred stock, par value	$ 0	$ 0
Preferred stock, shares authorized	10,000,000	10,000,000

XML

Notes payable, Loans and Derivative Liabilities:Notes Payable-Related Party(Details Narrative) (USD $) (Notes Payable Related Party, USD $)	9 Months Ended	12 Months Ended
	Sep. 30, 2013	Dec. 31, 2012
Note 1
Date	2008-09
Note Payable Issued	$ 15,000
Interest Rate	10.00%
Expiration date	Sep. 13, 2009
Note Payable	22,568	21,446
Note 2
Date	2009-11
Note Payable Issued	10,000
Date	2010-02
Additional Note payable issued	15,000
Interest Rate	5.00%
Warrants Authorized	2,770
Expiration date	Jun. 30, 2010
Expiration date	Sep. 30, 2010
Debt Discount	2,935
Note Payable	29,661	28,726
Note 3
Date	2010-03
Note Payable Issued	16,000
Date	2011-10
Additional Note payable issued	49,958
Interest Rate	5.00%
Warrants Authorized		47,690
Payments on notes payable	9,000
Additional payments on notes payable	8,000
Note Payable	56,381	54,551
Note 4
Date	Oct. 17, 2011
Note Payable Issued	400,000
Interest Rate	21.00%
Shares to purchase	2.5
Per loan amount	1
Warrants Authorized	1,000,000
Gross proceeds	125,000
Additional gross proceeds	275,000
Warrants Issued	312,500
Additonal Warrants Issued	687,500
Conversion Price	$ 0.10
Conversion price on modified note	$ 0.20
Expiration date	Apr. 17, 2012
Expiration Date - on Modified Note	Jun. 30, 2013
Debt Discount	85,342
Debt Discount on modified note	42,376
Vesting Terms	3 years
Warrants Fair Market Value	105,363
Warrant Issued - on Modified Note	49,439
Note Payable	462,828	400,000
Note 5
Date	Feb. 28, 2012
Note Payable Issued	50,000
Interest Rate	21.00%
Warrants Issued	125,000
Conversion Price	$ 0.10
Conversion price on modified note	$ 0.20
Expiration date	Aug. 28, 2012
Expiration Date - on Modified Note	Jun. 30, 2013
Debt Discount	7,997
Debt Discount on modified note	6,180
Vesting Terms	3 years
Warrant Issued - on Modified Note	5,298
Note Payable	60,500	52,647
Note 6
Date	2013-04
Note Payable Issued	37,050
Interest Rate	18.00%
Note Payable	$ 39,319

XML

Accrued Expenses and other Liabilities - Accrued Liabilities (Details) (USD $)	Sep. 30, 2013	Dec. 31, 2012
Accrued expenses and other current liabilities	$ 1,828,834	$ 1,734,863
Payroll tax liabilities	320,622	286,027
Consultant
Accrued expenses and other current liabilities	100,000	100,000
Payroll and payroll taxes payable
Accrued expenses and other current liabilities	1,692,089	1,399,049
Other Accrued Liabilites
Accrued expenses and other current liabilities	$ 36,745	$ 235,814

XML

Stock options and Warrants - Common Stock Warrant Summary (Details) (Common Stock Warrants, USD $)	9 Months Ended	12 Months Ended
	Sep. 30, 2013	Dec. 31, 2012
Common Stock Warrants
Warrant Activity
Beginning Balance	14,494,341	5,862,140
Granted	610,586	10,775,000
Exercised		(2,039,735)
Forfeited/cancelled		(103,064)
Balance outstanding and exercisable, Number of Warrants	15,104,927	14,494,341
Weighted Average Exericse Price
Beginning Balance	$ 0.28	$ 0.12
Granted	$ 0.15	$ 0.34
Exercised		$ 0.10
Forfeited/cancelled		$ 0.10
Ending Balance	$ 0.28	$ 0.28
Weighted Remaining Contractual Life (Years)
Exercisable at September 30, 2013	2 years 1 month 4 days
Intrinsic Value
Balance	$ 23,758
Exercisable at September 30, 2013	$ 23,758
Intinsic value per share	$ 0.03

XML

Condensed Consolidated Balance Sheet (Parenthetical) (USD $)	Sep. 30, 2013	Dec. 31, 2012
Statement of Financial Position [Abstract]
Preferred stock, par value	$ 0	$ 0
Preferred stock, shares authorized	10,000,000	10,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value	$ 0.0001	$ 0.0001
Common stock, shares authorized	100,000,000	100,000,000
Common stock, shares issued	18,473,554	17,795,376
Common stock, shares outstanding	18,473,554	17,795,376
Common stock in reserve, shares issued	36,300,000

XML

Stock options and Warrants

9 Months Ended

Sep. 30, 2013

Temporary Equity Disclosure [Abstract]

Stock options and Warrants

9. STOCK OPTIONS AND WARRANTS

Stock Options – Employment Letter Agreement:

On July 3, 2011, in conjunction with Chris White’s employment as the Company’s Vice President of Global Supply Chain, the Company granted Mr. White a seven-year option to purchase 2,950,000 shares of the Company’s common stock at $0.20 per share. The option vested as to 1,180,000 shares on the date of grant, and vests as to 295,000 on each of the first six semi-annual anniversaries of the grant date. The fair value of the option was approximately $317,400. During May 2013, Mr. White resigned from the Company and in accordance with the terms of his non-qualified stock option agreement, all the option shares vest immediately with a revised expiration date of November 17, 2013.

On January 6, 2012, in conjunction with Mark Zeller’s employment as the Company’s North American Director of Sales, the Company granted Mr. Zeller a five-year option to purchase 1,500,000 shares of the Company’s common stock at $0.20 per share. The option vested as to 250,000 on the date of grant, and vests as to 416,667 on each of the first three anniversaries of the grant date. The fair value of the option was approximately $44,000. On May 1, 2012, Mr. Zeller resigned from the Company and the option terminated in accordance with its terms.

On April 24, 2012, in conjunction with Roger Zardo’s employment as the Company’s Director of National Procurement, the Company granted Mr. Zardo a three-year option to purchase 325,000 shares of the Company’s common stock at $0.25 per share. The option vested as to 100,000 on the date of grant, vests as to 75,000 shares on each of the first two anniversaries of the grant date, and vests as to 75,000 shares on November 28, 2014. The fair value of the option was approximately $18,400. During March 2013, Mr. Zardo resigned from the Company and the option terminated in accordance with its terms.

On May 18, 2012, in conjunction with Jack Connelly’s employment as the Company’s Director of National Sales, the Company granted Mr. Connelly a three-year option to purchase 500,000 shares of the Company’s common stock at $0.25 per share. The option vested as to 100,000 on the date of grant, vests as to 134,000 shares on each of the first two anniversaries of the grant date, and vests as to the final 132,000 shares on November 29, 2014. The fair value of the option was approximately $33,900. On July 1, 2013, Mr. Connelly resigned from the Company and in accordance with the terms of his non-qualified stock option agreement, all the option shares vest immediately with a revised expiration date of December 31, 2013.

On August 31, 2012, in conjunction with George Borzilleri’s employment as the Company’s Manager, National Retail Sales, the Company granted Mr. Borzilleri a three-year option to purchase 396,427 shares of the Company’s common stock at $0.35 per share. The option vested as to 135,714 shares on the date of grant, vests as to 86,904 shares on each of the first two anniversaries of the grant date, and vests as to the final 86,905 shares on March 6, 2015. The fair value of the option was approximately $102,524. On July 1, 2013, Mr. Borzilleri resigned from the Company and in accordance with the terms of his non-qualified stock option agreement, all the option shares vest immediately with a revised expiration date of December 31, 2013.

On October 5, 2012, Chris White, the Company’s Vice President of Global Supply was granted a seven year non-qualified stock option to purchase 3,837,719 shares of the Company’s common stock at $0.62 per share. The fair value of the option was $1,221,493. The option vests as follows:

750,000 shares vest immediately.

750,000 shares vest upon receipt of certificates issued by IMO Control (Institute for Marker Ecology) certifying compliance with IMO Controls ‘For Life’ Fair Trade standards for three key Company suppliers.

750,000 shares vest upon the launch by Mr. White of an internal “alpha” demonstration website that contains certain functionality.

198,250 shares vest on each of the next 8 quarter dates starting January 6, 2013 through October 6,^, 2014. The final quarterly vesting will be 199,969 shares.

The Company recognized stock based compensation expense associated with stock options included in general and administrative expenses on the condensed consolidated statement of operations of $0 and $35,099 for the three months ended September 30, 2013 and 2012, respectively, and $294,276 and $97,922 for the nine months ended September 30, 2013 and 2012, respectively for these awards.

Options Summary:

A summary of option activity during the nine months ended September 30, 2013 and the year ended December 31, 2012 is presented below:

						Weighted
				Weighted		Average
				Average		Remaining
				Exercise		Contractual		Intrinsic
	Shares			Price		Term		Value
Balance at December 31, 2011		2,983,750		$	0.31		4.00	$	—
Granted		6,559,146			0.46		3.55		—
Exercised		—			—		—		—
Forfeited		(1,500,000	)		0.20		—		—
Balance at December 31, 2012		8,042,896			0.45		3.47		88,500
Granted		—			—		—		—
Exercised		—			—		—		—
Forfeited		(325,000	)		0.25		—		—
Balance at September 30, 2013		7,717,896		$	0.46		.18	$	—
Exercisable at September 30, 2013		7,191,183		$	0.46		.18	$	—

The Company has fully amortized all stock options.

Common Stock Warrants:

During June 2013, a consultant was granted a three-year warrant to purchase 250,000 shares of our Company’s common stock at $0.15 per share for accounting services to our Company. The warrant vests immediately.

Warrant transactions during the nine months ended September 30, 2013 and the year ended December 31, 2012 were as follows:

				Weighted		Average
				Average		Remaining
	Number of			Exercise		Life		Intrinsic
	Warrants			Price		In Years		Value
Balance, December 31, 2011		5,862,140		$	0.12
Granted		10,775,000			0.34
Exercised		(2,039,735	)		0.10
Forfeited		(103,064	)		0.10
Balance, December 31, 2012		14,494,341		$	0.28
Granted		610,586			0.18
Exercised		—			—
Forfeited		—			—
Balance, September 30, 2013		15,104,927		$	0.28		2.14	$	23,758
Exercisable, September 30, 2013		15,104,927		$	0.28		2.14	$	23,758

The intrinsic value is calculated on the difference between the fair market value of the Company’s restricted stock, which was $0.03 per share as of September 30, 2013, and the exercise price of the warrants.

The following table presents information related to warrants at September 30, 2013:

Warrants Outstanding				Warrants Exercisable
				Weighted
				Average		Exercisable
Exercise		Number of		Remaining Life		Number of
Price		Warrants		In Years		Warrants
$	0.01		452,354		2.33		452,354
	0.10		692,802		2.38		692,802
	0.25		705,882		2.58		705,882
	0.25		575,000		2.71		575,000
	0.01		452,355		2.75		452,355
	0.25		1,098,220		2.79		1,098,220
	0.001		195,291		1.00		195,291
	0.10		1,000,000		1.13		1,000,000
	0.10		125,000		1.42		125,000
	0.25		300,000		1.42		300,000
	0.10		1,197,437		1.46		1,197,437
	0.50		50,000		1.83		50,000
	0.50		25,000		1.83		25,000
	0.50		50,000		1.92		50,000
	0.50		25,000		1.92		25,000
	0.25		250,000		1.75		250,000
	0.50		1,870,000		1.92		1,870,000
	0.50		55,000		2.00		55,000
	0.50		1,550,000		2.08		1,550,000
	0.50		1,125,000		2.17		1,125,000
	0.50		1,000,000		2.17		1,000,000
	0.25		1,200,000		2.25		1,200,000
	0.50		500,000		2.25		500,000
	0.10		25,000		2.63		25,000
	0.20		335,586		4.21		335,587
	0.15		250,000		2.67		250,000
			15,104,927		2.14		15,104,927

XML

Consolidated Statements of Cash Flows (USD $)	3 Months Ended	9 Months Ended
	Sep. 30, 2013	Sep. 30, 2013	Sep. 30, 2012
Cash flows from operating activities:
Net loss	$ (1,650,119)	$ (3,551,619)	$ (7,879,251)
Adjustments to reconcile net loss to net cash used in operating activities:
Common stock issued for services		55,000	47,250
Share-based compensation		330,266	587,456
Non-cash interest		535,570	77,172
Provision for doubtful accounts		2,001	(500)
Change in fair value of derivative liability		843,338	4,272,565
Amortization on discount of note payable		433,638	1,067,539
Changes in operating assets and liabilities:
Accounts receivable		209,287	(79,679)
Inventory		139,888	(244,630)
Prepaid expenses and other current assets		88,322	(37,955)
Accounts payable		544,073	(99,560)
Accrued expenses and other current liabilities		127,543	242,629
Net cash used in operating activities		(242,693)	(2,046,964)
Cash flows from financing activities
Proceeds from notes and loans payable		190,995	2,055,000
Principal payments on note payable		(11,000)	(8,000)
Cash Overdraft
Net advances (repayments) from/to factor		(95,217)	66,755
Net cash provided by financing activities		84,778	2,113,755
Net (decrease) increase in cash		(157,915)	66,791
Cash - beginning of the period		159,346	5,852
Cash - end of the period	1,431	1,431	72,643
Supplemental disclosures:
Interest paid		85,145	467,538
Supplemental disclosure for non-cash financing activities:
Discount on notes payable		113,901	1,343,248
Reclassification of derivative liabilities upon conversion of note			1,787,541
Issuance of common stock to convert notes payable			12,380
Issuance of common stock to settle liability		33,572	1,146,702
Development Stage [Member]
Cash flows from operating activities:
Net loss	(1,650,119)
Adjustments to reconcile net loss to net cash used in operating activities:
Common stock issued for services
Share-based compensation	31,277
Non-cash interest	181,941
Provision for doubtful accounts	2,001
Change in fair value of derivative liability	1,136,732
Amortization on discount of note payable	30,196
Changes in operating assets and liabilities:
Accounts receivable	36,577
Inventory	75,228
Prepaid expenses and other current assets	60,975
Accounts payable	51,856
Accrued expenses and other current liabilities	11,555
Net cash used in operating activities	(31,781)
Cash flows from financing activities
Proceeds from notes and loans payable	96,167
Principal payments on note payable
Cash Overdraft	(34,536)
Net advances (repayments) from/to factor	(28,419)
Net cash provided by financing activities	33,212
Net (decrease) increase in cash	1,431
Supplemental disclosures:
Interest paid	39,151
Supplemental disclosure for non-cash financing activities:
Discount on notes payable	84,500
Reclassification of derivative liabilities upon conversion of note
Issuance of common stock to convert notes payable
Issuance of common stock to settle liability

XML

Condensed Consolidated Balance Sheet (USD $)	Sep. 30, 2013	Dec. 31, 2012
Assets
Cash	$ 1,431	$ 159,346
Accounts receivable, net		211,288
Inventory		139,888
Prepaid expenses and other current assets	9,752	98,074
Total current assets	11,183	608,596
Total Assets	11,183	608,596
Current liabilities:
Accounts payable	1,537,313	993,240
Due to factor	118,561	213,778
Accrued expenses and other current liabilities	1,828,834	1,734,863
Derivative liabilities	1,393,054	432,030
Notes payable to related parties and others, net of discounts	4,972,257	3,936,955
Total current liabilities	9,850,019	7,310,866
Stockholders' Deficiency:
Preferred stock, no stated value; 10,000,000 shares authorized; -0- shares issued and outstanding as of September 30, 2013 and December 31, 2012	0	0
Common stock, $.0001 par value, 100,000,000 shares authorized, 18,473,554 and 17,795,376 shares issued and outstanding as of September 30, 2013 and December 31, 2012,respectively. In addition,36,300,000 and 0 shares issued in reserve and outstanding at September 30, 2013 and December 31, 2012, respectively.	1,848	1,780
Additional paid-in capital	14,287,582	13,872,597
Accumulated deficit	(22,478,147)
Deficit accumulated during the development stage	(1,650,119)	(20,576,647)
Total stockholders' deficiency	(9,838,836)	(6,702,270)
Total Liabilities and Stockholders' Deficiency	$ 11,183	$ 608,596

XML

Subsequent Events (Details Narrative) (Convertible Promissory Note, USD $)	0 Months Ended
	Dec. 31, 2013
Convertible Promissory Note
Note Payable	$ 13,000
Interest Rate	8.00%
Shares reserved for issuance of common stock	20,000,000

XML

Summary of Significant Accounting Policies Net Loss Per Share (Details Narrative) (USD $)	9 Months Ended
	Sep. 30, 2013		Sep. 30, 2012
Common stock in reserve, shares issued	36,300,000
Common stock issued upon conversion of certain convertible notes	8,442,099	[1]
Earnings Per Share
Options	7,717,896		4,455,177
Warrants	14,004,927		9,104,403
Convertible notes	89,155,749		4,938,403
Common Stock Equivalents	110,878,572		18,497,983
Warrants Issued	1,100,000		1,100,000
Exercise Price	$ 0.01		$ 0.01
Shares earned, not issued	56,189		56,189

[1] 80,713,650 shares of common stock issuable upon conversion of convertible notes are not covered by reserve shares.

XML

Stock options and Warrants (Tables)

9 Months Ended

Sep. 30, 2013

Temporary Equity Disclosure [Abstract]

Options Summary

						Weighted
				Weighted		Average
				Average		Remaining
				Exercise		Contractual		Intrinsic
	Shares			Price		Term		Value
Balance at December 31, 2011		2,983,750		$	0.31		4.00	$	—
Granted		6,559,146			0.46		3.55		—
Exercised		—			—		—		—
Forfeited		(1,500,000	)		0.20		—		—
Balance at December 31, 2012		8,042,896			0.45		3.47		88,500
Granted		—			—		—		—
Exercised		—			—		—		—
Forfeited		(325,000	)		0.25		—		—
Balance at September 30, 2013		7,717,896		$	0.46		.18	$	—
Exercisable at September 30, 2013		7,191,183		$	0.46		.18	$	—

Common Stock Warrant Summary

				Weighted		Average
				Average		Remaining
	Number of			Exercise		Life		Intrinsic
	Warrants			Price		In Years		Value
Balance, December 31, 2011		5,862,140		$	0.12
Granted		10,775,000			0.34
Exercised		(2,039,735	)		0.10
Forfeited		(103,064	)		0.10
Balance, December 31, 2012		14,494,341		$	0.28
Granted		610,586			0.18
Exercised		—			—
Forfeited		—			—
Balance, September 30, 2013		15,104,927		$	0.28		2.14	$	23,758
Exercisable, September 30, 2013		15,104,927		$	0.28		2.14	$	23,758

Warrants

Warrants Outstanding				Warrants Exercisable
				Weighted
				Average		Exercisable
Exercise		Number of		Remaining Life		Number of
Price		Warrants		In Years		Warrants
$	0.01		452,354		2.33		452,354
	0.10		692,802		2.38		692,802
	0.25		705,882		2.58		705,882
	0.25		575,000		2.71		575,000
	0.01		452,355		2.75		452,355
	0.25		1,098,220		2.79		1,098,220
	0.001		195,291		1.00		195,291
	0.10		1,000,000		1.13		1,000,000
	0.10		125,000		1.42		125,000
	0.25		300,000		1.42		300,000
	0.10		1,197,437		1.46		1,197,437
	0.50		50,000		1.83		50,000
	0.50		25,000		1.83		25,000
	0.50		50,000		1.92		50,000
	0.50		25,000		1.92		25,000
	0.25		250,000		1.75		250,000
	0.50		1,870,000		1.92		1,870,000
	0.50		55,000		2.00		55,000
	0.50		1,550,000		2.08		1,550,000
	0.50		1,125,000		2.17		1,125,000
	0.50		1,000,000		2.17		1,000,000
	0.25		1,200,000		2.25		1,200,000
	0.50		500,000		2.25		500,000
	0.10		25,000		2.63		25,000
	0.20		335,586		4.21		335,587
	0.15		250,000		2.67		250,000
			15,104,927		2.14		15,104,927

XML

Stock options and Warrants - Options Summary (Details) (Options, USD $)	9 Months Ended	12 Months Ended
	Sep. 30, 2013	Dec. 31, 2012
Options
Stock Options
Beginning Balance	8,042,896	2,983,750
Granted		6,559,146
Exercised		0
Forfeited/cancelled	(325,000)	(1,500,000)
Common Stock Options, Outstanding	7,717,896	8,042,896
Ending Balance	7,191,183
Weighted Average Exercise Price
Beginning Balance	$ 0.45	$ 0.31
Granted		$ 0.46
Exercised		$ 0
Forfeited/cancelled	$ 0.25	$ 0.20
Ending Balance	$ 0.46	$ 0.45
Exercisable at September 30, 2013	$ 0.46
Weighted Remaining Contractual Life (Years)
Beginning Balance	3 years 4 months 7 days	4 years
Granted		3 years 5 months 5 days
Ending Balance	1 year 8 months 0 days	3 years 4 months 7 days
Exercisable at September 30, 2013	1 year 8 months 0 days
Intrinsic Value
Outstanding	$ 88,500
Balance		88,500
Stock Based Compensation Balance

XML

Notes payable, Loans and Derivative Liabilities:Notes Payable-Convertible Notes Payable (Details Narrative) (USD $) (Convertible Notes Payable, USD $)	9 Months Ended	12 Months Ended
	Sep. 30, 2013	Dec. 31, 2012
Note 1
Date Issued	Jul. 30, 2010
Convertible Promissory Note	$ 8,000
Interest rate	6.00%
Debt Discount	8,000
Conversion price	$ 0.05
Note Payable	9,164	9,523
Note 2
Date Issued	Apr. 28, 2011
Convertible Promissory Note	70,588	0
Discount rate	15.00%
Equity financing to be raised	600,000
Debt Discount	60,000
Conversion price	$ 0.05
Vesting Terms	5 years
Warrant Issue Date	Apr. 28, 2011
Warrant to purchase common stock	705,882
Exercise price	0.25
Note Payable	70,588	70,588
Note 2 Amended Note
Vesting Terms		3 years
Warrant Issue Date		Jun. 30, 2012
Warrant to purchase common stock		61,856
Debt discount		4,923
Note 3
Date Issued	Jul. 15, 2011
Convertible Promissory Note	109,822	0
Discount rate	15.00%
Equity financing to be raised	600,000
Debt Discount	95,497
Payment on note payable	1,784
Conversion price	$ 0.05
Vesting Terms	5 years
Warrant to purchase common stock	1,098,220
Exercise price	0.25
Debt discount	95,497
Note Payable	109,789	109,789
Note 4
Date Issued	Mar. 31, 2012
Convertible Promissory Note	1,000,000	0
Interest rate	18.00%
Maturity date beginning	Sep. 02, 2012
Debt Discount	789,073
Past due payment on note	78,329
Vesting Terms	5 years
Warrant to purchase common stock	2,500,000
Exercise price	0.10
Note Payable	963,356	850,000
Note Payable A	879,338	775,000
Note Payable C	84,018	75,000
Note 4 Sold in Offering
Convertible Promissory Note	850,000
Vesting Terms	3 years
Warrant to purchase common stock	2,337,500
Exercise price	0.10
Note 4 Modifed Note
Convertible Promissory Note	775,000
Expiration Date	Jun. 30, 2013
Debt Discount	140,759
Warrant to purchase common stock	1,550,000
Exercise price	0.50
Note 5
Date Issued	Aug. 31, 2012
Convertible Promissory Note	3,000,000	0
Interest rate	18.00%
Debt Discount	499,186
Warrant Issue Date	May 13, 2013
Warrant to purchase common stock	6,000,000
Exercise price	0.50
Note Payable	992,801	875,000
Note 5 Sold in Offering
Convertible Promissory Note	875,000
Vesting Terms	3 years
Warrant to purchase common stock	1,750,000
Exercise price	0.50
Note 6
Date Issued	May 01, 2013
Convertible Promissory Note	500,000
Interest rate	12.00%
Debt Discount	50,000
Fair Market Value	61,033	40,000
Shares reserved for issuance of common stock	28,000,000
Debt discount	3,559
Note Payable	47,445
Note 7
Date Issued	Jul. 01, 2013
Convertible Promissory Note	53,000
Interest rate	8.00%
Conversion price	$ 0.51
Shares reserved for issuance of common stock	6,500,000
Note Payable	$ 54,045

XML

Notes payable, Loans and Derivative Liabilities - Notes payable (Details) (Parenthetical) (USD $)	Sep. 30, 2013	Dec. 31, 2012
Notes Payable
Debt Discount	$ 0	$ 133,827
Notes Payable Related Party
Debt Discount	0	47,673
Convertible Notes Payable
Debt Discount	$ 79,298	$ 217,535

XML

Notes payable, Loans and Derivative Liabilities:Notes Payable(Details Narrative) (Notes Payable, USD $)	9 Months Ended	12 Months Ended
	Sep. 30, 2013	Dec. 31, 2012
Note 1
Date Issued	2010-05
Note Payable Issued	$ 20,000
Interest Rate	6.00%
Warrants Issued	20,000
Conversion Price	$ 1.00
Expiration date	2011-11
Debt Discount	9,200
Note Payable	23,944	23,046
Note 2
Date Issued	Feb. 03, 2011
Note Payable Issued	500,000
Interest Rate	15.00%
Warrants Issued	452,354
Conversion Price	$ 0.01
Debt Discount	137,703
Debt Discount Interest Expense		63,114
Vesting Terms	3 years and 5 years
Note Payable	777,069	698,534
Default	21% interest rate
Note 3
Date Issued	Aug. 01, 2012
Note Payable Issued	60,000
Discount rate	20.00%
Warrants Issued	50,000
Conversion Price	$ 0.50
Debt Discount	11,088
Debt Discount Interest Expense	11,088
Vesting Terms	3 years
Aggregate cash proceeds	1,875,000
Note Payable	60,000
Note 4
Date Issued	Aug. 07, 2012
Note Payable Issued	30,000
Discount rate	20.00%
Warrants Issued	25,000
Conversion Price	$ 0.50
Debt Discount	3,406
Debt Discount Interest Expense	3,406
Vesting Terms	3 years
Aggregate cash proceeds	1,875,000
Note Payable	30,000	30,000
Note 5
Date Issued	Aug. 22, 2012
Note Payable Issued	60,000
Discount rate	20.00%
Warrants Issued	50,000
Conversion Price	$ 0.50
Debt Discount	9,495
Debt Discount Interest Expense	9,495
Vesting Terms	3 years
Aggregate cash proceeds	1,850,000
Note Payable	60,000	60,000
Note 6
Date Issued	Dec. 31, 2012
Note Payable Issued	2,500,000
Interest Rate	18.00%
Warrants Issued	5,000,000
Conversion Price	$ 0.50
Expiration date	2013-06
Debt Discount		32,202
Debt Discount Interest Expense	28,257
Aggregate cash proceeds		1,000,000
Warrants sold		2,000,000
Additional warrants issued		200,000
Note Payable	1,134,630	1,000,000
Note 7
Date Issued	May 08, 2013
Discount rate	20.00%
Warrants Issued	30,000
Conversion Price	$ 0.10
Debt Discount	928
Debt Discount Interest Expense	928
Vesting Terms	3 years
Aggregate cash proceeds	1,850,000
Note Payable	20,000
Payments on notes payable	10,000
Note 8
Date Issued	Jul. 09, 2013
Note Payable Issued	10,000
Discount rate	18.00%
Note Payable	$ 10,409

XML

Fair Value Measures

9 Months Ended

Sep. 30, 2013

Fair Value Disclosures [Abstract]

Fair Value Measures

8. FAIR VALUE MEASURES 

ASC 820 “Fair Value Measurements and Disclosures” defines fair value, establishes a framework for measuring fair value and requires enhanced disclosures about fair value measurements. As defined in ASC 820, fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The Standard clarifies that the exchange price is the price in an orderly transaction between market participants to sell an asset or transfer a liability at the measurement date, and emphasizes that fair value is a market-based measurement and not an entity-specific measurement.

ASC 820 establishes the following hierarchy used in fair value measurements and expands the required disclosures of assets and liabilities measured at fair value:

· Level 1 – Inputs use quoted prices in active markets for identical assets or liabilities that the Company has the ability to access.

· Level 2 – Inputs use other inputs that are observable, either directly or indirectly. These inputs include quoted prices for similar assets and liabilities in active markets as well as other inputs such as interest rates and yield curves that are observable at commonly quoted intervals.

· Level 3 – Inputs are unobservable inputs, including inputs that are available in situations where there is little, if any, market activity for the related asset or liability.

In instances where inputs used to measure fair value fall into different levels in the above fair value hierarchy, fair value measurements in their entirety are categorized based on the lowest level input that is significant to the valuation. The Company’s assessment.

The following table provides the assets and liabilities carried at fair value measured on a recurring basis as of September 30, 2013 and December 31, 2012, respectively:

	Fair Value Measurements
		Level 1		Level 2		Level 3		Total
Derivative liabilities:
September 30, 2013	$	—	$	—	$	1,393,054	$	1,393,054
December 31, 2012	$	—	$	—	$	432,030	$	432,030

The 2013 and 2012 derivative liabilities are measured at fair value using the binomial lattice options pricing model, and are classified within Level 3 of the valuation hierarchy. The following table sets forth a summary of the changes in the fair value of the Company’s Level 3 financial liabilities that are measured at fair value on a recurring basis:

		Nine months Ended September 30, 2013		Year Ended December 31, 2012
Fair value, beginning of period	$	432,030	$	155,813
Derivative liabilities recorded during the period		153,968		1,323,548
Reclassification to equity upon conversion of note		—		(1,787,542	)
Reclassification to equity upon amendment of notes and warrants		—		(1,152,144	)
Net unrealized (gain) loss on derivative financial instruments		807,056		1,892,355
Fair value, end of period	$	1,393,054	$	432,030

XML

Going Concern (Details Narrative) (USD $) (USD $)	Sep. 30, 2013	Dec. 31, 2012
Going Concern Details Narrative Usd
Working Capital Deficit	$ 9,839,000
Accumulated Losses	24,128,000
Deficit accumulated during the development stage	1,650,119
Payroll tax liability	320,622	286,027
Aggregate notes payable	$ 4,838,000

XML

FAIR VALUE MEASUREMENTS - Liability measured at fair value on a recurring basis Additional (Details) (USD $)	9 Months Ended	12 Months Ended
	Sep. 30, 2013	Dec. 31, 2012
Fair Value Measurements - Liability Measured At Fair Value On Recurring Basis Additional Details
Fair value, beginning of period	$ 432,030	$ 155,813
Derivative liabilities recorded during the period	153,968	1,323,548
Reclassification to equity upon conversion of note		(1,787,542)
Reclassification to equity upon amendment of notes and warrants		(1,152,144)
Net unrealized (gain) loss on derivative financial instruments	807,056	1,892,355
Fair value, end of period	$ 1,393,054	$ 432,030

XML

Commitments and Contingencies

9 Months Ended

Sep. 30, 2013

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies

11 . COMMITMENTS AND CONTINGENCIES

Agreements

During October 2012 we leased approximately 1,641 square feet of office space located at 2030 Addison Street, Berkeley, CA for approximately $4,200 per month under a 29 month agreement with rental payments commencing on January 1, 2013. The rental fee escalated to approximately $4,350 on April 1, 2013 and approximately $4,500 on April 1, 2014. The lease was terminated on August 31, 2013.

Legal matters

In the normal course of business, the Company is, and in the future may be, subject to various disputes, claims, lawsuits, and administrative proceedings arising in the ordinary course of business with respect to commercial, product liability, employment, and other matters, which could involve substantial amounts of damages. In the opinion of management, any liability related to any such known proceedings would not have a material adverse effect on the business or financial condition of the Company. Additionally, from time to time, the Company may pursue litigation against third parties to enforce or protect the Company’s rights under the Company’s trademarks, trade secrets and intellectual property rights generally.

During 2010, the Company was served with a lawsuit for the Company’s past due liabilities. The lawsuit was Peri & Sons, plaintiff, vs. Organic Alliance, Inc. and Parker Booth, defendants, for past due produce liabilities. An agreement was reached and the Company has been making payments to the plaintiff. The Company was dismissed from the action and signed a confession of judgment. Over half of the past due amount has been paid with a balance of approximately $21,000 remaining. The Company has accrued for this balance.

On June 20, 2013, the Company was served a lawsuit for a disputed loan issued by the Company. The lawsuit was Austin Noll Jr. plaintiff, vs. Organic Alliance, Inc. and DOES 1 through 50, defendants, for a $50,000 loan issued in July 2009. The case will be reviewed by the Company’s legal counsel. In July 2010, the Company issued stock to a third party with the obligation to pay Mr. Noll. The Company’s position is the loan was repaid by the Company in July 2010.

On July 30, 2013, the Company was served with a lawsuit for past due liabilities of the Company.  The lawsuit was Tom Ver. LLC d/b/a MexFresh Produce, plaintiff, vs. Organic Alliance, Inc., et al, for past due produce liabilities of $53,863.53. The lawsuit was filed in the United States District Court of the Northern District of California. . The case will be reviewed by the Company’s legal counsel.

On August 1, 2013, the Company received a “Notice of Labor Laws Violation” under California Labor Code 2699, 2699.3 and 2699.5. The notice was file by an employee, Kenneth Horwitz and all current and former employees against Organic Alliance, Inc. Parker Booth, CEO and Barry Brookstein, CFO. The notice alleges various California labor laws violations and seeks wages and penalties from the Company, Mr. Booth and Mr. Brookstein. The notice will be reviewed by the Company’s legal counsel.

XML

Notes payable, Loans and Derivative Liabilities

9 Months Ended

Sep. 30, 2013

Debt Disclosure [Abstract]

Notes payable, Loans and Derivative Liabilities

7.  NOTES PAYABLE, LOANS AND DERIVATIVE LIABILITIES

Notes payable to related parties and others, net of discounts consist of the following:

	September 30,		December 31,
	2013		2012
	(unaudited)
Notes Payable (net of debt discount $0 and $133,827 at September 30, 2013 and December 31, 2012, respectively) (A)	$	2,995,390	$	2,512,753
Notes Payable – Related Parties (net of debt discount of $0 and $47,673 at September 30, 2013 and December 31, 2012, respectively) (B)		671,257		509,696
Convertible Notes Payable (net of debt discount of $79,298and  $217,535 at September 30, 2013 and at December 31, 2012, respectively) (C)		1,305,610		914,506
Totals	$	4,972,257	$	3,936,955

(A) Notes Payable

i. In May 2010, an individual advanced to the Company $20,000 bearing interest at 6% per annum. As a financing incentive, the individual received a warrant to purchase 20,000 shares of the Company’s common stock at $1.00 per share. The warrants expired in November 2011. The gross proceeds of the note were recorded net of a debt discount of $9,200. The debt discount consisted of the relative fair value of the warrant of $9,200 and is accreted to interest expense ratably over the term of the note. The promissory note matured on November 17, 2011. The unpaid balance, including accrued interest, was $23,944 and $23,046 at September 30, 2013 and December 31, 2012, respectively. The Company is not compliant with the repayment terms of the note.

ii. On February 3, 2011, the Company signed a $500,000 promissory note with a maturity date of August 2, 2012, and has a stated interest rate of 15% per annum. As a financing incentive, the lender received a three-year warrant vesting on January 31, 2011, to purchase 452,354 shares of common stock at an exercise price of $0.01 per share, and also received a five-year warrant, vesting on June 30, 2011, to purchase 452,354 shares at an exercise price of $0.01 per share. The gross proceeds from the sale of the note of $500,000 were recorded net of a discount of $137,703. The debt discount consisted of $137,703 related to the fair value of the warrants and is accreted to interest expense ratably over the term of the note which amounted to $63,114 for the nine months ended September 30, 2012. The Company has not made any note payments and received a waiver from the lender on September 1, 2011 that deferred payment until September 1, 2012 and increased the interest rate to 21% beginning April 4, 2011, the date of the first event of default. The unpaid balance, including accrued interest, was $777,069 and $698,534 at September 30, 2013 and December 31, 2012, respectively. The Company is not compliant with the repayment terms of the note.

iii. On August 1, 2012, the Company issued a $60,000 promissory note with an original issue discount of 20%. The promissory note is due on the earlier of (i) the closing by the Company of a financing or series of financings for aggregate cash proceeds of at least $1,850,000, or, (ii) July 31, 2013. As a financing incentive, the lender received a three-year warrant, vesting immediately, to purchase 50,000 shares of common stock at an exercise price of $0.50 per share. The gross proceeds from the sale of the note of $60,000 were recorded net of a discount of $11,088. The debt discount consisted of $11,088 related to the fair value of the warrant and is accreted to interest expense ratably over the term of the note which amounted to $11,088 for the year ended December 31, 2012. Since the Company satisfied the requirement of item (i) and raised $1,875,000 after August 1, 2012, the discount was recognized over the shorter maturity term. The carrying value of the unpaid balance was $60,000 at September 30, 2013 and December 31, 2012. The Company is not compliant with the repayment terms of the note.

iv. On August 7, 2012, the Company issued a $30,000 promissory note with an original issue discount of 20%. The promissory note is due on the earlier of (i) the closing by the Company of a financing or series of financings for aggregate cash proceeds of at least $1,850,000, or, (ii) August 6, 2013. As a financing incentive, the lender received a three-year warrant, vesting immediately, to purchase 25,000 shares of common stock at an exercise price of $0.50 per share. The gross proceeds from the sale of the note of $30,000 were recorded net of a discount of $3,406. The debt discount consisted of $3,406 related to the fair value of the warrant and is accreted to interest expense ratably over the term of the note which amounted to $3,406 for the year ended December 31, 2012. Since the Company satisfied the requirement of item (i) and raised $1,875,000 after August 7, 2012, the discount was recognized over the shorter maturity term. The carrying value of the unpaid balance was $30,000 at September 30, 2013 and December 31, 2012. The Company is not compliant with the repayment terms of the note.

v. On August 22, 2012, the Company issued a $60,000 promissory note with an original issue discount of 20%. The promissory note is due on the earlier of (i) the closing by the Company of a financing or series of financings for aggregate cash proceeds of at least $1,850,000, or, (ii) August 21, 2013. As a financing incentive, the lender received a three-year warrant, vesting immediately, to purchase 50,000 shares of common stock at an exercise price of $0.50 per share. The gross proceeds from the sale of the note of $60,000 were recorded net of a discount of $9,495. The debt discount consisted of $9,495 related to the fair value of the warrant and is accreted to interest expense ratably over the term of the note which amounted to $9,495 for the year ended December 31, 2012. Since the Company satisfied the requirement of item (i) and raised $1,875,000 after August 22, 2012, the discount was recognized over the shorter maturity term. The carrying value of the unpaid balance was $60,000 September 30, 2013 and December 31, 2012. The Company is not compliant with the repayment terms of the note.

vi. In December 2012, the Company commenced an offering of secured promissory notes for an aggregate principal amount of $2,500,000 with three-year warrants to purchase an aggregate of 5,000,000 shares our common stock (two shares for each $1 of the principal amount of the notes purchased) exercisable at $0.50 per share. The notes bear interest at 18% and have a maturity date of September 30, 2013. Notes in the aggregate principal amount of $1,000,000 and warrants to purchase an aggregate of 2,000,000 common shares were sold in the offering. In addition, the investment banker who facilitated the sale of the notes and warrants received a three-year warrant to purchase 200,000 shares of our common stock (10% of the number of shares of common stock issuable upon exercise of the warrants sold in the offering) exercisable at $0.50 per share. The fair value of the three-year warrants issued in connection with the notes on the date of issuance aggregated $32,202, and was recorded as debt discount. The debt discount was amortized through the term of the notes and amounted to $28,257 for the nine months ended September 30, 2013. The unpaid balance, including accrued interest, was $1,134,630 and $1,000,000 at September 30, 2013 and December 31, 2012, respectively. The Company is not compliant with the repayment terms of the note.

vii. On May 8, 2013, the Company issued a $30,000 promissory note with an original issue discount of 20%. The promissory note is due on the earlier of (i) the closing by the Company of a financing or series of financings for aggregate cash proceeds of at least $1,850,000, or, (ii) July 5, 2013. As a financing incentive, the lender received a three-year warrant, vesting immediately, to purchase 25,000 shares of common stock at an exercise price of $0.10 per share. The gross proceeds from the sale of the note of $30,000 were recorded net of a discount of $928. The debt discount consisted of $928 related to the fair value of the warrant and is accreted to interest expense ratably over the term of the note which amounted to $80 and $928 for the three months and nine months ended September 30, 2013, respectively. The Company repaid $10,000 during May and June 2013. The carrying value of the unpaid balance was $20,000 at September 30, 2013. The Company is not compliant with the repayment terms of the note.

viii. On July 9, 2013, an individual advanced to the Company $10,000. The advance is evidenced by a promissory note payable with interest at 18% and is due on demand. The unpaid balance, including accrued interest, was $10,409 at September 30, 2013.

(B) Notes Payable – Related Parties

i. In September 2008, Earnest Mathis, a former shareholder, advanced to the Company $15,000. The advance is evidenced by a promissory note bearing interest at 10% per annum. The promissory note matured on September 13, 2009. The unpaid balance, including accrued interest, was $22,568 and $21,446 at September 30, 2013 and December 31, 2012, respectively. The Company is not compliant with the repayment terms of the note.

ii. In November 2009 and February 2010, Morrison Partners, LLC (an affiliate of Thomas Morrison, former CEO and Chairman of the Board of Directors of the Company), advanced to the Company $10,000 and $15,000, respectively. The advances are evidenced by promissory notes bearing interest at 5% per annum. The November advance provides for the issuance of 2,770 shares of the Company’s common stock as a financing incentive. The Company recorded a debt discount of $2,935 for the relative fair value of the common stock. The discount was accreted over the life of the note.   The November 2009 and February 2010 notes were due on June 30, 2010 and September 30, 2010, respectively. The unpaid balance, including accrued interest, was $29,661 and $28,726 at September 30, 2013 and December 31, 2012, respectively. The shares have not been issued to Morrison Partners, LLC, and the Company is not in compliance with the repayment terms of the notes.

iii. During March, 2010 through October 2011, a former employee of the Company loaned to the Company $65,958, of which $16,000 and $49,958 was advanced during 2011 and 2010, respectively. The loans are evidenced by promissory notes payable with interest at 5% and are due on demand. The Company repaid $9,000 during 2010 and $8,000 during April 2012. In addition, the former employee will be issued 47,690 shares of the Company’s common stock upon repayment of the promissory notes as additional consideration. The Company will record a fair value for these shares on the measurement date as a charge to interest expense. The unpaid balance, including accrued interest, was $56,381 and $54,551 at September 30, 2013 and December 31, 2012, respectively.

iv. On October 17, 2011, the Company entered into a $400,000 convertible multi-draw term loan facility with an entity owned by a related party. The loan bears interest at 21% and has a maturity date of the earlier of an event of default or April 17, 2012. The Company has not made a note payment and is currently negotiating an extension of such loan. At the time of any new debt or equity financing of the Company, the loan balance, including principal and interest, may be converted into the number of fully paid and non-assessable debt instruments, shares/or units to be issued in the financing. In addition, with each drawdown the related party received a three-year warrant to purchase 2.5 shares of the Company’s common stock for each $1.00 of principal loaned at such time, up to 1,000,000 shares in the aggregate for all drawdowns. Each warrant has an exercise price of $0.10 per share, is vested upon issuance, and expires on October 17, 2014. The Company received $125,000 and $275,000 in gross proceeds during the years ended December 31, 2012 and December 31, 2011, respectively. The Company issued warrants to purchase an aggregate of 312,500 and 687,500 shares of the Company’s common stock during the years ended December 31, 2012 and December 31, 2011, respectively. The unpaid balance of the loan, including accrued interest, was $462,828 and $400,000 at September 30, 2013 and December 31, 2012, respectively. The Company is not compliant with the repayment terms of the note.   The conversion price of the outstanding loan amounts was not fixed and determinable on the date of issuance and, as such in accordance with ASC Topic 815 “Derivatives and Hedging” (“ASC 815”), the embedded conversion option on the date of issuance was valued using the binomial lattice options pricing model and recorded as derivative liabilities. The fair value of the three-year warrants on the date of issuance aggregated $105,363, and was recorded as debt discount. The debt discount was fully amortized through the term of the loan and amounted to $85,342 for the nine months ended September 30, 2012.

During December 2012 the Company amended the notes to remove the conversion right and extend the due date to June 30, 2013, and to amend the warrants to remove certain anti-dilution provisions. For executing the agreement, the holder was granted a three-year warrant to purchase 1,000,000 shares of the Company’s common stock, equal to two and one-half times the principal amount of the note amended, exercisable at $0.20 per share. The Company evaluated the change in cash flows in connection with the December amendment and determined that there was a greater than 10% change between the present value of the existing debt and the amended debt. As a result, the fair value of the three-year warrants aggregated $49,439 and were recorded as a discount to the modified debt and will be accreted over the remaining term of the modified debt and recognized as interest expense. The debt discount on the modified debt amounted to $42,376 for the nine months ended September 30, 2013.

v. On February 28, 2012, Michael Rosenthal, Chairman of the Company’s Board of Directors, advanced the Company $50,000. The advance is evidenced by a promissory note bearing interest at 21% and has a maturity date of the earlier of an event of default or August 28, 2012. In addition, Mr. Rosenthal received a three-year warrant to purchase 125,000 shares of the Company’s common stock at an exercise price of $0.10 per share. The Company recorded a debt discount of $7,997 to the face value of the note based upon the fair values of the warrants. The discount was being accreted over the life of the note which amounted to $2,592 and $7,997 for the three and nine months ended September 30, 2012, respectively. The unpaid balance, including accrued interest, was $60,500 and $52,647 at September 30, 2013 and December 31, 2012, respectively. The Company is not compliant with the repayment terms of the note.   During December 2012 the Company amended the note to extend the due date to June 30, 2013. For executing the agreement, the holder was granted a three-year warrant to purchase 125,000 shares of the Company’s common stock, equal to two and one-half times the principal amount of the note amended, exercisable at $0.20 per share. The Company evaluated the change in cash flows in connection with the December amendment and determined that there was a greater than 10% change between the present value of the existing debt and the amended debt. As a result, the fair value of the three-year warrants aggregated $6,180 and were recorded as a discount to the modified debt and will be accreted over the remaining term of the modified debt and recognized as interest expense. The debt discount on the modified debt amounted to $5,298 nine months ended September 30, 2013.

vi. During April 2013 and June 2013, Barry Brookstein, CFO, loaned to the Company $37,050. The loan is evidenced by a promissory note payable with interest at 18% and is due on demand. The unpaid balance, including accrued interest, was $39,319 at September 30, 2013.

 (C) Convertible Notes Payable

i. On July 30, 2010, an individual advanced the Company $8,000. The advance is evidenced by a promissory note bearing interest at 6% per annum and maturing on March 2, 2011. The holder, at any time, may convert the promissory note into shares of the Company’s common stock at $0.05 per share. The Company calculated the fair value of the beneficial conversion feature using the Black-Scholes pricing model on the date of issuance. The fair value of the conversion option in connection with the note on the date of issuance aggregated $8,000, and was recorded as debt discount. The debt discount was amortized through the term of the note. The unpaid balance, including accrued interest, was $9,523 and $9,164 at September 30, 2013 and December 31, 2012, respectively. The Company is not compliant with the repayment terms of the note.

ii. On April 28, 2011, the Company issued a $70,588 convertible promissory note with an original issue discount of 15%. The convertible promissory note has a maturity date of the earlier of (i) the Company raising debt or equity financing of $600,000 or more, or (ii) May 31, 2011. The note may be converted into the Company’s common stock by the holder at $0.05 per share. As a financing incentive, the lender received a five-year warrant, vesting April 28, 2011, to purchase 705,882 shares of the Company’s common stock at an exercise price of $0.25 per share. The Company has not made a note payment, and the Company received a waiver from the lender on September 1, 2011 that defers payment until May 31, 2012 and waives the provision for payment upon the Company’s closing a debt or equity financing of $600,000 or more. The unpaid balance on the note was $70,588 at September 30, 2013 and December 31, 2012. The Company is not compliant with the repayment terms of the note.

The conversion price of the note and five-year warrants was not fixed and determinable on the date of issuance and as such in accordance with ASC Topic 815 “Derivatives and Hedging” (“ASC 815”), the embedded conversion options of the note and warrants on the date of issuance were valued using the binomial lattice options pricing model and recorded as derivative liabilities. The fair value of the conversion option and five-year warrants issued in connection with the note on the date of issuance aggregated $60,000, and were recorded as debt discount. The debt discount was amortized through the term of the note.

During December 2012 the Company amended the note to remove the conversion right and extend the due date to June 30, 2013, and to amend the warrants to remove certain anti-dilution provisions. For executing the agreement, the holder was granted a three-year warrant to purchase 61,856 shares of the Company’s common stock, exercisable at $0.18 per share. The Company evaluated the change in cash flows in connection with the December amendment and determined that there was a less than 10% change between the present value of the existing debt and the amended debt. As a result, the fair value of the new three-year warrants of $4,923 was expensed on the date of the amendment.

On July 15, 2011, the Company issued a $109,822 convertible promissory note with an original issue discount of 15% that consolidated various demand notes from September 2010 through July 2011. The convertible promissory note has a maturity date of the earlier of (i) the Company raising debt or equity financing of $600,000 or more, or (ii) August 31, 2011. The loan holder advanced an additional $1,750 in September 2011. The note may be converted into the Company’s common stock by the holder at $0.05 per share. As a financing incentive, the lender received a five-year warrant, vesting July 15, 2011, to purchase 1,098,220 shares of the Company’s common stock at an exercise price of $0.25 per share. The Company repaid $1,784 during 2012. The unpaid balance was $109,789 at September 30, 2013 and December 31, 2012. The Company is not compliant with the repayment terms of the note.

The conversion price of the note and five-year warrants were not fixed and determinable on the date of issuance and as such in accordance with ASC Topic 815 “Derivatives and Hedging” (“ASC 815”), the embedded conversion options of the note and warrants on the date of issuance were valued using the binomial lattice options pricing model and recorded as derivative liabilities. The fair value of the conversion option and five-year warrants issued in connection with the note on the date of issuance aggregated $95,497, and were recorded as debt discount. The debt discount was amortized through the term of the note.

iii. In March 2012, the Company commenced an offering of secured promissory notes for an aggregate principal amount of $1,000,000 with three-year warrants to purchase an aggregate of 2,500,000 shares the Company’s common stock (2.5 shares for each $1 of the principal amount of the notes purchased) exercisable at $0.10 per share. The notes bear interest at 18% and have various maturity dates beginning September 2, 2012. At the time of any new debt or equity financing by the Company, the principal and interest then due under the notes may be converted into the number of fully paid and non-assessable debt instruments, shares/or units issued in the financing. Notes in the aggregate principal amount of $850,000 and warrants to purchase an aggregate of 2,125,000 common shares were sold in the offering. In addition, the investment banker who facilitated the sale of the notes and warrants received a three-year warrant to purchase 212,500 shares of the Company’s common stock (10% of the number of shares of common stock issuable upon exercise of the warrants sold in the offering) exercisable at $0.10 per share. The unpaid balance, included accrued interest was $963,356 and $850,000 at September 30, 2013 and December 31, 2012, respectively. Since only a portion of the March 2012 secured promissory notes are convertible into shares of the Company’s common stock, the note value is split to reflect $879,338 in section A and $84,018 in section C at September 30, 2013, and $775,000 in Section A and $75,000 in section C at December 31, 2012 in the Note 7 table above. The Company is not compliant with the repayment terms of the notes.   The conversion price of the note and three-year warrants were not fixed and determinable on the date of issuance and as such in accordance with ASC Topic 815 “Derivatives and Hedging” (“ASC 815”), the embedded conversion options of the note and warrants on the date of issuance were valued using the binomial lattice options pricing model and recorded as derivative liabilities. The fair value of the conversion option and three-year warrants issued in connection with the note on the date of issuance aggregated $789,073, and was recorded as debt discount. The debt discount was fully amortized through the term of the notes and amounted to $443,655 and $789,073 for the three and nine months ended September 30, 2012, respectively.   During October 2012 the Company amended the notes to remove the conversion right and extend the due date to June 30, 2013, and to amend the warrants to remove certain anti-dilution provisions. Holders of an aggregate of

$775,000 of principal agreed to such amendments and were granted a warrant to purchase 1,550,000 shares of our common stock equal to two times the principal amount of the note amended, exercisable at $0.50 per share.

The Company evaluated the change in cash flows in connection with the October amendment and determined that there was a greater than 10% change between the present value of the existing debt and the amended debt. As a result, the fair value of the three-year warrants aggregated $140,759 and were recorded as a discount to the modified debt and will be accreted over the remaining term of the modified debt and recognized as interest expense. The accretion of the debt discount on the modified debt amounted to $105,570 for the nine months ended September 30, 2013.

iv. In August 2012, the Company commenced an offering of secured promissory notes for an aggregate principal amount of $3,000,000 with three-year warrants to purchase an aggregate of 6,000,000 shares of the Company’s common stock (two shares for each $1 of the principal amount of the notes purchased) exercisable at $0.50 per share. The notes bear interest at 18% and have various maturity dates beginning March 13, 2013. At the time of any new debt or equity financing by the Company, the principal and interest then due under the notes may be converted into the number of fully paid and non-assessable debt instruments, shares/or units issued in the financing. During year ended December 31, 2012, notes in the aggregate principal amount of $875,000 and warrants to purchase an aggregate of 1,750,000 shares of the Company’s common stock were sold in the offering. In addition, the investment banker who facilitated the sale of the notes and warrants received a three-year warrant to purchase 175,000 shares of the Company’s common stock (10% of the number of shares of common stock issuable upon exercise of the warrants sold in the offering) exercisable at $0.50 per share. The unpaid balance, included accrued interest was $992,801 and $875,000 at September 30, 2013 and December 31, 2012, respectively. The Company is not compliant with the repayment terms of the note.   The conversion price of the note and three-year warrants were not fixed and determinable on the date of issuance and as such in accordance with ASC Topic 815 “Derivatives and Hedging” (“ASC 815”), the embedded conversion options of the note and warrants on the date of issuance were valued using the binomial lattice options pricing model and recorded as derivative liabilities. The fair value of the conversion option and three-year warrants issued in connection with the note on the date of issuance aggregated $499,186, and were recorded as debt discount. The debt discount was amortized through the term of the notes and amounted to $64, 116 for the three months ended September 30, 2012 and $217,535 and $64,116 for the nine months ended September 30, 2013 and September 30, 2012, respectively.

v. During May 2013, the Company issued a $500,000 convertible promissory note with an original issue discount of $50,000. The convertible promissory note is due one year from each advance. After 90 days from each advance, a one-time 12% interest charge shall also be added to note. At any time, the outstanding principle and interest may be converted into fully paid and non-assessable shares of the Company’s common stock. The conversion price shall be 60% of the lowest closing price of the stock for the twenty-five (25) business days preceding the conversion notice. As of December 31, 2013, the Company has been advanced $40,000 on this note. In addition, the agreement requires the Company reserve 28,000,000 shares of the Company’s common stock for issuance upon conversion of the convertible promissory note. The unpaid balance, included accrued interest was $47,445 at September 30, 2013.   The conversion price of the note was not fixed and determinable on the date of issuance and as such in accordance with ASC Topic 815 “Derivatives and Hedging” (“ASC 815”), the embedded conversion options of the note and warrants on the date of issuance were valued using the binomial lattice options pricing model and recorded as derivative liabilities. The fair value of the conversion option issued in connection with the note on the dates of issuance was $61,033, and $40,000 was recorded as a debt discount and the excess balance was booked directly to interest expense. The debt discount was amortized through the term of the notes and amounted to $7,118 and $10,677 for the three and nine months ended September 30, 2013, respectively.

vi. During July 2013, the Company issued a $53,000 convertible promissory note bearing interest at 8% per annum. The convertible promissory note is due on March 10, 2014 and may be converted at any time into fully paid and non-assessable shares of the Company’s common stock. The conversion price shall be 51% of the closing price for the average three lowest trading days during the previous thirty (30) trading days preceding the conversion notice. In addition, the agreement requires the Company reserve 6,500,000 shares of the Company’s common stock for issuance upon full conversion of the convertible promissory note. The unpaid balance, included accrued interest was $54,045 at September 30, 2013.

The conversion price of the note was not fixed and determinable on the date of issuance and as such in accordance with ASC Topic 815 “Derivatives and Hedging” (“ASC 815”), the embedded conversion options of the note on the date of issuance was valued using the binomial lattice options pricing model and recorded as a derivative liability. The fair value of the conversion option issued in connection with the note on the dates of issuance was $68,488, and $53,000 was recorded as a debt discount and the excess balance was booked directly to interest expense. The debt discount was amortized through the term of the notes and amounted to $18,706 for the three and nine months ended September 30, 2013.

During August 2013, the Company issued a $16,500 convertible promissory note bearing interest at 8% per annum. The convertible promissory note is due on May 8, 2014 and may be converted at any time into fully paid and non-assessable shares of the Company’s common stock. The conversion price shall be 51% of the closing price for the average three lowest trading days during the previous ten (10) trading days preceding the conversion notice. In addition, the agreement requires the Company reserve 1,800,000 shares of the Company’s common stock for issuance upon full conversion of the convertible promissory note. The unpaid balance, included accrued interest was $16,699 at September 30, 2013.

The conversion price of the note was not fixed and determinable on the date of issuance and as such in accordance with ASC Topic 815 “Derivatives and Hedging” (“ASC 815”), the embedded conversion options of the note on the date of issuance was valued using the binomial lattice options pricing model and recorded as a derivative liability. The fair value of the conversion option issued in connection with the note on the dates of issuance was $19,734, and $16,500 was recorded as a debt discount and the excess balance was booked directly to interest expense. The debt discount was amortized through the term of the notes and amounted to $3,667 for the three and nine months ended September 30, 2013.

XML

Summary of Significant Accounting Policies

9 Months Ended

Sep. 30, 2013

Accounting Policies [Abstract]

Summary of Significant Accounting Policies

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Development Stage – The Company is considered to be in the development stage as defined in ASC 915, “Accounting and Reporting by Development Stage Enterprises”.

On July 1, 2013, the Company temporarily suspended operations and elected to enter the development stage. All inventories and deposits from the former operations were written off as of July 1, 2013.

Due to unfavorable financing conditions and inability to obtain suitable financing, the Company has determined that it will develop other markets in addition to the organic and Fair Trade certified fruits and vegetables global market.

Basis of Presentation - The Company's unaudited condensed consolidated financial statements have been prepared on an accrual basis of accounting, in conformity with accounting principles generally accepted in the United States of America (US GAAP) for interim financial information applicable for a going concern, which assumes that the Company will realize its assets and discharge its liabilities in the ordinary course of the business, and in accordance with the instructions for Form 10-Q and Article 10 of Regulation S-X promulgated under the Securities Exchange Act of 1934, as amended. Certain information and disclosures included in the financial statements prepared in accordance with US GAAP have been condensed or omitted pursuant to such rules and regulations.

In the opinion of management, the condensed consolidated financial statements contain all material adjustments, consisting

only of normal recurring adjustments necessary to present fairly the financial condition, results of operations, and cash flows of the Company for the interim periods presented.

The results for the three and nine months ended September 30, 2013 are not necessarily indicative of the results of operations for the full year. These financial statements and related footnotes should be read in conjunction with the consolidated financial statements and footnotes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2012 filed with the Securities and Exchange Commission on June 13, 2013.

Use of Estimates - The preparation of consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Significant estimates that are particularly sensitive to change in the near term include, but are not limited to, realization of deferred tax assets, allowance for doubtful accounts, and assumptions used in derivative valuations and share based payment transactions. Actual results could differ from those estimates.

Principles of Consolidation - The consolidated financial statements include the accounts of Organic Alliance, Inc. and its wholly-owned subsidiary, Organic Texas, Inc. (collectively, the “Company”). All significant inter-company transactions and balances have been eliminated in consolidation.

Allowance for Doubtful Accounts - An allowance for uncollectible accounts receivable is recorded based on a combination of aging analysis, past practices and any specific troubled accounts. The Company’s produce is sold to the Company’s customers for cash or on credit terms which are established in accordance with local and industry practices and typically require payment within 10 to 30 days of delivery. Accounts are written off when uncollectibility is confirmed. Subsequent recoveries, if any, are credited to the allowance account. The allowance for doubtful accounts amounted to $7,001 and $5,000 at September 30, 2013 and December 31, 2012, respectively.

In addition, the Company factors its receivables with full recourse and, as a result, accounts for the factoring akin to a secured borrowing, maintaining the gross receivable asset and due to factor liability on its books and records. In connection with the factoring of its receivables, the Company estimates an allowance for factoring fees associated with the collections. These fees range from 3% to 5% depending on the actual timing of the collection. The actual recognition and amount of such fees may differ from the estimates depending upon the timing of collections. The Company has not factored any receivables since May 2013.

Inventory - Inventory is stated at the lower of cost (first-in, first-out) or market. All inventories were written off as of July 1, 2013. At December 31. 2012, inventory included principally produce the Company purchased from growers ($34,547) and packaging materials ($105,341). The Company held $139,888 of inventory as of December 31, 2012.

Income Taxes - The Company uses the asset and liability method of accounting for income taxes in accordance with ASC Topic 740, “Income Taxes”. Under this method, income tax expense is recognized for the amount of (i) taxes payable or refundable for the current year and (ii) deferred tax consequences of temporary differences resulting from matters that have been recognized in an entity’s financial statements or tax returns. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the results of operations in the period that includes the enactment date. A valuation allowance is provided to reduce the deferred tax assets reported if based on the weight of the available positive and negative evidence, it is more likely than not some portion or all of the deferred tax assets will not be realized.

Fair Value of Financial Instruments - The carrying amounts of financial instruments, including cash, receivables, accounts payable and accrued expenses approximated fair value as of the balance sheet dates presented, because of the relatively short maturity dates on these instruments. The carrying amounts of the notes payable issued approximate fair value as of the balance sheet dates presented, because interest rates and other terms on these instruments approximate terms currently available on similar instruments.

Derivative Financial Instruments - The Company does not use derivative instruments to hedge exposures to cash flow, market or foreign currency risks. The Company evaluates all of its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement of the instrument could be required within 12 months of the balance sheet date.

The accounting treatment of derivative financial instruments requires that the Company record the conversion option and related warrants at their fair values as of the inception date of the agreements, and at fair value as of each subsequent balance sheet date. As a result of entering into the convertible notes, the Company is required to classify certain non-employee warrants as derivative liabilities and record them at their fair values at each balance sheet date. Any change in fair value was recorded as a change in the fair value of derivative liabilities for each reporting period at each balance sheet date. The Company reassesses the classification at each balance sheet date. If the classification changes as a result of events during the period, the contract is reclassified as of the date of the event that caused the reclassification.

The fair value of conversion options at a fixed number of shares are recorded using the intrinsic value method. Conversion options at variable rates and any options and warrants with ratchet provisions are deemed to contain a “down-round protection”. Accordingly, they do not meet the scope exception for treatment as a derivative under ASC 815 since “down-round protection” is not an input into the calculation of the fair value of the equity instruments and cannot be considered “indexed to the Company’s own stock”, which is a requirement for the scope exception as outlined under ASC 815.

The Company signed convertible notes and has determined that a conversion option is embedded in the note and it is required to bifurcate the conversion option from the host contract under ASC 815 and account for the derivatives at fair value. The estimated fair value of the conversion option was determined using the binomial model. The fair value of the conversion option will be classified as a liability until the debt is converted by the note holders or paid back by the Company. The fair value will be affected by changes in inputs to that model including our stock price, expected stock price volatility, the contractual term, and the risk-free interest rate. The Company will continue to classify the fair value of the conversion option as a liability until the conversion option is exercised, expires or is amended in a way that would no longer require these conversion options to be classified as a liability, whichever comes first. The Company has adopted a sequencing policy that reclassifies contracts (from equity to assets or liabilities) with the most recent inception date first. Thus any available shares are allocated first to contracts with the most recent inception dates.

For the binomial lattice options pricing model, the Company used the following assumptions and weighted average fair value ranges for the nine months ended September 30:

	2013	2012
Risk-free interest rate	0.02%-0.63%	0.14%-0.31%
Dividend yield	N/A	N/A
Expected volatility	26.4%-48.7%	31.6%-56.0%
Expected life in months and years	3 months – 2.8 years	3 months – 4.3 years

Since the Company’s common is thinly traded, the expected volatility is based on the average historical stock volatility data for three similar public companies over the expected term of the derivative financial instrument.

Revenue Recognition - Revenue is recorded when (1) the customer accepts delivery of the product, title has been transferred, and the Company has no significant obligations remaining to be performed; (2) a final understanding as to specific nature and terms of the agreed upon transaction has occurred; (3) price is fixed and (4) collection is reasonably assured.

Share Based Compensation – The Company accounts for share-based compensation in accordance with the fair value recognition provisions of the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) No. 718. For employees and directors, the fair value of the award is measured on the grant date, and for non-employees the fair value of the award is generally re-measured on interim financial reporting dates until the service period is complete.

Option valuation models require the input of highly subjective assumptions, including the expected life of the option, and such assumptions can materially affect the fair value estimate. The fair value of share-based payment awards was estimated using the Black-Scholes option pricing model. The Company uses historical data to estimate option exercise and employee termination within the valuation model; separate groups of employees that have similar historical exercise behavior are considered separately for valuation purposes. The expected term of options granted is derived from the output of the option valuation model and represents the period of time that options granted are expected to be outstanding. The risk-free interest rate for periods within the contractual life of the option is based on the U.S. Treasury yield curve in effect at the time of grant.

For the Black-Scholes pricing model, the Company used the following assumptions and weighted average fair value ranges for the nine months ended September 30:

	2013	2012
Risk-free interest rate	0.34%-2.54%	0.32%-2.54%
Dividend yield	N/A	N/A
Expected volatility	34.7%-54.2%	36.4%-50.2%
Expected life in years	3-7	2.5-7

Concentrations - The Company maintains cash balances at various high quality federally insured financial institutions, with balances at times, in excess of federally insured limits. Management believes that the financial institutions that hold the Company’s deposits are financially sound and therefore pose a minimum credit risk. The Company has not experienced any losses in such accounts.

The Company had no sales, receivables or purchases during the three months ended September 30, 2013.

Net Loss Per Share - Basic loss per share was computed using the weighted average number of outstanding common shares. Diluted loss per share includes the effect of dilutive common stock equivalents from the assumed exercise of options, warrants and convertible notes. Common stock equivalents were excluded in the computation of diluted loss per share since their inclusion would be anti-dilutive.

In accordance with ASC 260 “Earnings per Share”, the Company has given effect to the issuance of warrants to purchase approximately 1,100,000 shares of the Company’s common stock as of September 30, 2013 and 2012, exercisable at $0.01. These warrants have been included in computing the basic net loss per share for the three and nine months ended September 30, 2013 and 2012. Additionally, included in the Company’s weighted average shares outstanding are 56,189 shares earned, but not issued, as at September 30, 2013 and 2012.

Total common stock equivalents which were excluded (since their inclusion would be anti-dilutive) are those shares issuable upon the exercise of warrants, options and the conversion of convertible notes, as of September 30, 2013 and 2012 were as follows:

	September 30,
	2013		2012
Options		7,717,896		4,455,177
Warrants		14,004,927		9,104,403
Convertible notes (1)		89,155,749		4,938,403
Total Common stock equivalents		110,878,572		18,497,983

Due to the insufficient authorized but unissued shares of common stock to meet the required amount of shares for options, warrants and convertible instruments, the Company has accounted for the excess in common stock equivalents as a derivative liability in accordance with FASB ASC 815 Derivatives and Hedging.  Accordingly, the derivative is marketed to market through earnings at the end of each reporting period.  For the three and nine months ended September 30, 2013 the Company has recorded an expense of $25,047, as a part of the derivative liability on the accompanying condensed balance sheet.

(1) At September 30, 2013, the Company reserved 36,300,000 shares of Common Stock from its authorized shares, which covers 8,442,099 shares of common stock issuable upon conversion of certain convertible notes. The remaining 80,713,650 shares of common stock issuable upon conversion of convertible notes are not covered by reserve shares. There were no reserves shares at September 30, 2012.

Recently Issued Accounting Standards

Management does not believe that any recently issued, but not effective, accounting standards, if currently adopted, would have a material effect on the Company’s financial statements.

XML

Related Party Transactions (Details Narrative) (USD $)	0 Months Ended			1 Months Ended	9 Months Ended
	Jul. 01, 2008	Sep. 30, 2013	Dec. 31, 2012	Feb. 29, 2012 Employee	Sep. 30, 2013 Employee
Monthly Consulting Fees	$ 6,250
Consulting Fees		100,000	100,000
Warrants Issued				300,000
Per Share				$ 0.25
Life				3 years
Stock Based Compensation Expense					$ 6,149

XML

Equity Transactions (Details Narrative) (USD $)	3 Months Ended
	Mar. 31, 2013	Mar. 30, 2013
Equity [Abstract]
Common stock issued for services (in shares)	500,000
Common stock issued for services	$ 55,000
Share price		$ 0.11

XML

Summary of Significant Accounting Policies (Policies)

9 Months Ended

Sep. 30, 2013

Accounting Policies [Abstract]

Development Stage

Development Stage – The Company is considered to be in the development stage as defined in ASC 915, “Accounting and Reporting by Development Stage Enterprises”.

On July 1, 2013, the Company temporarily suspended operations and elected to enter the development stage. All inventories and deposits from the former operations were written off as of July 1, 2013.

Due to unfavorable financing conditions and inability to obtain suitable financing, the Company has determined that it will develop other markets in addition to the organic and Fair Trade certified fruits and vegetables global market.

Basis of Presentation

Basis of Presentation - The Company's unaudited condensed consolidated financial statements have been prepared on an accrual basis of accounting, in conformity with accounting principles generally accepted in the United States of America (US GAAP) for interim financial information applicable for a going concern, which assumes that the Company will realize its assets and discharge its liabilities in the ordinary course of the business, and in accordance with the instructions for Form 10-Q and Article 10 of Regulation S-X promulgated under the Securities Exchange Act of 1934, as amended. Certain information and disclosures included in the financial statements prepared in accordance with US GAAP have been condensed or omitted pursuant to such rules and regulations.

In the opinion of management, the condensed consolidated financial statements contain all material adjustments, consisting

only of normal recurring adjustments necessary to present fairly the financial condition, results of operations, and cash flows of the Company for the interim periods presented.

The results for the three and nine months ended September 30, 2013 are not necessarily indicative of the results of operations for the full year. These financial statements and related footnotes should be read in conjunction with the consolidated financial statements and footnotes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2012 filed with the Securities and Exchange Commission on June 13, 2013.

Use of estimates

Use of Estimates - The preparation of consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Significant estimates that are particularly sensitive to change in the near term include, but are not limited to, realization of deferred tax assets, allowance for doubtful accounts, and assumptions used in derivative valuations and share based payment transactions. Actual results could differ from those estimates.

Principles of Consolidation

Principles of Consolidation - The consolidated financial statements include the accounts of Organic Alliance, Inc. and its wholly-owned subsidiary, Organic Texas, Inc. (collectively, the “Company”). All significant inter-company transactions and balances have been eliminated in consolidation.

Allowance for Doubtful Accounts

Allowance for Doubtful Accounts - An allowance for uncollectible accounts receivable is recorded based on a combination of aging analysis, past practices and any specific troubled accounts. The Company’s produce is sold to the Company’s customers for cash or on credit terms which are established in accordance with local and industry practices and typically require payment within 10 to 30 days of delivery. Accounts are written off when uncollectibility is confirmed. Subsequent recoveries, if any, are credited to the allowance account. The allowance for doubtful accounts amounted to $7,001 and $5,000 at September 30, 2013 and December 31, 2012, respectively.

In addition, the Company factors its receivables with full recourse and, as a result, accounts for the factoring akin to a secured borrowing, maintaining the gross receivable asset and due to factor liability on its books and records. In connection with the factoring of its receivables, the Company estimates an allowance for factoring fees associated with the collections. These fees range from 3% to 5% depending on the actual timing of the collection. The actual recognition and amount of such fees may differ from the estimates depending upon the timing of collections. The Company has not factored any receivables since May 2013.

Inventory

Inventory - Inventory is stated at the lower of cost (first-in, first-out) or market. All inventories were written off as of July 1, 2013. At December 31. 2012, inventory included principally produce the Company purchased from growers ($34,547) and packaging materials ($105,341). The Company held $139,888 of inventory as of December 31, 2012.

Income Tax

Income Taxes - The Company uses the asset and liability method of accounting for income taxes in accordance with ASC Topic 740, “Income Taxes”. Under this method, income tax expense is recognized for the amount of (i) taxes payable or refundable for the current year and (ii) deferred tax consequences of temporary differences resulting from matters that have been recognized in an entity’s financial statements or tax returns. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the results of operations in the period that includes the enactment date. A valuation allowance is provided to reduce the deferred tax assets reported if based on the weight of the available positive and negative evidence, it is more likely than not some portion or all of the deferred tax assets will not be realized.

Fair Value of Financial Instruments

Fair Value of Financial Instruments - The carrying amounts of financial instruments, including cash, receivables, accounts payable and accrued expenses approximated fair value as of the balance sheet dates presented, because of the relatively short maturity dates on these instruments. The carrying amounts of the notes payable issued approximate fair value as of the balance sheet dates presented, because interest rates and other terms on these instruments approximate terms currently available on similar instruments.

Derivative Financial Instruments

Derivative Financial Instruments - The Company does not use derivative instruments to hedge exposures to cash flow, market or foreign currency risks. The Company evaluates all of its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement of the instrument could be required within 12 months of the balance sheet date.

The accounting treatment of derivative financial instruments requires that the Company record the conversion option and related warrants at their fair values as of the inception date of the agreements, and at fair value as of each subsequent balance sheet date. As a result of entering into the convertible notes, the Company is required to classify certain non-employee warrants as derivative liabilities and record them at their fair values at each balance sheet date. Any change in fair value was recorded as a change in the fair value of derivative liabilities for each reporting period at each balance sheet date. The Company reassesses the classification at each balance sheet date. If the classification changes as a result of events during the period, the contract is reclassified as of the date of the event that caused the reclassification.

The fair value of conversion options at a fixed number of shares are recorded using the intrinsic value method. Conversion options at variable rates and any options and warrants with ratchet provisions are deemed to contain a “down-round protection”. Accordingly, they do not meet the scope exception for treatment as a derivative under ASC 815 since “down-round protection” is not an input into the calculation of the fair value of the equity instruments and cannot be considered “indexed to the Company’s own stock”, which is a requirement for the scope exception as outlined under ASC 815.

The Company signed convertible notes and has determined that a conversion option is embedded in the note and it is required to bifurcate the conversion option from the host contract under ASC 815 and account for the derivatives at fair value. The estimated fair value of the conversion option was determined using the binomial model. The fair value of the conversion option will be classified as a liability until the debt is converted by the note holders or paid back by the Company. The fair value will be affected by changes in inputs to that model including our stock price, expected stock price volatility, the contractual term, and the risk-free interest rate. The Company will continue to classify the fair value of the conversion option as a liability until the conversion option is exercised, expires or is amended in a way that would no longer require these conversion options to be classified as a liability, whichever comes first. The Company has adopted a sequencing policy that reclassifies contracts (from equity to assets or liabilities) with the most recent inception date first. Thus any available shares are allocated first to contracts with the most recent inception dates.

For the binomial lattice options pricing model, the Company used the following assumptions and weighted average fair value ranges for the nine months ended September 30:

	2013	2012
Risk-free interest rate	0.02%-0.63%	0.14%-0.31%
Dividend yield	N/A	N/A
Expected volatility	26.4%-48.7%	31.6%-56.0%
Expected life in months and years	3 months – 2.8 years	3 months – 4.3 years

Since the Company’s common is thinly traded, the expected volatility is based on the average historical stock volatility data for three similar public companies over the expected term of the derivative financial instrument.

Revenue Recognition

Revenue Recognition - Revenue is recorded when (1) the customer accepts delivery of the product, title has been transferred, and the Company has no significant obligations remaining to be performed; (2) a final understanding as to specific nature and terms of the agreed upon transaction has occurred; (3) price is fixed and (4) collection is reasonably assured.

Share Based Compensation

Share Based Compensation – The Company accounts for share-based compensation in accordance with the fair value recognition provisions of the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) No. 718. For employees and directors, the fair value of the award is measured on the grant date, and for non-employees the fair value of the award is generally re-measured on interim financial reporting dates until the service period is complete.

Option valuation models require the input of highly subjective assumptions, including the expected life of the option, and such assumptions can materially affect the fair value estimate. The fair value of share-based payment awards was estimated using the Black-Scholes option pricing model. The Company uses historical data to estimate option exercise and employee termination within the valuation model; separate groups of employees that have similar historical exercise behavior are considered separately for valuation purposes. The expected term of options granted is derived from the output of the option valuation model and represents the period of time that options granted are expected to be outstanding. The risk-free interest rate for periods within the contractual life of the option is based on the U.S. Treasury yield curve in effect at the time of grant.

For the Black-Scholes pricing model, the Company used the following assumptions and weighted average fair value ranges for the nine months ended September 30:

	2013	2012
Risk-free interest rate	0.34%-2.54%	0.32%-2.54%
Dividend yield	N/A	N/A
Expected volatility	34.7%-54.2%	36.4%-50.2%
Expected life in years	3-7	2.5-7

Concentration

Concentrations - The Company maintains cash balances at various high quality federally insured financial institutions, with balances at times, in excess of federally insured limits. Management believes that the financial institutions that hold the Company’s deposits are financially sound and therefore pose a minimum credit risk. The Company has not experienced any losses in such accounts.

The Company had no sales, receivables or purchases during the three months ended September 30, 2013.

Net Loss Per Share

Net Loss Per Share - Basic loss per share was computed using the weighted average number of outstanding common shares. Diluted loss per share includes the effect of dilutive common stock equivalents from the assumed exercise of options, warrants and convertible notes. Common stock equivalents were excluded in the computation of diluted loss per share since their inclusion would be anti-dilutive.

In accordance with ASC 260 “Earnings per Share”, the Company has given effect to the issuance of warrants to purchase approximately 1,100,000 shares of the Company’s common stock as of September 30, 2013 and 2012, exercisable at $0.01. These warrants have been included in computing the basic net loss per share for the three and nine months ended September 30, 2013 and 2012. Additionally, included in the Company’s weighted average shares outstanding are 56,189 shares earned, but not issued, as at September 30, 2013 and 2012.

Total common stock equivalents which were excluded (since their inclusion would be anti-dilutive) are those shares issuable upon the exercise of warrants, options and the conversion of convertible notes, as of September 30, 2013 and 2012 were as follows:

	September 30,
	2013		2012
Options		7,717,896		4,455,177
Warrants		14,004,927		9,104,403
Convertible notes (1)		89,155,749		4,938,403
Total Common stock equivalents		110,878,572		18,497,983

Due to the insufficient authorized but unissued shares of common stock to meet the required amount of shares for options, warrants and convertible instruments, the Company has accounted for the excess in common stock equivalents as a derivative liability in accordance with FASB ASC 815 Derivatives and Hedging.  Accordingly, the derivative is marketed to market through earnings at the end of each reporting period.  For the three and nine months ended September 30, 2013 the Company has recorded an expense of $25,047, as a part of the derivative liability on the accompanying condensed balance sheet.

(1) At September 30, 2013, the Company reserved 36,300,000 shares of Common Stock from its authorized shares, which covers 8,442,099 shares of common stock issuable upon conversion of certain convertible notes. The remaining 80,713,650 shares of common stock issuable upon conversion of convertible notes are not covered by reserve shares. There were no reserves shares at September 30, 2012.

Recently Issued Accounting Standards

Recently Issued Accounting Standards

Management does not believe that any recently issued, but not effective, accounting standards, if currently adopted, would have a material effect on the Company’s financial statements.

XML

Related Party Transactions

9 Months Ended

Sep. 30, 2013

Related Party Transactions [Abstract]

Related Party Transactions

10. RELATED PARTY TRANSACTIONS

Consulting Agreement

On July 1, 2008, the Company signed a 16-month consulting agreement with a related party. The consulting services include financial advisory, investment relations and certain administrative and other services for $6,250 monthly fees. At September 30, 2013 and December 31, 2012, the Company owed $100,000 related to above consulting services, which is included in accrued expenses and other current liabilities in the condensed consolidated balance sheets.

Employee Warrants

On February 29, 2012, an employee was granted a three year warrant to purchase 300,000 shares of the Company’s common stock for services rendered. The warrant vested upon grant, and was exercisable at $0.25 per share. The Company recorded a charge for $6,149 to stock based compensation for the nine months ended September 30, 2012.

XML

Fair Value Measures (Tables)

9 Months Ended

Sep. 30, 2013

Fair Value Disclosures [Abstract]

Fair Value Measures on a recurring basis

	Fair Value Measurements
		Level 1		Level 2		Level 3		Total
Derivative liabilities:
September 30, 2013	$	—	$	—	$	1,393,054	$	1,393,054
December 31, 2012	$	—	$	—	$	432,030	$	432,030

Fair value liability on recurring basis

		Nine months Ended September 30, 2013		Year Ended December 31, 2012
Fair value, beginning of period	$	432,030	$	155,813
Derivative liabilities recorded during the period		153,968		1,323,548
Reclassification to equity upon conversion of note		—		(1,787,542	)
Reclassification to equity upon amendment of notes and warrants		—		(1,152,144	)
Net unrealized (gain) loss on derivative financial instruments		807,056		1,892,355
Fair value, end of period	$	1,393,054	$	432,030

XML

Summary of Significant Accounting Policies (Tables)

9 Months Ended

Sep. 30, 2013

Accounting Policies [Abstract]

Binomial lattice options pricing model

	2013	2012
Risk-free interest rate	0.02%-0.63%	0.14%-0.31%
Dividend yield	N/A	N/A
Expected volatility	26.4%-48.7%	31.6%-56.0%
Expected life in months and years	3 months – 2.8 years	3 months – 4.3 years

Share Based Compensation Assumptions

	2013	2012
Risk-free interest rate	0.34%-2.54%	0.32%-2.54%
Dividend yield	N/A	N/A
Expected volatility	34.7%-54.2%	36.4%-50.2%
Expected life in years	3-7	2.5-7

Common Stock Equivalents

	September 30,
	2013		2012
Options		7,717,896		4,455,177
Warrants		14,004,927		9,104,403
Convertible notes (1)		89,155,749		4,938,403
Total Common stock equivalents		110,878,572		18,497,983

XML

Document and Entity Information	9 Months Ended
	Sep. 30, 2013	Dec. 31, 2013
Document And Entity Information
Entity Registrant Name	Organic Alliance, Inc.
Entity Central Index Key	0001442634
Document Type	10-Q
Document Period End Date	Sep. 30, 2013
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Is Entity a Well-known Seasoned Issuer?	No
Is Entity a Voluntary Filer?	No
Is Entity's Reporting Status Current?	Yes
Entity Filer Category	Smaller Reporting Company
Entity Common Stock, Shares Outstanding		18,473,554
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2013

XML

Notes payable, Loans and Derivative Liabilities (Tables)

9 Months Ended

Sep. 30, 2013

Debt Disclosure [Abstract]

Notes payable

	September 30,		December 31,
	2013		2012
	(unaudited)
Notes Payable (net of debt discount $0 and $133,827 at September 30, 2013 and December 31, 2012, respectively) (A)	$	2,995,390	$	2,512,753
Notes Payable – Related Parties (net of debt discount of $0 and $47,673 at September 30, 2013 and December 31, 2012, respectively) (B)		671,257		509,696
Convertible Notes Payable (net of debt discount of $79,298and  $217,535 at September 30, 2013 and at December 31, 2012, respectively) (C)		1,305,610		914,506
Totals	$	4,972,257	$	3,936,955